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Cancer as a chronic disease
The number of people who are confronted with a diagnosis of cancer is increasing 
worldwide (1). In 2018, more than 18 million people received this diagnosis. By 2030, 
the number of people diagnosed with cancer each year is expected to increase to 
26 million (2). Reasons for this increase include aging and the expanding worldwide 
population (1). 
Fortunately, the number of people surviving cancer is also increasing, especially in 
Western countries where survival rates have almost doubled (3, 4). Early detection 
and diagnosis combined with improved anti-cancer treatment have contributed to 
this increase (5). However, surviving cancer may also bring new disabilities into the 
lives of this increasing group of cancer survivors. Cancer is therefore increasingly 
recognized as a chronic disease, with its own rehabilitation challenges (6). 
Psychological distress in cancer 
One of the disabilities a potential life-threatening diagnosis like cancer can bring 
is psychological distress. The National Comprehensive Cancer Network defines 
cancer-related distress as “a multi-determined unpleasant emotional experience 
of a psychological, social and/or spiritual nature that may interfere with the ability 
to cope effectively with cancer” (7). Psychological distress can comprise symptoms 
of depression or anxiety, for instance, fear of the cancer’s recurrence. Research 
showed that as much as one in three or even one in two cancer patients and survivors 
experience significant psychological distress (8-10). This significant psychological 
distress impairs quality of life (QoL) (11) and could require psychological treatment (8). 
Twenty to 80% of cancer patients and survivors with significant psychological distress 
receive a form of psychosocial care (8, 12, 13). Overall, it seems that patients with 
more severe distress symptoms are more likely to receive psychosocial care (13, 14), 
as they are more likely to seek help. However, these studies also show that some 
distressed cancer patients do not receive psychosocial treatment. This may be due 
to a lack of good screening or inadequate referral (15), or because patients do not 
want help, for instance, due to a low impact of the psychological distress symptoms, 
negative attitudes towards help seeking or low expectations regarding intervention 
outcomes (14). However, good screening, which is recommend in the Dutch oncology 
guidelines (www.oncoline.nl) can help determine whether psychological distress is 
present, and can help initiate a conversation between the patient and health care 
provider on the possibilities of psychosocial help. 
If psychosocial help is indicated, evidence-based treatment options should be the 
first to consider. Psychological interventions such as cognitive behavioral therapy 
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Furthermore, there is increasing evidence that mindfulness-based interventions 
(MBIs) are effective in reducing distress in cancer patients as well (18, 19). This thesis 
focuses on these MBIs for cancer patients and survivors. 
An introduction to mindfulness-based interventions 
Mindfulness is commonly defined as a particular kind of attention, that is on purpose, 
in the present moment and without judgment (20). Another well-known definition 
describes mindfulness as “the willingness and capacity to be equally present with 
all events and experiences with discernment, curiosity, and kindness” (21). Some 
people are by nature more mindful than others. In this context, we speak about trait 
mindfulness, or mindfulness skills. If a person practices mindfulness, they can increase 
their state mindfulness, i.e. their mindful attentiveness to the present moment. In 
turn, by practicing state mindfulness, mindfulness skills can be increased (22). These 
mindfulness skills can be helpful in daily life. If people experience negative events, 
internal or external, mindfulness helps to disengage from them. This distance from 
events can help to stop or even prevent automatic, dysfunctional reactions to these 
stressors. Instead, people can deliberately choose a more functional response (23). 
The roots of mindfulness meditation lie in ancient Buddhist traditions. Jon Kabat-Zinn, 
a molecular biologist, extracted mindfulness from its roots, and introduced the first 
mindfulness training in the seventies of the past century, called Mindfulness-Based 
Stress Reduction (MBSR) (24, 25). This training was developed as an outpatient program 
to help patients who had chronic pain and who did not improve or insufficiently 
improved after regular medical care.
MBIs like MBSR usually consist of eight week group programs. Participants in the 
training (usually 8-16) meet weekly for a two to two and a half hour session. In these 
sessions, participants practice with mindfulness meditation, have group discussions, 
and receive psycho-education. The formal mindfulness meditations used in MBSR 
are the bodyscan, sitting meditation and gentle movement exercises. Furthermore, 
informal meditation exercises, like eating or doing daily activities with attention, or 
a three-minute breathing space, are also part of the program. A day of silence is 
scheduled between meeting six and seven. During the day of silence, participants 
are guided through various meditation exercises. Preferably, sessions are delivered 
by a qualified mindfulness trainer who is a (mental) health professional and has 
experience with the target group (26). Daily homework (30-60 min) consisting of 
both meditation and registration exercises is an important part of the program, as 
they help integrate mindfulness into daily life. 
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To date, MBIs have been used to help patients with different mental disorders and/
or somatic diseases, but also for healthy people with stress complaints. Different 
variations of the original program have been developed to fit the needs of the 
various target groups. The most commonly known and used variation of MBSR is 
Mindfulness-Based Cognitive Therapy (MBCT) (27). This program was originally 
developed for patients with recurrent depression. MBCT is largely similar to MBSR 
in content and delivery, but includes more elements derived from cognitive therapy 
(28). These elements focus on teaching participants that their thoughts are simply 
thoughts, and not facts. 
Several large meta-analyses have been conducted on the effectiveness of MBIs. 
Goldberg and colleagues integrated 142 studies with over 12,000 participants with a 
psychiatric disorder (29). They found that overall MBIs were superior to no treatment 
(Cohen’s D = 0.55) and non-specific active controls (D = 0.35), and equivalent 
compared to other evidence-based interventions for psychiatric symptoms directly 
after treatment. At follow-up, similar results were found. A meta-analysis including 
patients with a chronic somatic disease in eight randomized controlled trails found 
that MBIs reduced depression (Hedges’s g = 0.26) and anxiety (Hedges’s g = 0.24) (30). 
Mindfulness-based interventions for cancer patients
MBIs have been increasingly used for cancer patients, in particular to deal with 
psychological distress. The first comprehensive meta-analysis on MBIs for cancer 
patients dates from 2012. This meta-analysis included 22 studies with various 
designs, summarizing data of more than 1400 patients (18). In the 13 included non-
randomized studies, MBIs were associated with reductions in anxiety (Hedges’s 
g = 0.60) and depression (Hedges’s g = 0.42). The 9 randomized trials also showed 
significant reductions in anxiety (Hedges’s g = 0.37) and depression (Hedges’s 
g = 0.44). These results have been replicated by other, more recent meta-analyses, 
most of which focused solely on breast cancer patients (19, 31-33). Thus, MBIs seem 
effective interventions for cancer patients. 
However, previous meta-analyses all have one or more limitations. The most 
comprehensive meta-analysis is outdated (18), since the number of RCTs has almost 
tripled in the past years. Furthermore, the scope of previous meta-analyses is either 
narrow (e.g. MBSR for breast cancer, 34) or broad (e.g. ‘mind-body approaches’, 
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Mechanisms of mindfulness
Studying the mechanisms of change in MBIs is important to understand and optimize 
MBIs (36, 37). Furthermore, increased knowledge on working mechanisms can 
also help to reduce drop-out and non-response. Some meta-analyses have been 
conducted on the mediators of MBIs. Gu and colleagues have looked at the mediators 
of MBCT and MBSR in clinical (somatic and psychiatric) and non-clinical populations 
(38). Their findings combine results of 20 randomized controlled trials. Analyses 
revealed strong and consistent evidence for cognitive and emotional reactivity as 
a mediator. Reactivity can be seen as the extent to which a mild stressor can trigger 
negative thinking (cognitive reactivity) or negative emotions (emotional reactivity) 
(39). MBIs decrease reactivity, which in turn improves psychological outcomes (40). 
Moderate consistent evidence was found for mindfulness skills, rumination and worry 
(38). Increased mindfulness skills were related to improved psychological outcomes. 
Furthermore, MBIs resulted in reduced worry and rumination, which in turn improved 
psychological outcomes. A meta-analysis focusing on mechanisms of mindfulness 
in recurrent depression also reported mindfulness, worry, and rumination as most 
consistent mediators (41). 
The findings described above are in accordance with studies that look at the effects 
of meditation on the brain. Brain areas related to attention, like the anterior and 
mid cingulate cortex, show structural and functional changes that can be related 
to meditation (42, 43). Furthermore, structural changes are found in the pre-frontal 
cortex and body awareness regions when comparing experienced meditators with 
controls, suggesting that meditation is related to increased bodily awareness (44). 
Deactivations are found in the posterior cingulate cortex and inferior parietal lobule, 
which are associated with episodic memory and conceptual processing. This could 
indicate that spontaneous thoughts regarding past or future, such as rumination 
and worry, are reduced (43) and that present-moment awareness is increased (42). 
Finally, brain areas associated with emotion regulation (fronto-limbic networks) 
showed increased activation (42), which corresponds with findings on decreased 
reactivity as a mediator (38). 
Compared to research on effectiveness, research on working mechanisms of MBIs 
for cancer patients is still in its infancy. So far, most empirical evidence is available 
for the mediating role of mindfulness skills. Increases in mindfulness skills due to an 
MBI for cancer patients have been related to reductions in depressive symptoms 
(45), reductions in pain (46), increases in psychological wellbeing (47), and increases 
in spirituality and post-traumatic growth (48). An RCT on a six week MBI compared 
to a waitlist found that decreases in rumination mediated decreases in depressive 
symptoms in cancer patients (45). A non-randomized study in cancer patients 
comparing MBSR with a waitlist found early changes in rumination and worry, prior 
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to changes in other outcomes (49). Finally, reduction in fear of cancer recurrence 
(which can be seen as a cancer-specific form of worry) is also suggested to be a 
relevant moderator (50). 
Although offering interesting insights, most mediation studies, including those 
described above, have an important limitation. They relied on simple mediation 
models that assessed mediators only before and after the MBI, limiting the ability 
to unravel differential relations of mechanisms over time and to determine the 
direction of effects (36). Therefore, some researchers have started to use multiple 
measurements of potential mediators, combined with sophisticated statistical 
techniques to analyze these rich data. 
Dynamic interplay between mindfulness skills and affect
While the most studied mediator of MBIs in cancer patients and other populations 
is mindfulness skills, the most consistent evidence is found for the mediating role of 
emotion (regulation) (38, 41). Emotions and affect may be of special interest for cancer 
patients, as they have lower levels of positive affect compared to their healthy peers 
(51), and because psychological distress often comes with negative affect (52). The 
Mindfulness-to-Meaning theory explains how mindfulness skills and affect co-operate 
(53, 54). Going into a ‘mindful’ state of mind when experiencing a stressor involves 
decentering. Decentering is the process of psychological distancing from negative 
events (55). When decentering from negative events, the attention, which was biased 
towards negative events, can broaden to include all (positive and negative) events. 
This process gives room for increases in positive affect and reductions in negative 
affect. In turn, these increases in positive affect and reductions in negative affect 
help to broaden attention even more, reflecting further increases in mindfulness 
skills. Thus, increases in mindfulness skills are related to increases in positive affect 
and reductions in negative affect, and vice versa. 
Some researchers have studied the dynamic interplay between mindfulness skills and 
affect. Snippe and colleagues looked at day-to-day associations between mindfulness 
and affect during MBSR in individuals from the general population (56). They found 
that day-to-day differences in mindfulness skills were related to differences in both 
positive and negative affect on the subsequent day. They were able to show that 
increased mindfulness predicted increased positive affect and decreased negative 
affect, but not that positive or negative affect predicted mindfulness skills on the 
subsequent day. A study on a mindful walking intervention for mainly depressed 
patients showed that increases in mindfulness skills predicted subsequent increases 
in positive affect and vice versa (57). Furthermore, increases in mindfulness skills 
predicted decreases in negative affect, and vice versa. The dynamic interplay 
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What works for whom? 
Another question that recently received more attention in the field of mindfulness 
for cancer is ‘what works for whom?’. In particular, some studies have tried to gain 
insight into what types of individuals benefit most from an MBI with the aim of 
optimizing intervention outcomes and help the indication process. Usually, these are 
exploratory secondary analyses of randomized controlled trials. One study reported 
that cancer patients high on neuroticism improved substantially more in MBCT or 
internet-based MBCT compared to treatment as usual (58). Another study reported 
that higher levels of attachment avoidance predicted larger effects of MBCT in 
reducing pain intensity in breast cancer patients. However, the general finding from 
these RCTs is that significant intervention moderators are scarce, even though they 
test a large number of demographic, clinical, and psychological variables (58, 59). 
Although these null findings may imply that MBIs work for a large range of cancer 
patients and survivors, we should be careful not to interpret these null findings as 
similarities between different patient groups instead of the absence of differences. 
Besides differences between individuals, many different types of MBIs exist, and 
some are specifically developed for cancer patients (60, 61). A meta-analysis on 
different types of MBIs was conducted in patients with somatization disorders 
(62). The authors found that MBSR and MBCT were more effective than eclectic or 
unspecified MBIs. Furthermore, another meta-analysis showed there is no difference 
between efficacy of MBSR and MBCT in cancer patients (19). Integration of these 
results suggests that MBSR and MBCT, instead of eclectic or unspecified MBIs, are 
the options of choice for cancer patients, but this was never formally tested. 
Besides the differences in the type of MBI, differences in delivery mode exist as 
well. Cancer patients may suffer from fatigue (8, 63) or pain (64, 65) that prevents 
them from participating in a regular group MBI that requires traveling to a fixed 
location at a fixed day and time, and attending lengthy sessions. Researchers have 
therefore started to investigate whether internet-supported MBIs produce similar 
effects as regular, face-to-face group MBIs. Various types of internet-supported 
interventions exist, that differ in their amount and type of therapist guidance, 
that could be synchronous (real-time) or asynchronous (delayed) (66). The terms 
internet- or web-based intervention are used for mostly self-guided intervention 
programs that consist of an online program operated through a website, with or 
without some form of therapist assistance (67). The terms online intervention or 
counseling are reserved for real-time therapist guidance, mostly without the use 
of an online intervention website (67). While both forms reduce travel costs and 
efforts, internet-based interventions have a high flexibility and 24-hour availability 
(68). Participants are able to practice at a location and time of their own choice and 
at their own pace (69).
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Due to these possible benefits, a number of RCTs have been conducted on internet-
supported MBIs in cancer patients. Zernicke, Campbell (70) found that online 
synchronous group mindfulness-based cancer recovery was feasible and reduced 
symptoms of mood disturbance and stress in a randomized pilot study. In an actively 
controlled study, asynchronous guided internet-based MBCT reduced fatigue 
severity (63). A final study found that asynchronous guided internet-based MBCT 
outperformed treatment-as-usual at post-treatment (58). These results fit with the 
results of a meta-analysis on online and internet-based MBIs for improving mental 
health in various populations, which also demonstrated the beneficial effects of 
these interventions (71). 
Internet-based MBIs provide us with new opportunities to study intervention usage. 
Online usage measures include the number of log-ins, the duration of log-ins, and 
activity in the internet-based program, such as completed exercises or the number 
or pattern of mouse clicks (72). These usage measures have the potential to give 
us insight into the processes of change of each individual (73). Furthermore, they 
help to learn what types of patients start with internet-based interventions (uptake), 
and what types of patients complete them (adherence). This information can help 
to optimize the intervention. To date, the literature lacks research on the usage of 
internet-based MBIs in cancer patients. 
Aims of this thesis and outline
The main goal of this thesis is to unravel the effects of mindfulness-based interventions 
for cancer patients. Unravelling effects includes studying the effect size of MBIs in 
this group, but also focusing on potential mediators and moderators of both group 
face-to-face MBCT and individual internet-based MBCT. 
Central research questions within this thesis are: 
• What are the effects of MBIs on psychological distress reduction and other 
outcomes in cancer patients?
• What are the mediators of treatment effects of MBIs for cancer patients?
• What are the potential moderators of treatment effects of MBIs for cancer 
patients?
A meta-analysis was conducted that provides fruitful insights regarding all three 
research questions (Chapter 2). This meta-analysis included RCTs that tested 
the effects of MBIs on psychological distress in cancer patients and survivors. In 
addition, it tested the effects on a range of secondary outcomes. Furthermore, this 
meta-analysis aimed to shed light on potential mediators and, it studied possible 
moderating factors. These included clinical and personality characteristics, but 
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The other studies described in this thesis report secondary analyses of data of 
the BeMind project (74). The BeMind project is a large multicenter RCT (N=245) 
comparing the effects of group face-to-face MBCT and individual internet-based 
MBCT including asynchronous therapist guidance (eMBCT), with usual care on 
psychological distress in distressed cancer patients. The main result of this trial is 
that both MBCT and eMBCT outperform usual care, both in short-term effectiveness 
and cost-effectiveness (58, 75).
In Chapter 3, the long-term effects on the nine month follow-up of the BeMind 
project are reported. Furthermore, this study looked at various potential treatment 
moderators. Potential mediators, namely mindfulness, rumination and fear of 
recurrence, were also studied. 
Chapter 4 focuses specifically on mechanisms of change. Weekly measures of 
mindfulness and positive and negative affect were obtained during MBCT and 
eMBCT. Autoregressive latent trajectory models were used to learn about general 
effects over the course of (e)MBCT, and short-term week-to-week tendencies. 
Chapter 5 targets eMBCT. This study focuses on the usage measures that were 
automatically tracked in eMBCT when participants interacted with the program. This 
study provides insight into the usage of an internet-based intervention like eMBCT, 
and focuses on the prediction of usage and the relationship between intervention 
usage and outcomes. 
The final chapter, Chapter 6, provides a summary of the main findings in this thesis. 
This summary is followed by a general discussion including suggestions for future 
research. Subsequently, strengths and limitations of the current work are outlined. 
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CHAPTER 2: Mindfulness-Based 
Interventions for psychological and 
physical health outcomes in cancer 
patients and -survivors: A systematic 






Objective: Mindfulness-based interventions (MBIs) are increasingly used within psycho-
oncology. Since the publication of the most recent comprehensive meta-analysis on 
MBIs in cancer in 2012, the number of published trials has more than doubled. We 
therefore conducted a systematic review and meta-analysis of randomized controlled 
trials (RCTs), testing the efficacy of MBIs on measures of psychological distress 
(primary outcome) and other health outcomes in cancer patients and -survivors. 
Methods: Two authors conducted independent literature searches in electronic 
databases from first available date to October 10th, 2018, selected eligible studies, 
extracted data for meta-analysis, evaluated risk of bias. 
Results: 29 independent RCTs (reported in 38 papers) with 3274 participants were 
included. Small and statistically significant pooled effects of MBIs on combined 
measures of psychological distress were found at post-intervention (Hedges’s 
g=0.32; 95%CI:0.22-0.41;p<0.001) and follow-up (g=0.19; 95%CI:0.07-0.30;p<0.002). 
Statistically significant effects were also found at either post-intervention or follow-
up for a range of self-reported secondary outcomes, including anxiety, depression, 
fear of cancer recurrence, fatigue, sleep disturbances, and pain (g: 0.20 to 0.51; 
p:<0.001 to 0.047). Larger effects of MBIs on psychological distress were found 
in studies (a) adhering to the original MBI manuals, (b) with younger patients, (c) 
with passive control conditions, and (d) shorter time to follow-up. Improvements in 
mindfulness skills were associated with greater reductions in psychological distress 
at post-intervention. 
Conclusions: MBIs appear efficacious in reducing psychological distress and other 
symptoms in cancer patients and -survivors. However, many of the effects were 
of small magnitude, suggesting a need for intervention optimization research. 
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Background
Approximately 38% of US citizens will be diagnosed with cancer at some point in 
their lives, and the number of cancer survivors increased from 10 million in 2002, to 
14 million in 2012 (1, 2). Furthermore, cancer mortality has steadily declined since 
the late 1980s, e.g., in the EU with reductions of 1.6% per year in men and 1% per 
year in women (3). Increased survival rates bring new rehabilitation challenges, as 
more than one in three cancer patients and -survivors experience significant levels 
of psychological distress (4). The National Comprehensive Cancer Network defines 
distress as a multi-determined unpleasant emotional experience (5). Significant 
psychological distress impairs quality of life(QoL) (6) and requires psychological 
treatment (4), underscoring the need for evidence-based rehabilitation programs (7). 
In the last two decades, mindfulness-based interventions (MBIs) have increasingly 
been used to reduce psychological distress in patients during as well as after cancer 
treatment. 
A meta-analysis from 2012 of the nine RCTs available at the time found that MBIs 
reduced anxiety and depression with effects corresponding to small effect sizes 
(ESs; Hedges’s g: 0.37 and 0.44) (8). These findings have since been supported in 
a number of more recent meta-analyses focusing on depression and anxiety in 
cancer patients(9), primarily patients with breast cancer (10-12). In addition, these 
meta-analyses have found positive effects of MBIs on a range of other cancer-related 
outcomes (10, 12). 
However, while previous meta-analyses on MBIs for cancer patients and -survivors 
have contributed to our current knowledge, some issues remain. First, previous 
meta-analyses have been restricted in their scope by being either relatively narrow, 
e.g., focusing only on effects of mindfulness-based stress reduction (MBSR) in breast 
cancer survivors (13), or very broad, e.g., focusing on “mind-body approaches” (14). 
Second, the majority of previous meta-analyses have only included a small number of 
psychological outcomes (9, 11, 15), although psychological and physical consequences 
of cancer can be multifaceted (16). Third, none of the previous meta-analyses have 
explored the possible moderating role of between-study differences in patient-, 
cancer-, and intervention characteristics, e.g., mindfulness-based cognitive therapy 
(MBCT) versus MBSR or adapted versions like mindfulness-based cancer recovery 
(MBCR) (17). Knowing how between-study differences in such characteristics may 
influence the efficacy of MBIs may inform clinical practice as to “what works for 
whom”. Fourth, information that points to the working mechanisms of MBIs may 
be an important step toward optimization of MBIs (18), and associations between 
changes in possible mediators and effects of MBIs in cancer patients and -survivors 
have not previously been explored in meta-analyses. Finally, the possible associations 
between the quality of the MBIs and their effects in cancer patients and survivors 
have not yet been studied. As the number of RCTs of MBIs in cancer patients and 
survivors has more than doubled since the first comprehensive meta-analysis (8), 
an update is desirable. 
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On this background, we conducted an updated and comprehensive systematic 
review and meta-analysis of the immediate and longer-term effects of MBIs in cancer 
patients and survivors on the primary outcome of psychological distress. Psychological 
distress included various individual measures as well as combinations of anxiety, 
depression, and distress, representing central aspects of the psychological symptom 
cluster identified in this patient group (19). Furthermore, we explored effects on a 
number of secondary outcomes, namely cancer-related QoL and a range of individual 
psychological and physical symptoms commonly experienced by cancer patients 
and survivors, including anxiety, depression, post-traumatic stress symptoms, fear of 
cancer recurrence, pain, fatigue, and sleep disturbances. In addition, we examined 
the possible moderating role of a number of patient-, cancer-, and intervention 
characteristics. Finally, we explored the associations between changes in putative 
MBI mechanisms, including mindfulness skills, self-compassion, and rumination, 
and effects of MBIs on psychological distress.
Methods
The present review was pre-registered with PROSPERO (registration number: 
CRD42018096911) (20) and conducted and reported in accordance with the PRISMA 
guidelines (21, 22). 
Search strategy
Electronic databases (PubMed, Web of Science, PsychINFO and CINAHL) were 
independently searched by two authors (LC and MJ) for publications from first 
available date to October 10th, 2018 with pre-specified search terms to identify RCTs 
of MBIs for cancer patients and survivors. The final search strategy was based on 
the PICO approach (23), combining the following search terms: Population (cancer 
OR neoplasm) AND Intervention (mindful* OR meditation OR MBCT OR MBSR OR 
MBCR) AND Outcome (anxiety OR depression OR depressive OR symptom OR 
fear OR adaptation OR “mental health” OR “psychological distress” OR distress OR 
reaction)(full search string provided in the Supplementary material). No search term 
for Comparison was included as this proved too restrictive. In addition, a backwards 
search (snowballing) was conducted of reference lists from identified reports and 
earlier systematic reviews together with a forward search (citation tracking) until no 
additional relevant reports were found.
Selection procedure and data extraction
Two authors (LC and MJ) independently performed title and abstract screening, 
followed by full-text screening. Inter-rater reliability for full-text screening was 
adequate (agreement=92.6%, kappa=.70). Disagreements were discussed with a 
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Study eligibility was assessed using the PICO approach (23). Population: Adult 
(≥18 years) cancer patients or survivors (any type and stage). Intervention: MBIs 
with mindfulness as the main component, as opposed to being a sub-component 
of a program (e.g., Acceptance and Commitment Therapy) and including formal 
meditation homework. Comparison: RCTs with at least one non-MBI control arm. 
Outcomes: One or more measures of distress, including perceived stress, anxiety, 
depression, and combined measures of distress, e.g., the Hospital Anxiety and 
Depression Scale (HADS) total score (24). If results of the same trial were reported in 
more than one publication, additional publications reporting secondary outcomes 
could be included. Only original research reported in English was included. 
Data were extracted by LC and included: a) study characteristics (publication year, 
study design, type of control group (passive, active, competing), intent-to-treat (ITT) 
analyses (yes, no), and assessment time points); b) patient characteristics (gender, 
age, cancer type, cancer stage, time since diagnosis, symptom levels as study 
inclusion criteria); c) MBI characteristics (number and length of sessions (hours), 
intervention based on mindfulness-based stress reduction (MBSR) or mindfulness-
based cognitive therapy (MBCT), MBI changes/adaptations (minor, major), actual 
home practice (minutes)); and d) self-reported outcomes (psychological distress, PTSD 
symptoms, fear of cancer recurrence, physical symptoms, and cancer-related QoL) 
and hypothesized mediators (mindfulness skills, self-compassion, and rumination). 
Unadjusted means, standard deviations, and number of participants based on the 
ITT sample were extracted. If the data reported were insufficient for meta-analysis, 
authors were contacted and asked to provide these data. As our aim was to evaluate 
the overall efficacy, in case of more than two trial arms (K=5), we included the most 
passive control condition. E.g., if a nutrition intervention and a waitlist were the 
control conditions, the waitlist condition was included as comparison. 
Risk of bias assessment
Risk of bias was assessed by LC and MJ using the Cochrane Risk of Bias Tool (25). This 
tool evaluates risk of bias regarding 1) random sequence generation, 2) allocation 
concealment, 3) blinding of participants and personnel, 4) blinding of outcome 
assessment, 5) incomplete outcome data and 6) selective reporting. Risk of bias 
was rated as low, unclear, or high. 
MBI quality assessment
Two authors (LC and MJ) evaluated MBI quality using five criteria inspired by Shaw 
and colleagues (26). The criteria included: 1) clear description of structure and 
themes of the intervention (1 point) and possible adaptations (1 point) (if the study 
did not involve any adaptations, full points were given); 2) relevant profession of 
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mindfulness instructor (mental health specialist: 1 point); 3) adequate experience 
and training/education of mindfulness instructor (clinical experience: 1 point; 
mindfulness education: 1 point), 4) adherence to intervention protocol (assessed 
adherence: 1 point; adherence reported in the results: 1 point), and 5) assessment 
of teacher competence (assessed competence: 1 point; competence reported in the 
results: 1 point). The total MBI quality score ranged from 0 to 9. Inter-rater reliability 
was good (agreement 87.6%, kappa=0.81).
Quality of evidence assessment
The GRADE system (27) was used to rate the overall quality of evidence of the 
meta-analytic results as high, moderate, low or very low. GRADE assessment goes 
beyond risk of bias, which addresses internal validity of the included studies, as the 
GRADE assessment reflects the general confidence in the overall ES. GRADE uses 
a baseline rating of high for RCTs. This rating can be downgraded based on five 
assessment criteria: risk of bias, inconsistency of the results, indirectness, imprecision, 
and publication bias. The ratings were conducted and negotiated by all authors.
Computing effect sizes
All analyses were performed with Comprehensive Meta-Analysis(28). The primary 
outcome was overall psychological distress, which consisted of measures of perceived 
stress, anxiety, depression, and combined measures of distress, e.g., the Hospital 
Anxiety and Depression Scale (HADS) total score(24). We chose a broad outcome to 
represent the psychological symptom cluster(19) which, in addition, enabled us to 
include more studies and improve the statistical power of moderation analyses. To 
address possible differences between psychological symptoms, we also examined 
anxiety and depression separately as secondary outcomes. Additional secondary 
outcomes were PTSD symptoms, fear of cancer recurrence, fatigue, pain, sleep 
disturbance and QoL. Hedges’s g, a variation of Cohen’s d (29), correcting for possible 
bias due to small sample sizes(30), was used as the standardized ES. Hedges’s g can 
be characterized as small(0.2), medium(0.5) or large(0.8)(29). ESs were calculated 
for pre- to post-treatment and for pre-treatment to the last follow-up. Whenever 
possible, ESs were computed using reported means and standard deviations. If 
these data were unavailable, authors were contacted. If authors did not respond 
or were unable to provide the data, ESs were based on reported ESs or calculated 
based on N and other reported statistics, e.g., p-values, F-values. Pooled ESs were 
weighted by the inverse standard error, taking into account the precision of each 
study, with positive values chosen to indicate effects in the hypothesized direction. 
When multiple outcomes from one study were included in the same analysis, the 
average ES was calculated and weighted by the precision of the individual ESs. As 
differences in ESs can only very rarely be assumed to be purely attributed to sampling 
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Publication bias
The possibility of publication bias was evaluated with funnel plots and Egger’s tests (31, 
32). If the results were suggestive of publication bias, an adjusted ES was calculated 
using the Duval and Tweedie trim-and-fill method (33), which imputes “missing” 
studies and recalculates the ES accordingly. In case of statistically significant results 
(p<0.05), we calculated the failsafe N, i.e., the number of unpublished studies with 
null findings that would reduce the results to statistical non-significance (p>0.05). 
A failsafe N exceeding 5K+10 (K=number of studies) has been suggested to be 
sufficiently robust in the face of possible publication bias (34).
Analytical strategy
Pooled ESs were calculated for the primary outcome, i.e., psychological distress, as 
various combinations of anxiety, depression, and stress measures, as well as for all 
secondary psychological and physical outcomes (see Supplementary material Table 
S1 for included outcomes per study). To satisfy the assumption of independence 
(35), effects were averaged within and across outcomes, so that any given study 
in any given analysis was only represented once in each analysis. The influence of 
possible outliers was explored with sensitivity analyses omitting ESs above or below 
two standard deviations from the pooled ES (36). In addition, the influence of studies 
with online MBIs was examined with sensitivity analyses omitting these studies. 
When available for at least 8 studies per parameter in the analysis, possible moderators 
of the effect on the primary outcome were explored with meta-regression. Categorical 
and continuous moderators related to study design included type of control group 
(passive control, active control, competing intervention), time to post-intervention 
(weeks) and follow-up (months), attrition rates (percentage), risk of bias score, and 
publication year (year). Patient-related moderators included sample mean age (years), 
gender (percent women) and symptom inclusion criteria (yes, no). Cancer-related 
moderators included cancer type (breast, mixed), cancer stage (non-metastatic, 
mixed) and time since diagnosis (months). Intervention-related moderators included 
MBI type (MBSR, MBCT), intervention dose (hours), adaptations from the original 
protocol (minor, major), and MBI quality score. Moderation analyses were based on 
random-effects models and the Maximum Likelihood method. 
Results
In total, 38 research papers describing results of 29 independent RCTs were included. 




The main characteristics of the included studies are presented in Table 1 (for further 
details, see supplementary Table S2. The 29 RCTs included a total of 3274 participants 
with an average study sample size of 117 (range: 16-245). The majority (86%) of 
participants were women, 70% had breast cancer, and sample mean age was 55 
years (range: 46-71). The most common type of MBI was MBSR (K=13, 45%). Interventions 
involved on average 16.6 contact hours (range:4.5-28.5 hours). Mean follow-up time 
was 6.6 months (range 3–24 months) in the 19 studies which included follow-up 
assessment. The outcomes included in each study are shown in supplementary 
Table S1. 
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Table 1. Main characteristics of included studies.
Study (authors + year) Participant characteristics: type of cancer, 
stage of cancer, time since diagnosis, severity 
inclusion criteria
Total n in 
analyses
Intervention and control 
groups(n 1)




Bower et al. 2015 (53); 
Boyle et al. 2017 (54)
Breast; stage 0 to III; 4 years since diagnosis 71 MAPS (39)
WL (32)
Bränström et al. 2010 (55); 
Bränström et al. 2012 (56)
Mixed ,76% breast 71 MBSR (32)
WL (39)
Bruggeman-Everts et al. 
2017 (57)
Mixed, 47% breast; with severe fatigue 84 Online eMBCT (55)
Ambulant activity feedback (62)2
PE emails (50)
Carlson et al. 2013 (58); 
Schellekens et al.2017 (59)





Chambers et al. 2017 (60) Prostate; advanced; 6 years since diagnosis 189 MBCT in teleconference groups 
(94)
Enhanced UC (95)
Compen et al. 2018 (61) Mixed, 62% breast; 4 years since diagnosis; with at 








Garland et al. 2014 (63); 
Garland et al. 2015 (64)
Mixed, 48% breast; non-metastatic; with insomnia 110 MBSR (64)
CBT (47)
Henderson et al. 2012 (65) Breast; stage I or II 114 MBSR (56)
NEP (52)2
UC (58)
Hoffman et al. 2012 (66) Breast; 0 to III; 18 months since diagnosis 214 MBSR (114)
WL (115)
Jang et al. 2016 (37) Breast; 0 to III; treatment less than 2 years ago 24 MBAT (12)
UC WL (12)
Johannsen et al. 2016 (67); 
Johannsen et al. 2018 (68)








Johns, Brown, et al. 2016 
(70); Johns, Von Ah, et al. 
(2016) (71)
Breast (85%) and colorectal; 2.4 years since cancer 
treatment completion; with cancer-related fatigue
71 Tailored MBSR (35)
PE support group (36)
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Abbreviations: MAPS: mindfulness awareness practices; MBAT: mindfulness-based art therapy; MBCR: mindfulness-based 
cancer recovery; MBCT: mindfulness-based cognitive therapy; MBSR: mindfulness-based stress reduction; MBT: mindfulness-
based training; na: not available; NEP: nutrition education program; PE: psycho-education; SMS: stress management seminar; 
UC: usual care; WL: waitlist control group 
1) Sample size represents number of participants randomized to each group. 
2)	 Not	included	in	the	meta-analysis,	due	to	primary	focus	on	efficacy.
3) MBCT and eMBCT were combined for analyses.
4) Not included in meta-analysis due to overlap with mindfulness-based interventions.
Study (authors + year) Participant characteristics: type of cancer, 
stage of cancer, time since diagnosis, severity 
inclusion criteria
Total n in 
analyses
Intervention and control 
groups(n 1)
Kenne Sarenmalm et al. 
2017 (72)
Breast 114 MBSR (62)
MBSR-self-instruct (52)2
No intervention (52)




Lengacher et al. 2016 (74); 
Reich et al. 2017 (19)
Breast; 0 to III; 33 weeks since treatment 332 MBSR(BC) (167)
UC (155)
Lengacher et al. 2009 (75) Breast; stage 0 to III; 19 weeks since treatment 82 MBSR(BC) (41)
WL UC (43)
Lerman et al. 2012 (76) Mixed, 71% breast; 3.8 years since diagnosis 68 MBSR (53)
WL (24)
Monti et al. 2006 (77) Mixed, 46% breast; no terminal patients; beyond 




Monti et al. 2013 (78) Breast; all stages; 34 months since diagnosis 191 MBAT (126)
Support group (125)
Nakamura et al. (2013) (79) Mixed, 54% breast; 42 months since diagnosis; with 
clinically	significant	sleep	disturbance
38 Mindfulness meditation (20)
PE sleephygiene (18)
Mind-body bridging program 
(19)4
Reynolds et al. 2017 (80) Mixed, 40% breast; non-metastatic; 3 months since 
diagnosis
68 Brief MBT (32)
Relaxation (36)
Schellekens et al. 2017 (81) Lung; stage I to IV; 7 months since diagnosis 45 MBSR (31)
UC (32)
Speca et al. 2000 (82) Mixed, 41% breast; stage I to IV; 90 MBCR (53)
WL (37)
Würtzen et al. 2013 (83); 
Würtzen et al. 2015 (84); 
Andersen et al. 2013 (85)
Breast; stage I to III; 8 months since diagnosis 336 MBSR (168)
UC (168)
Zernicke et al. 2014 (86) Mixed, 34% breast; stage I to IV; completed primary 
cancer treatment in last three years; with at least 
moderate distress
62 Online MBCR (30)
WL-UC (32)
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Pooled effects at post-treatment
A forest plot of ESs for psychological distress is shown in Figure 2. As seen in Table 2, 
MBIs had a statistically significant effect on psychological distress at post-treatment 
corresponding to a small ES (Hedges’s g=0.32). In addition, MBIs were found to have 
statistically significant effects on self-reported symptoms of anxiety, depression, fear 
of cancer recurrence, and fatigue with ESs ranging from small to medium (Hedges’s 
g: 0.29-0.51) (Table 2). With the exception of fear of cancer recurrence, the majority of 
the statistically significant results were robust with failsafe Ns exceeding the criterion. 
Figure 2. Forest plot of effect sizes for combined psychological distress outcomes at post-
intervention.
Indications of possible publication bias were found for both the primary outcome 
of combined psychological distress and the secondary outcome of anxiety. When 
adjusting for publication bias, ESs remained statistically significant and were only 
slightly smaller. A sensitivity analysis excluding studies of online MBIs did not 
substantially change the pooled ES for psychological distress. Likewise, omitting 
the outlier ES of one study(37) (Hedges’s g=2.31) did not substantially change the 
results (Hedges’s g=0.29). Heterogeneity was relatively low (38%) for psychological 
distress, and omitting the outlier(37) further reduced heterogeneity to 10% (data 
not shown). As seen in Table 2, heterogeneity of the remaining outcomes varied 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































As seen in Table 3, only two out of the 17 possible moderators, mean sample age 
and type of control group, reached statistical significance at post-intervention. 
Larger ESs were found in studies with younger participants (β=-0.02) and with 
passive (g=0.40) compared to active control groups (g=0.15) (β=0.23) (for detailed 
subgroup analyses, see Supplementary material S3). 
Pooled effects at follow-up
As shown in Table 2, statistical significant pooled effects of MBIs were found for both 
self-reported psychological distress (g=0.19), and for the secondary outcomes of 
depressive symptoms, sleep disturbance, pain, and symptoms of anxiety (g: 0.20-
0.36). Heterogeneity varied from none (pain) to high (fatigue). With the exception of 
anxiety, the failsafe Ns did not exceed the criteria, suggesting less robust findings, 
but there were no indications of publication bias. 
As shown in Table 3, five out of the 16 analyzed moderators reached statistical 
significance at follow-up. The significant moderators were type of control group, 
time to follow-up, ITT analysis, mean sample age, and adaptation of MBI, with 
larger ESs found for studies with passive (g=0.30) vs. active control groups (g=0.01) 
(β=0.29), for studies with shorter time to follow-up (β=-0.02), for studies with no 
ITT analysis (g=0.84) vs. studies with ITT analysis (g=0.14) (β=-0.70), for studies with 
younger samples (β=-0.02), and for studies including none or minor (g=0.25) vs. 
major adaptations of MBI (g=0.05) (β=-0.21) (for results of subgroup analyses, see 
Supplementary material S3).
Exploring possible MBI mechanisms
As seen in Table 2, statistically significant changes were found for all analyzed possible 
mechanisms of change at both post-intervention and follow-up. As indicated by the 
failsafe Ns, the results were less robust. A statistically significant association was 
found between improvements from pre- to post-intervention in mindfulness skills 
and psychological distress (K=17, β=0.49, 95%CI: 0.10-0.89; p=.015). The association 
did not reach statistical significance at follow-up (K=11, β=0.20, 95%CI: -0.35-0.75; 
p=.472). The studies were too few (K< 8) to explore the associations of changes 
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Table 3. Exploring moderators of effects on psychological distress1 at post-intervention and 
follow-up: results of meta-regression.
Moderator (post-intervention)2 K3 Beta4 95% CI p (two-tailed)
Cancer type: Breast (referent: mixed) 27 -0.10 -0.25 – 0.05 0.174
Cancer stage: Non-metastatic (referent: mixed) 24 -0.08 -0.24 – 0.09 0.349
Distress level inclusion criterion (referent: no) 27 -0.02 -0.19 – 0.15 0.818
Control: Passive (referent: active) 25 0.23 0.03 – 0.43 0.027
Intervention adaptation: Major (referent: minor) 28 0.00 -0.15 – 0.15 0.991
Intention to treat: Yes (referent: no) 29 -0.06 -0.29 – 0.17 0.632
Gender (% women) 29 0.00 0.00 – 0.01 0.137
Mean sample age (years) 29 -0.02 -0.03 – -0.00 0.017
Time since cancer diagnosis 12 0.00 -0.01 – 0.00 0.698
Time to post-intervention (weeks) 29 0.00 -0.04 – 0.03 0.794
Intervention dose (total hours intervention) 26 0.01 0.00 – 0.02 0.122
Home practice/day (minutes) 11 0.01 0.00 – 0.03 0.082
Attrition rate at post-intervention (%) 28 0.00 -0.01 – 0.01 0.549
Publication year 29 -0.02 -0.04 – 0.00 0.062
Mindfulness-based intervention quality (range: 0-9) 28 -0.04 -0.10 – 0.02 0.193
Moderator (follow-up)2 K3 Beta4 95% CI p (two-tailed)
Cancer type: Breast (referent: mixed) 16 -0.05 -0.25 – 0.16 0.670
Cancer stage: Non-metastatic (referent: mixed) 16 0.12 -0.09 – 0.32 0.273
Distress level inclusion criterion (referent: no) 16 0.00 -0.22 – 0.23 0.985
Control: Passive (referent: active) 14 0.29 0.06 – 0.52 0.014
Intervention adaptation: Major (referent: minor) 18 -0.21 -0.39 – -0.03 0.024
Intention to treat: Yes (referent: no) 18 -0.70 -1.12 – -0.28 0.001
Gender (% women) 18 0.00 -0.00 – 0.01 0.078
Mean sample age (years) 18 -0.02 -0.03 – 0.00 0.028
Time since cancer diagnosis (months) 8 0.00 -0.01 – 0.00 0.062
Time to follow-up (weeks) 18 -0.02 -0.04 – 0.00 0.046
Intervention dose (total hours intervention) 15 0.00 -0.01 – 0.02 0.662
Attrition rate at follow-up (%) 16 -0.01 -0.02 – 0.00 0.124
Publication year 18 0.01 -0.04 – 0.05 0.778
Mindfulness-based intervention quality (range: 0-9) 18 -0.05 -0.14 – 0.04 0.283
Bold	values	indicate	statistical	significance.	Italicized	values	indicate	marginal	statistical	significance.
1) Primary outcome variable – psychological distress, anxiety, depression.
2)	 Analyses	conducted	when	>	8	studies	available	for	the	analysis.
3) Number of included studies.
4) Maximum Likelihood. 
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Risk of Bias and MBI quality
As shown in Supplementary material Table S4, most included RCTs were categorized 
as being at low risk regarding the domains of randomization sequence generation 
and incomplete outcome data (K=18 (62%) and K=22 (76%) respectively). The risk 
of bias was high or unclear for blinding of participants/personnel and outcome 
assessment in a majority of studies (K=27, 93% and K=20, 67% respectively). Likewise, 
allocation concealment often went unreported (K=16, 55%), and twelve studies (41%) 
were evaluated as being at high risk of bias with respect to selective reporting. 
Concerning MBI study quality, most interventions were well-described (K=28 (97%)) 
and in the majority of studies, mindfulness instructors were reported to be mental 
health professionals (K=21, 72%) (See Table S4). A full description of both education 
and experience of the mindfulness instructors was only found in 11 RCTs (40%), and 
only two studies (7%) provided a full description of adherence to the intervention 
protocol and teacher competency. As shown in Table 3, MBI quality scores were 
unassociated with effects on psychological distress at both post-intervention and 
follow-up.
Overall quality of the evidence
Using GRADE (27), the overall quality of the evidence was rated as moderate, 
suggesting a moderate level of confidence in the effect estimate. The level of 
evidence for RCTs was downgraded from high to moderate due to serious concerns 
regarding inconsistency, i.e., considerable heterogeneity and inability to identify 
the reasons for the heterogeneity. Overall, no serious concerns were found for risk 
of bias, indirectness, imprecision, or publication bias. 
Discussion
The present comprehensive meta-analysis provides updated ES estimates for 
the efficacy of MBIs in cancer patients and -survivors, and is the first to address 
moderators and putative working mechanisms in this group. Our results showed 
small, but robust effects of MBIs in cancer patients and -survivors on psychological 
distress combined as well as individual symptoms of anxiety and depression at post-
intervention. The effect on anxiety at follow-up was robust and of similar magnitude, 
whereas the effects on overall psychological distress and depression were smaller 
and less robust. The results in our updated meta-analysis are generally similar to 
those reported in previous meta-analyses of fewer studies for anxiety (8, 10, 12) and 
depression (8, 12), but smaller than those reported in two previous meta-analyses 
of seven RCTs with usual care or no-intervention control groups (respectively, 
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In addition, MBIs were found to reduce self-reported fear of cancer recurrence 
and fatigue at post-treatment, and pain and sleep disturbance at follow-up, while 
no effects were found for measures of cancer-related QoL or post-traumatic stress 
symptoms. A previous meta-analysis of MBSR and MBCT for breast cancer patients 
did find small but significant effects of these interventions on health-related QoL in 
general (12). Possibly, MBIs target general health-related QoL, and not specifically 
cancer-related QoL. Studies with passive control conditions (compared to active/
competing conditions) and studies with younger participants reported greater 
reductions in psychological distress at post-intervention. At follow-up, larger effects 
were found for MBIs adhering to the original protocols (38, 39) and studies with 
shorter follow-up periods. Changes in mindfulness were related to reductions in 
psychological distress at post-treatment, but not at follow-up. 
Clinical implications
Our estimates of effects were generally of small magnitude. While ESs cannot be 
directly interpreted in terms of clinical relevance, the combined ESs in the literature 
do not appear to reach the threshold of a minimal clinically important effect (40). It 
should be noted here, that the studies included not only passive control conditions, 
but also active controls and competing interventions, which were found associated 
with smaller effects and should be considered when interpreting effects (41). 
Furthermore, despite modest effects, MBIs have previously been found to be cost-
effective (42), easily accessible, and non-pathologizing (43). It should also be noted 
that the theoretical underpinnings of mindfulness suggest that, in addition to symptom 
reduction, MBIs can lead to beneficial effects across various domains, e.g., personal 
growth, healthy lifestyle changes (44). Finally, ESs of MBIs are similar to those found 
for cognitive behavioral therapy (CBT) with breast cancer patients, with CBT being 
the currently most commonly used psychosocial intervention for psychological 
distress in cancer (45). Taken together, MBIs may be relevant treatment options for 
cancer patients and survivors, although direct comparisons of MBIs with, e.g., CBTs, 
are needed for this patient group. This is an important area for future research. 
Our results indicate that time since diagnosis was unrelated to intervention gain 
and that patients with different types and at different stages of cancer may benefit 
from MBIs, which is accordance with previous qualitative research (46). Younger 
patients, on the other hand, appeared to benefit more from MBIs than older 
patients. Considering that participants were relatively young (mean sample age: 
55 years) compared to the general population of cancer patients (median age 66 
years at diagnosis) (2), clinical oncologists are advised that older cancer patients 
may benefit less from MBIs. 
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The guidelines of the National Comprehensive Cancer Network suggest that treatment 
only be offered when distress symptoms are significant (5). These guidelines are 
inconsistent with our results showing that studies which included patients based 
on high baseline symptomatology did not find larger effects of MBIs compared to 
studies that did not. This could, on the other hand, also suggest a possible bias, 
namely that patients willing to participate in RCTs are also those who are likely to 
benefit, even when baseline symptoms are minimal, especially when self-referral 
sampling strategies are used (47). In terms of clinical practice, this could indicate 
that patients with a preference for MBIs are also those who should be referred to 
MBIs, which is in accordance with research suggesting that patients benefit more 
when they receive their preferred treatment (48).
We did not find differences in efficacy between MBSR and MBCT-based interventions, 
suggesting that different types of MBIs may be equally beneficial for cancer patients. 
However, our results also indicate that it may be important to use MBIs that adhere 
strongly to the original MBSR or MBCT protocols (38, 39), as these interventions 
showed larger effects compared to MBIs with major adaptations in duration and 
content. The number of contact hours during the intervention did not fully explain 
the difference in efficacy of MBIs with major versus minor adaptations. Exploring 
MBI quality showed that adherence to the intervention protocol was frequently not 
reported, and monitoring protocol adherence and trainer quality (49) is recommended 
for clinical practice and future research. 
Research implications
GRADE evaluation showed a moderate level of confidence in our effect estimates 
due to some level of heterogeneity, with patient-, cancer- and intervention 
characteristics unable to fully explain this heterogeneity. Other type of moderators, 
e.g., psychological traits, could be relevant to explore in future research aiming to 
optimize intervention gain. The risk of bias assessment also indicated that reporting 
of allocation concealment and blinding of outcome assessors can be improved. In 
addition, most studies failed to assess adverse effects, an issue to be addressed in 
future of MBIs with cancer patients and survivors (50).
Changes in mindfulness skills were associated with post-treatment effects on 
psychological distress, which is in concordance with findings of a meta-analysis 
focusing on mediating mechanisms in a broader sample of participants (51). However, 
we found no associations at follow-up, thus impeding an unambiguous interpretation 
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Study limitations
Among the strengths of the present meta-analysis are its comprehensiveness, 
including the relatively large number of RCTs (K=29) reporting on a broad range 
of cancer-related symptoms and late effects and focusing on both immediate and 
longer-term effects. In addition, to our knowledge, the present meta-analysis is the 
first to explore moderators and putative working mechanisms of MBI in this patient 
group. The primary outcome of psychological distress was broad and included several 
aspects of psychological distress. This can be viewed as a strength, as it enabled 
the inclusion of a large number of studies and represents a common psychological 
symptom cluster in cancer patients and survivors (19). It could, nevertheless, also 
be a potential cause of heterogeneity challenging the interpretability of results. The 
heterogeneity of the results was, however, only medium, and was mainly due to one 
outlier study, and we also analyzed all individual distress outcomes separately. Another 
possible limitation relates to the large number of moderator analyses increasing the 
risk of type-1 error. While we did not adjust for multiple comparisons, as this could 
increase the risk of type-2 error, it is recommended that results are interpreted not 
only according to their statistical significance, but also their ES. 
In conclusion, MBIs appear efficacious in reducing psychological distress and a 
number of other psychological and physical symptoms in cancer patients and 
-survivors, while noting that the effects are generally of small magnitude. Patients 
with different types of cancer at different stages may benefit, and MBIs adhering 
closely to the original protocols (MBSR and MBCT) appear to have larger effects. 
Future research could focus on non-inferiority trials comparing MBI with other 
psychosocial interventions as well as on working mechanisms of MBIs with the aim 
of optimizing treatment effects. Moderation studies are needed to identify for whom 




1. De Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, et al. Cancer survivors in the United States: prevalence 
across the survivorship trajectory and implications for care. Cancer Epidemiology and Prevention Biomarkers. 2013.
2. Noone A, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975-2015, National Cancer 
Institute. Bethesda, MD. 2018.
3. Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005–2009, and an 
overview of trends since 1980. Annals of oncology. 2013;24(10):2657-71.
4. Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, et al. High levels of untreated distress and fatigue in 
cancer patients. British Journal of cancer. 2004;90(12):2297-304.
5. National Comprehensive Cancer Network. Distress management. Clinical practice guidelines. Version 2.2018. NCCN 
Guidelines. 2018.
6. Nayak MG, George A, Vidyasagar MS, Mathew S, Nayak S, Nayak BS, et al. Quality of Life among Cancer Patients. Indian 
Journal of Palliative Care. 2017;23(4):445-50.
7. Weis J. Psychosocial Care for Cancer Patients. Breast Care. 2015;10(2):84-6.
8. Piet J, Wurtzen H, Zachariae R. The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult 
cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol. 2012;80(6):1007-20.
9. Zhang M-F, Wen Y-S, Liu W-Y, Peng L-F, Wu X-D, Liu Q-W. Effectiveness of mindfulness-based therapy for reducing anxiety and 
depression in patients with cancer: a meta-analysis. Medicine. 2015;94(45):e0897.
10. Zhang J, Xu R, Wang B, Wang J. Effects of mindfulness-based therapy for patients with breast cancer: A systematic review 
and meta-analysis. Complementary therapies in medicine. 2016;26:1-10.
11. Cramer H, Lauche R, Paul A, Dobos G. Mindfulness-based stress reduction for breast cancer—a systematic review and meta-
analysis. Current Oncology. 2012;19(5):e343.
12. Haller H, Winkler MM, Klose P, Dobos G, Kümmel S, Cramer H. Mindfulness-based interventions for women with breast 
cancer: an updated systematic review and meta-analysis. Acta Oncologica. 2017;56(12):1665-76.
13.	 Huang	H-p,	He	M,	Wang	H-y,	Zhou	M.	A	meta-analysis	of	 the	benefits	of	mindfulness-based	stress	reduction	(MBSR)	on	
psychological function among breast cancer (BC) survivors. Breast Cancer. 2016;23(4):568-76.
14. Hall DL, Luberto CM, Philpotts LL, Song R, Park ER, Yeh GY. Mind-body interventions for fear of cancer recurrence: A 
systematic review and meta-analysis. Psycho-oncology. 2018;27(11):2546-58.
15.	 Zainal	 NZ,	 Booth	 S,	 Huppert	 FA.	 The	 efficacy	 of	mindfulness-based	 stress	 reduction	 on	mental	 health	 of	 breast	 cancer	
patients: A meta-analysis. Psycho-Oncology. 2013;22(7):1457-65.
16. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 
2008;112(S11):2577-92.
17. Carlson LE, Speca M, Segal Z. Mindfulness-based cancer recovery. Oakland, CA: New Harbinger. 2010.
18. Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol. 2007;3:1-27.
19. Reich RR, Lengacher CA, Alinat CB, Kip KE, Paterson C, Ramesar S, et al. Mindfulness-based stress reduction in post-
treatment breast cancer patients: immediate and sustained effects across multiple symptom clusters. Journal of pain and 
symptom management. 2017;53(1):85-95.
20. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: an international 
prospective register of systematic reviews. Systematic reviews. 2012;1(1):2.
21. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the 
PRISMA statement. PLoS medicine. 2009;6(7):e1000097.
22. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and 
meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews. 2015;4(1):1.
23. Sackett DL. Evidence-based Medicine How to practice and teach EBM: WB Saunders Company; 1997.
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta psychiatrica scandinavica. 1983;67(6):361-70.
25. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk 
of bias in randomised trials. Bmj. 2011;343:d5928.
26. Shaw JM, Sekelja N, Frasca D, Dhillon HM, Price MA. Being mindful of mindfulness interventions in cancer: A systematic 
review of intervention reporting and study methodology. Psycho-oncology. 2018;27(4):1162-71.
27. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality 








Unraveling the effects of Mindfulness-Based Interventions for cancer patients
28. Biostat inc. Comprehensive Meta-Analysis. version 3 2018.
29. Cohen J. Statistical power analysis for the behavioral sciences. 2nd. Hillsdale, NJ: erlbaum; 1988.
30. Hedges L, Olkin I. Statistical Methods for Meta-analysis. New York: Academic Press; 1985.
31. Copas J, Shi JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics. 2000;1(3):247-62.
32. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic 
reviews of diagnostic test accuracy was assessed. Journal of clinical epidemiology. 2005;58(9):882-93.
33.	 Duval	 S,	 Tweedie	 R.	 Trim	 and	 fill:	 a	 simple	 funnel-plot–based	method	 of	 testing	 and	 adjusting	 for	 publication	 bias	 in	
meta-analysis. Biometrics. 2000;56(2):455-63.
34.	 Rosenthal	R.	The	file	drawer	problem	and	tolerance	for	null	results.	Psychological	bulletin.	1979;86(3):638.
35. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to meta-analysis: John Wiley & Sons; 2011.
36. Lipsey MW, Wilson DB. Practical meta-analysis: Sage Publications, Inc; 2001.
37.	 Jang	S-H,	Kang	S-Y,	Lee	H-J,	 Lee	S-Y.	Beneficial	effect	of	mindfulness-based	art	 therapy	 in	patients	with	breast	 cancer—a	
randomized controlled trial. Explore: The Journal of Science and Healing. 2016;12(5):333-40.
38. Kabat-Zinn J, Hanh TN. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness: 
Delta; 2009.
39. Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression. New York: Guilford Press; 2013.
40. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality 
of half a standard deviation. Medical care. 2003:582-92.
41. Rosenkranz MA, Dunne JD, Davidson RJ. The Next Generation of Mindfulness-Based Intervention Research: What have we 
learned and where are we headed? Current Opinion in Psychology. 2019.
42. Compen F, Adang E, Bisseling E, van der Lee M, Speckens A. Cost-utility of individual internet-based and face-to-face 
Mindfulness-Based Cognitive Therapy compared to Treatment As Usual in reducing psychological distress in cancer 
patients. Psycho-Oncology. 2020; 29(2): 294-303.
43. Monteiro LM, Compson JF, Musten F. Practitioner’s Guide to Ethics and Mindfulness-Based Interventions: Springer; 2017.
44. Ludwig DS, Kabat-Zinn J. Mindfulness in medicine. Jama. 2008;300(11):1350-2.
45. Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-
analysis. Journal of behavioral medicine. 2006;29(1):17-27.
46. Bisseling EM, Schellekens MP, Jansen ET, van Laarhoven HW, Prins JB, Speckens AE. Mindfulness-based stress reduction 
for breast cancer patients: a mixed method study on what patients experience as a suitable stage to participate. Supportive 
Care in Cancer. 2017;25(10):3067-74.
47. Thewes B, Rietjens JA, van den Berg SW, Compen FR, Abrahams H, Poort H, et al. One way or another: The opportunities 
and pitfalls of self-referral and consecutive sampling as recruitment strategies for psycho-oncology intervention trials. 
Psycho-Oncology. 2018.
48. Carlson LE, Tamagawa R, Stephen J, Doll R, Faris P, Dirkse D, et al. Tailoring mind-body therapies to individual needs: 
patients’ program preference and psychological traits as moderators of the effects of mindfulness-based cancer recovery and 
supportive-expressive therapy in distressed breast cancer survivors. Journal of the National Cancer Institute Monographs. 
2014;2014(50):308-14.
49. Crane RS, Eames C, Kuyken W, Hastings RP, Williams JMG, Bartley T, et al. Development and validation of the mindfulness-
based interventions–teaching assessment criteria (MBI: TAC). Assessment. 2013;20(6):681-8.
50. Baer R, Crane C, Miller E, Kuyken W. Doing no harm in mindfulness-based programs: Conceptual issues and empirical 
findings.	Clinical	Psychology	Review.	2019.
51. Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction 
improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clinical Psychology 
Review. 2015;37:1-12.
52. Blaes AH, Fenner D, Bachanova V, Torkelson C, Geller M, Haddad T, et al. Mindfulness-based cancer recovery in survivors 
recovering from chemotherapy and radiation. Journal of Community and Supportive Oncology. 2016;14(8):351-8.
53. Bower JE, Crosswell AD, Stanton AL, Crespi CM, Winston D, Arevalo J, et al. Mindfulness meditation for younger breast 
cancer survivors: a randomized controlled trial. Cancer. 2015;121(8):1231-40.
54. Boyle CC, Stanton AL, Ganz PA, Crespi CM, Bower JE. Improvements in emotion regulation following mindfulness 
meditation: Effects on depressive symptoms and perceived stress in younger breast cancer survivors. Journal of consulting 
and clinical psychology. 2017;85(4):397.
46
Chapter 2 
55. Bränström R, Kvillemo P, Brandberg Y, Moskowitz JT. Self-report mindfulness as a mediator of psychological well-being in a 
stress reduction intervention for cancer patients—A randomized study. Annals of behavioral medicine. 2010;39(2):151-61.
56. Bränström R, Kvillemo P, Moskowitz JT. A randomized study of the effects of mindfulness training on psychological well-
being and symptoms of stress in patients treated for cancer at 6-month follow-up. International journal of behavioral 
medicine. 2012;19(4):535-42.
57. Bruggeman-Everts FZ, Wolvers MD, van de Schoot R, Vollenbroek-Hutten MM, Van der Lee ML. Effectiveness of Two Web-
Based Interventions for Chronic Cancer-Related Fatigue Compared to an Active Control Condition: Results of the “Fitter na 
kanker” Randomized Controlled Trial. Journal of Medical Internet Research. 2017;19(10):e336.
58. Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E, et al. Randomized controlled trial of mindfulness-based 
cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer. J Clin Oncol. 
2013;31(25):3119-26.
59. Schellekens MP, Tamagawa R, Labelle LE, Speca M, Stephen J, Drysdale E, et al. Mindfulness-Based Cancer Recovery (MBCR) 
versus Supportive Expressive Group Therapy (SET) for distressed breast cancer survivors: evaluating mindfulness and social 
support as mediators. Journal of behavioral medicine. 2017;40(3):414-22.
60. Chambers SK, Occhipinti S, Foley E, Clutton S, Legg M, Berry M, et al. Mindfulness-based cognitive therapy in advanced 
prostate cancer: a randomized controlled trial. Journal of Clinical Oncology. 2017;35(3):291-7.
61. Compen F, Bisseling E, Schellekens M, Donders A, Carlson L, Van der Lee M, et al. Face-to-Face and Internet-Based 
Mindfulness-Based Cognitive Therapy Compared With Treatment as Usual in Reducing Psychological Distress in Patients 
With Cancer: A Multicenter Randomized Controlled Trial. Journal of Clinical Oncology. 2018;36(23):2413-21.
62. Foley E, Baillie A, Huxter M, Price M, Sinclair E. Mindfulness-based cognitive therapy for individuals whose lives have been 
affected by cancer: a randomized controlled trial. Journal of consulting and clinical psychology. 2010;78(1):72.
63. Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS. Mindfulness-based stress reduction compared 
with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, 
noninferiority trial. Journal of Clinical Oncology. 2014;32(5):449-57.
64. Garland SN, Rouleau CR, Campbell T, Samuels C, Carlson LE. The comparative impact of mindfulness-based cancer recovery 
(MBCR) and cognitive behavior therapy for insomnia (CBT-I) on sleep and mindfulness in cancer patients. Explore: The 
Journal of Science and Healing. 2015;11(6):445-54.
65. Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hébert JR. The effects of mindfulness-based stress reduction on 
psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast cancer research 
and treatment. 2012;131(1):99-109.
66. Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. Effectiveness of mindfulness-based stress 
reduction in mood, breast-and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, 
controlled trial. J Clin Oncol. 2012;30(12):1335-42.
67.	 Johannsen	M,	O’Connor	M,	O’Toole	MS,	Jensen	AB,	Højris	I,	Zachariae	R.	Efficacy	of	mindfulness-based	cognitive	therapy	
on late post-treatment pain in women treated for primary breast cancer: a randomized controlled trial. Journal of clinical 
oncology. 2016;34(28):3390-9.
68. Johannsen M, O’Connor M, O’Toole MS, Jensen AB, Zachariae R. Mindfulness-based Cognitive Therapy and Persistent 
Pain in Women Treated for Primary Breast Cancer: Exploring Possible Statistical Mediators Results From a Randomized 
Controlled Trial. The Clinical journal of pain. 2018;34(1):59-67.
69. Johns SA, Brown LF, Beck-Coon K, Monahan PO, Tong Y, Kroenke K. Randomized controlled pilot study of mindfulness-based 
stress reduction for persistently fatigued cancer survivors. Psycho-Oncology. 2015;24(8):885-93.
70. Johns SA, Brown LF, Beck-Coon K, Talib TL, Monahan PO, Giesler RB, et al. Randomized controlled pilot trial of mindfulness-
based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer 
survivors. Supportive care in cancer. 2016;24(10):4085-96.
71. Johns SA, Von Ah D, Brown LF, Beck-Coon K, Talib TL, Alyea JM, et al. Randomized controlled pilot trial of mindfulness-based 
stress reduction for breast and colorectal cancer survivors: effects on cancer-related cognitive impairment. Journal of Cancer 
Survivorship. 2016;10(3):437-48.
72.	 Kenne	Sarenmalm	E,	Mårtensson	LB,	Andersson	BA,	Karlsson	P,	Bergh	I.	Mindfulness	and	its	efficacy	for	psychological	and	
biological responses in women with breast cancer. Cancer medicine. 2017;6(5):1108-22.
73. Kingston T, Collier S, Hevey D, McCormick M, Besani C, Cooney J, et al. Mindfulness-based cognitive therapy for psycho-
oncology patients: an exploratory study. Irish Journal of Psychological Medicine. 2015;32(3):265-74.
74. Lengacher CA, Reich RR, Paterson CL, Ramesar S, Park JY, Alinat C, et al. Examination of broad symptom improvement 









Unraveling the effects of Mindfulness-Based Interventions for cancer patients
75. Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, et al. Randomized controlled trial of 
mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology. 2009;18(12):1261-72.
76. Lerman R, Jarski R, Rea H, Gellish R, Vicini F. Improving symptoms and quality of life of female cancer survivors: a 
randomized controlled study. Annals of Surgical Oncology. 2012;19(2):373-8.
77. Monti DA, Peterson C, Kunkel EJS, Hauck WW, Pequignot E, Rhodes L, et al. A randomized, controlled trial of 
mindfulness-based art therapy (MBAT) for women with cancer. Psycho-Oncology: Journal of the Psychological, Social and 
Behavioral Dimensions of Cancer. 2006;15(5):363-73.
78.	 Monti	 DA,	 Kash	 KM,	 Kunkel	 EJ,	 Moss	 A,	 Mathews	 M,	 Brainard	 G,	 et	 al.	 Psychosocial	 benefits	 of	 a	 novel	 mindfulness	
intervention versus standard support in distressed women with breast cancer. Psycho-Oncology. 2013;22(11):2565-75.
79.	 Nakamura	Y,	Lipschitz	DL,	Kuhn	R,	Kinney	AY,	Donaldson	GW.	Investigating	efficacy	of	 two	brief	mind–body	intervention	
programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial. Journal of Cancer 
Survivorship. 2013;7(2):165-82.
80. Reynolds LM, Bissett IP, Porter D, Consedine NS. A brief mindfulness intervention is associated with negative outcomes in a 
randomised controlled trial among chemotherapy patients. Mindfulness. 2017;8(5):1291-303.
81. Schellekens MPJ, Hurk DGM, Prins JB, Donders ART, Molema J, Dekhuijzen R, et al. Mindfulness-based stress reduction 
added to care as usual for lung cancer patients and/or their partners: A multicentre randomized controlled trial. 
Psycho-Oncology. 2017;26(12):2118-26.
82. Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness 
meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med. 
2000;62(5):613-22.
83.	 Würtzen	H,	Dalton	SO,	Elsass	P,	Sumbundu	AD,	Steding-Jensen	M,	Karlsen	RV,	et	al.	Mindfulness	significantly	reduces	self-
reported levels of anxiety and depression: results of a randomised controlled trial among 336 Danish women treated for 
stage I–III breast cancer. European Journal of Cancer. 2013;49(6):1365-73.
84. Würtzen H, Dalton SO, Christensen J, Andersen KK, Elsass P, Flyger HL, et al. Effect of mindfulness-based stress reduction 
on somatic symptoms, distress, mindfulness and spiritual wellbeing in women with breast cancer: Results of a randomized 
controlled trial. Acta Oncologica. 2015;54(5):712-9.
85. Andersen SR, Würtzen H, Steding-Jessen M, Christensen J, Andersen KK, Flyger H, et al. Effect of mindfulness-based 
stress reduction on sleep quality: results of a randomized trial among Danish breast cancer patients. Acta Oncologica. 
2013;52(2):336-44.
86. Zernicke KA, Campbell TS, Speca M, McCabe-Ruff K, Flowers S, Carlson LE. A Randomized Wait-List Controlled Trial of 
Feasibility	 and	 Efficacy	 of	 an	 Online	 Mindfulness-Based	 Cancer	 Recovery	 Program:	 The	 eTherapy	 for	 Cancer	 Applying	
Mindfulness Trial. Psychosom Med. 2014;76(4):257-67.
87. Zhang J-Y, Zhou Y-Q, Feng Z-W, Fan Y-N, Zeng G-C, Wei L-. Randomized controlled trial of mindfulness-based stress reduction 










Unraveling the effects of Mindfulness-Based Interventions for cancer patients
50
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Background: Group face-to-face and individual internet-based mindfulness-based 
cognitive therapy (MBCT and eMBCT) have been demonstrated to reduce psychological 
distress for distressed cancer patients in a randomized controlled trial (RCT). The 
current study focused on the long-term effects of this RCT during the nine month 
follow-up period, and on possible predictors, moderators and working mechanisms. 
Methods: Distressed cancer patients (n = 245) were randomized to MBCT or eMBCT. 
Data were collected at baseline, post-treatment, three and nine month follow-up. Data 
were analyzed with linear mixed effect models and (hierarchical) linear regressions. 
Results: Analyses revealed long-term reductions in psychological distress and 
rumination, and long-term increases in positive mental health and mental health-
related quality of life in both interventions over the course of the nine month follow-up. 
Interestingly, patients reported less psychological distress in the follow-up period 
after eMBCT in comparison to MBCT. Less psychological distress, rumination and 
neuroticism, and more extraversion and agreeableness at baseline predicted less 
psychological distress at the nine month follow-up after both interventions. Less 
mindful and conscientious patients at baseline benefited more from eMBCT than 
from MBCT. Regarding working mechanisms, changes in mindfulness skills, fear 
of cancer recurrence and rumination during both interventions predicted less 
psychological distress at follow-up.
Conclusions: Our findings suggest most improvements in cancer patients increase 
over time after both interventions. Furthermore, patients seemed to benefit more 
from eMBCT than MBCT based on psychological distress levels, especially those 
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Introduction
Cancer is one of the leading causes of morbidity and mortality worldwide, and the 
number of cases is expected to increase by 70% in the upcoming two decades (1). 
Receiving a cancer diagnosis and undergoing cancer treatment have a major 
impact on patients. Not surprisingly, one in three patients experiences significant 
psychological distress (2, 3). Especially anxiety disorders are common in cancer 
survivors, with prevalence rates of almost one in five (4). In turn, psychological distress 
may result in worse outcomes. For instance, anxiety and depression are related to 
lower quality of life in cancer patients (5), and depression might even predict cancer 
progression and mortality (6). 
In recent years, mindfulness-based cognitive therapy (MBCT; 7) has proven to be 
an effective intervention to reduce psychological distress in cancer patients (8-10). 
Mindfulness is defined as ‘paying attention in a particular way: on purpose, in the 
present moment, and non-judgmentally’ (11). MBCT instructs patients in mindfulness 
skills and is usually delivered as an eight week group training, including a so-called 
silent day. 
The classical format of MBCT, with weekly group meetings, poses a number of 
challenges for cancer patients. While often suffering from fatigue (12), cancer 
patients have to travel to the MBCT location on a fixed date and time, resulting in 
little flexibility and travel costs. Internet-based MBCT (eMBCT), on the other hand, 
has a number of benefits, like availability, but also flexibility in time and location 
(13). A small waitlist randomized controlled trial about an online group mindfulness-
based intervention (MBI ) for cancer patients revealed positive effects on stress 
symptoms and mood disturbances (14). Moreover, an active-controlled study showed 
eMBCT could reduce cancer-related fatigue (15). Our research group conducted 
a large randomized controlled trial (the BeMind project) comparing group MBCT 
with individual internet-based MBCT, showing that both types of treatments are 
superior to usual care (16). However, long term effects, predictors/moderators and 
working mechanisms of both MBCT and eMBCT still need to be addressed, which 
is the goal of the current study. 
Long-term effects
In a large meta-analysis, Piet, Wurtzen (8) found small to moderate effects of 
mindfulness-based interventions for cancer patients in the long-term (on average 
six months after the intervention), but concluded this as preliminary evidence, 
due to the small amount of studies that included long-term results. More recent 
randomized controlled trials for breast cancer patients showed that intervention 
effects of mindfulness-based interventions persist, even up to one year after the 




Although MBCT and eMBCT are beneficial for cancer patients in general, not all 
patients respond to these interventions. In order to guide clinical practice, research on 
predictors and moderators is necessary to know what works for whom. Predictors are 
variables that predict outcomes regardless of treatment allocation, while moderators 
are variables that influence the relationship between treatment and outcome, 
answering the question which type of treatment works best for whom (19). In the field 
of MBIs for cancer, a small number of studies focused on identifying predictors and 
moderators of face-to-face MBIs. With regard to the demographic characteristics, 
earlier research showed higher education predicted stronger improvement from 
pre to post treatment, while gender and age did not predict outcomes in MBIs 
for cancer patients (20). Personality aspects (neuroticism, extraversion, openness, 
agreeableness, and conscientiousness) did not moderate treatment outcome of a 
MBI for cancer patients versus supportive expressive therapy (21). Presence of mood 
or anxiety disorders was associated with larger treatment effects in face-to-face 
MBCT in patients with a range of medical and psychiatric conditions (22). Moreover, 
baseline psychological distress and more generally, baseline complaints moderated 
treatment outcome; patients with more severe complaints benefited more from the 
intervention compared to control (21, 23-25). 
Working mechanisms
Another way of advancing treatment research is by gaining a deeper understanding 
of the working mechanism of an intervention. This can help clinicians to identify the 
active component of an intervention and tailor the program accordingly. A small 
number of previous studies focused on this topic in cancer patients. In breast cancer 
patients, fear of cancer recurrence was a mediator for psychological and physical 
outcomes (26). Other studies found rumination and mindfulness skills as mediators 
of disturbed mood in cancer patients (27, 28), although findings seemed mixed (29). 
A large meta-analyses combining psychiatric and medical conditions also found 
rumination and mindfulness skills as mediators of MBIs (30). 
Research questions
The current study reports on the long-term effects of MBCT and eMBCT in cancer 
patients who experience at least mild psychological distress (31). We expected our 
primary outcome (psychological distress) and secondary outcomes (fear of cancer 
recurrence, rumination, positive mental health, health-related quality of life [QoL]) 
to remain stable over the course of the follow-up, without a difference between 
MBCT and eMBCT, as they are similar in content. In addition, we studied prediction 
and moderation of treatment outcome in MBCT versus eMBCT. Potential predictors 
and moderators were gender, age, level of education, work, anticancer treatment 
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psychological distress, fear of cancer recurrence, rumination and mindfulness skills. 
These predictors and moderators were studied exploratory. Finally, the current 
study investigated whether change in fear of cancer recurrence, rumination and 
mindfulness skills over (e)MBCT, could predict psychological distress at the last 
follow-up. We expected that decreases in fear of cancer recurrence and rumination, 
and increases in mindfulness skills during (e)MBCT predict psychological distress 
at the nine-month follow-up. 
Materials and methods
The current study involved the follow-up data from a three-armed, multicenter, 
randomized controlled trail. Participants were randomized into one of three conditions; 
face-to-face group MBCT, individual internet-based MBCT (eMBCT) or treatment 
as usual (TAU). Patients in the TAU condition were randomized to MBCT or eMBCT 
after they had completed the three month TAU period, thus, follow-up data is only 
available for MBCT and eMBCT. Information regarding inclusion of participants and 
content of the intervention is described in the study protocol (31). The study was 
approved by an ethical review board (CMO Arnhem-Nijmegen, registered under 
number 2013/542).
Participants
Participants were recruited through various online (e.g. Facebook) and offline (e.g. 
newspapers) media. Interested patients were directed to a study website, containing 
further information. Inclusion criteria were having any cancer diagnosis; experiencing 
at least mild psychological distress (a score of ≥ 11 on the Hospital Anxiety and 
Depression Scale (HADS), that patients could fill out on the study website; 32, 33); 
computer literacy and internet access; good command of the Dutch language; and 
willingness to participate in either mindfulness intervention. Potential participants 
could self-enroll for the study if they fulfilled the inclusion criteria, which were verified 
in a face-to-face or telephone interview. Exclusion criteria were severe psychiatric 
morbidity, change in psychotropic medication within three months of baseline, 
and current or previous participation in MBCT or MBSR. More details about the 
recruitment procedure can be found elsewhere (31). 
Procedure
Patients eligible for the study were randomized to one of the three arms: MBCT, 
eMBCT or TAU. Patients in the TAU condition were randomized to the MBCT or eMBCT 
after a three month period. Participants filled out questionnaires after randomization 
(baseline, T0), directly after the intervention (T1), and at three month (T2) and nine 
month (T3) follow-up. Participants in TAU completed an additional assessment (T0b) 




The content of the MBCT and eMBCT was similar, and based on the MBCT program 
of Segal, Williams (34). Minor adaptations were made to the program to suit the 
needs of cancer patients, in terms of psycho-education (e.g. about cancer-related 
fatigue) and movement exercises (e.g. suitable for patients with edema). In each 
MBCT group, a maximum of 12 patients participated. For eight weeks, patients had 
weekly 2.5 hour sessions, and they were requested to practice at home on a daily 
basis (45 minutes a day, six days a week). Between session six and seven, there was a 
silent day. For eMBCT, each participant was provided with information and exercises 
through a personal, secure webpage containing material for the eight sessions and 
the silent day. Participants were encouraged to read the information and do the 
exercises of a session within one week. Participants reflected on their experiences 
by keeping a personal log. The therapist assigned to the participant gave weekly 
written feedback based on this log on a set day of the week through a secured, 
integrated e-mail system, guiding the patient through the program. Therapists 
could encourage patients and answer their questions, they could ask questions to 
deepen understanding of patients, and help patients overcome the obstacles they 
encountered, through the e-mails. Different themes could be discussed, for example 
growing awareness about automatic tendencies like perfectionism, or resistance 
to feel an unpleasant sensation like a headache. Therapists could spent 30 minutes 
per patient per week on feedback in eMBCT. 
Both MBCT and eMBCT were taught by qualified mindfulness therapists, according 
to the criteria of the UK Mindfulness-Based Teacher Network (35). Seven therapists 
provided both interventions, two provided only MBCT and five provided only eMBCT. 
All therapists attended three full-day supervision meetings. MBCT sessions were 
videotaped to rate therapist competency with the Mindfulness-Based Interventions – 
Teachers Assessment Criteria (MBI-TAC; 36) by two independent therapists (interrater-
reliablity was .72). Randomly, two sessions of each of the nine MBCT therapists were 
rated; four were considered proficient (n = 64 patients), three competent (n = 64 
patients) and two beginner (n = 7 patients).
Materials
Outcome measures
The primary outcome measure was psychological distress, measured with the 14-item 
Hospital Anxiety and Depression Scale (HADS), developed to measure depression 
and anxiety (32, 33). The HADS has adequate psychometric properties to detect 
distress in cancer patients and is a suitable screening instrument for psychiatric 
disorders in this group (37, 38). Internal consistency in the present study was good 
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The secondary outcome measures were fear of cancer recurrence, rumination, 
positive mental health and health-related quality of life. Fear of cancer recurrence 
was measured with the 9-item Severity subscale of the Fear of Cancer Recurrence 
Inventory (FCRI; 39, 40). Internal consistency was good (α = .85). Rumination was 
measured with the 12-item rumination subscale of the Rumination and Reflection 
Questionnaire (RRQ; 41). Internal consistency was excellent (α = .91). Positive mental 
health was measured with the 14-item Mental Health Continuum-Short Form (MHC-
SF; 42, 43). Internal consistency was excellent (α = .92). Health-related QoL was 
measured with the 12-item Short Form-12 (SF-12; 44). Clinical Dutch norms were 
used to calculate two subscales, physical and mental health-related QoL (45). 
Predictors/moderators
Tested predictors/moderators were gender, age, education level, work, anticancer 
treatment intent, presence of depressive and/or anxiety disorder, personality, baseline 
psychological distress, fear of cancer recurrence, rumination and mindfulness skills. 
Sociodemographic and clinical characteristics were assessed via a self-report 
questionnaire. 
Presence of a depressive or anxiety disorder (according to DSM-IV) was assessed 
with the relevant sections of the Structural Clinical Interview for DSM-IV disorders 
(SCID-I; 46). The SCID-I was administered by trained interviewers. Personality was 
assessed with the NEO Five Factor Inventory (NEO-FFI; 47). This 60-item self-report 
questionnaire measures five personality characteristics; openness to experiences, 
conscientiousness, extraversion, agreeableness and neuroticism. Mindfulness skills 
were measured with the Five Facet Mindfulness Questionnaire Short Form (FFMQ-
SF), a 24-item self-report questionnaire (48). Internal consistency was good (α = .85). 
Working mechanisms
Tested working mechanisms were fear of cancer recurrence (FCRI), rumination (RRQ) 
and mindfulness skills (FFMQ) (measures described above). 
Statistical analyses
To facilitate transparency, the data-analysis plan was pre-registered online at Open 
Science Framework (https://osf.io/v9ud8/). Adaptations to the analysis plan were 
tracked. All analysis were conducted in SPSS version 22 (49). The mean percentage 
of missing data for the follow-up assessments of our primary outcome, combining 
both interventions and TAU, varied between 25 and 30% (see Figure 1 for a flowchart). 
Participants that missed T3 (primary outcome) had less positive mental health and 
more fear of cancer recurrence, rumination and neuroticism at T0 and they were 
more likely to be females. Therefore, we assumed data were not missing completely 
at random, but missing at random (MAR), allowing procedures to handle missing 
data, described below. For the TAU group, T0 scores on the primary and secondary 
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outcome measures were replaced with T0b (post-TAU) scores, as those were closer 
in time to the start of the intervention. These scores did not differ from T0 of the 
original MBCT and eMBCT group. In all analyses, data of patients that followed (e)
MBCT after TAU were combined with data of patients that were initially randomized 
to (e)MBCT. 
Long-term effects
To examine long-terms effects, we used linear mixed effect models with the 
primary outcome or secondary outcomes at T1, T2 and T3 as dependent variable. 
Independent variables were time (nested in individuals), intervention (MBCT/eMBCT), 
their interaction and the baseline measure (T0) of the outcome. Visual inspection of 
residual plots revealed linear relationships between time and outcomes, allowing 
us to treat time as covariate, to draw conclusions regarding general increases and 
decreases of outcomes over time. In case of a non-significant interaction, the model 
was rerun without the interaction. Random intercepts for participants were added. 
A heterogeneous first-order autoregressive (ARH(1)) covariance structure was used, 
which assumes measurements closer in time are more strongly related. Restricted 
maximum likelihood was used as estimation method, to handle missing data (50). 
In case of a significant difference between interventions, effect sizes (Cohen’s d) 
were calculated with the difference between the estimated marginal means of the 
interventions, corrected for T0, divided by the pooled baseline standard deviation, 
following the guidelines of Cohen (51). 
Prediction/moderation
To examine prediction, we conducted separate linear regression models. Psychological 
distress at T3 acted as dependent variable. Independent variables were the baseline 
level of psychological distress, intervention (MBCT/eMBCT) and the baseline 
characteristic (testing prediction). To test moderation, we used the same model, 
but added the interaction between the baseline characteristic and the intervention. 
As these analyses were exploratory, an alpha level of .05 was used. Analyses were 
run on the completer data, and on imputed data, as sensitivity analysis. Missing 
data were imputed with the Fully Conditional Specification method, based on all 
variables included in the models, and the stratification variables (gender, location, 
treatment intention, breast cancer yes/no). Following guidelines of White, Royston 
(52), 30 imputed datasets were created, representing the maximum % of missing data.
Working mechanisms
To examine working mechanisms, data from participants that completed four or 
more sessions were included. Residual change scores of fear of cancer recurrence, 
rumination and mindfulness skills from T0 to T1 were calculated. Next, separate 
hierarchical linear regression models were run. Step 1 was identical for the three 
regressions, and included baseline psychological distress and intervention (MBCT/
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in the model. Psychological distress at T3 acted as dependent variable. Analyses 
were run on the completer data, and on imputed data, as sensitivity analysis. Missing 
data were imputed following the same procedure as described above.
Figure 1. Flowchart indicating randomization, completion of interventions and assessments 
(based on the primary outcome). 
1 Completed at least four sessions.  




The final sample consisted of 245 cancer patients with at least mild psychological 
distress (HADS ≥ 11). Baseline characteristics can be found in Table 1. No baseline 
differences were found between participants in eMBCT and MBCT, except for 
mindfulness skills, with significantly higher levels of mindfulness skills in eMBCT. 
Table 1. Sample characteristics per intervention (MBCT/eMBCT) at T0. 
MBCT (n=120) eMBCT (n=125) Test-statistic  
(t or X2)
p







Age in years (M; SD) 51.5 (11.1) 51.8 (10.2) -.18 .857





















Depressive and/or anxiety 
disorder (n, %)
35 (29.2%) 34 (27.2%) .12 .732
Psychological distress HADS 
(M; SD)
18.2 (6.7) 16.8 (6.9) 1.64 .103
Fear of cancer recurrence severity 
FRCI (M; SD)
21.2 (6.6) 21.1 (6.3) .04 .970
Rumination RRQ (M; SD) 43.6 (8.2) 42.4 (8.4) 1.16 .247
Mindfulness FFMQ-SF (M; SD) 73.5 (10.4) 77.1 (11.2) -2.55 .011
Note. Both categories include the patients that were initially randomized to the TAU group. 
Long-term effects
The results of the linear mixed effect models regarding the long-term effects of 
MBCT and eMBCT on the primary and secondary outcomes can be found in Table 2. 
None of the time x intervention interactions were significant, therefore, these were 
excluded from the models. In contrast to our expectations, rather than remaining 
stable, the level of psychological distress further decreased over the course of the 
follow-up in both interventions. Furthermore, participants in eMBCT reported less 
psychological distress during the follow-up period compared to participants in 
MBCT. The effect size for the difference between groups at T3, corrected for T0, 
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Table 2. Descriptive statistics and effects of time, intervention and baseline on primary and 
secondary outcomes in separate linear mixed effect models. 
Descriptive statistics 
M (SD)
Results linear mixed models
MBCT eMBCT F df p
Primary outcome:
Psychological distress (HADS) T1 13.5 (6.5) 11.6 (6.2) T0 HADS 130.2 1, 199 <.001
T2 12.9 (7.2) 11.1 (7.0) Time 14.3 1, 178 <.001
T3 12.6 (6.7) 9.6 (6.4) Intervention 3.9 1, 201 .049
Secondary outcomes:
Fear of cancer 
recurrence severity (FCRI - severity)
T1 17.9 (6.7) 17.0 (7.5) T0 FCRI 272.0 1, 196 <.001
T2 16.7 (5.4) 16.3 (5.5) Time 1.2 1, 157 .282
T3 17.3 (6.4) 16.3 (6.7) Intervention 1.6 1, 191 .201
Rumination (RRQ – rumination) T1 37.9 (8.6) 36.0 (8.9) T0 RRQ - rum 146.4 1, 190 <.001
T2 37.3 (7.6) 35.4 (8.3) Time 38.4 1,185 <.001
T3 34.6 (5.8) 33.9 (6.1) Intervention .5 1, 194 .489
Positive mental health (MHC-SF) T1 40.1 (12.9) 43.4 (13.2) T0 MHC-SF 191.9 1, 195 <.001
T2 39.7 (13.7) 46.2 (11.8) Time 21.7 1, 169 <.001
T3 43.6 (13.7) 48.3 (12.2) Intervention 2.7 1, 190 .101
Physical health-related QoL (SF-12 
PCS)
T1 48.5 (8.2) 47.8 (10.1) T0 SF-12 PCS 76.7 1, 198 <.001
T2 47.2 (9.2) 47.5 (9.3) Time 0 1, 177 .995
T3 48.3 (9.4) 47.8 (10.5) Intervention .3 1, 192 .610
Mental health-related QoL (SF-12 
MCS)
T1 42.6 (10.2) 43.8 (10.6) T0 SF-12 MCS 52.9 1, 191 <.001
T2 45.4 (11.0) 47.0 (11.8) Time 25.5 1, 172 <.001
T3 46.5 (11.5) 48.9 (10.6) Intervention 1.8 1, 197 .182
Note: all time x intervention interactions were non-significant, and therefore excluded from the models.  
T1 = post-treatment; T2 = three month follow-up; T3 = nine month follow-up. 
With regard to the secondary outcome measures, rumination significantly decreased 
over the nine month follow-up in both MBCT and eMBCT. Furthermore, positive 
mental health and mental health-related QoL significantly increased over the course 
of the nine month follow-up. Fear of cancer recurrence and physical health-related 
QoL did not significantly change over time. There were no differences between 




Table 3 shows the results of the linear regression models to determine prediction of 
treatment effect. In all analyses, more baseline psychological distress predicted more 
psychological distress at the nine month follow-up. With regard to predictors, baseline 
rumination, extraversion, agreeableness and neuroticism predicted psychological 
distress at the nine month follow-up. More rumination and more neuroticism were 
related to more psychological distress at nine month follow-up. More extraversion 
and more agreeableness were related to less psychological distress at nine month 
follow-up. These results were confirmed with sensitivity analyses on the imputed data. 
No other significant predictors were found. Regarding moderation (Table 4), we found 
that mindfulness skills and conscientiousness moderated the relationship between 
the intervention and psychological distress at nine month follow-up (controlling for 
baseline psychological distress). Patients who were less mindful and conscientious 
at baseline, had lower psychological distress at the nine month follow-up in the 
eMBCT intervention than in the MBCT intervention. This was confirmed in sensitivity 
analyses on the imputed data. No other moderators were found. 
Working mechanisms
Results of the three hierarchical regressions analyses testing working mechanisms 
can be found in Table 5. The residual change scores of fear of cancer recurrence, 
rumination and mindfulness skills all added a significant contribution in step 2. 
A decrease in rumination and fear of cancer recurrence, and an increase in mindfulness 
skills over the course of (e)MBCT predicted lower levels of psychological distress 
at the nine month follow-up. These results were confirmed with sensitivity analyses 
on the imputed data.
Discussion
The current study focused on long-term outcome, prediction, moderation and 
working mechanisms of MBCT and eMBCT for distressed cancer patients. 
Long-term effects
In contrast to our expectations, psychological distress and rumination further 
decreased and positive mental health and mental health related QoL further increased 
over the duration of the follow-up period in both interventions. A few other studies 
on MBIs for cancer patients also reported further improvements over the course of 
follow-up (e.g. 53). It is possible that the cumulative practice of mindfulness resulted 
in increased gains over time. This observation fits with the idea of mindfulness as a 
mental training (54), that keeps improving with practice like a muscle, as suggested 
by Parsons, Crane (55). Fear of cancer recurrence and physical health-related QoL 
did not change over time, suggesting improvements gained during the training 
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Table 3. Relationship between predictor (corrected for baseline psychological distress and 
the main effect of intervention) and psychological distress at the nine month follow-up with 






R2 B t p
Psychological distress (T0) 39.11
(2, 167)
< .001 .311 .51 8.16 <.001
Gender 26.59
(3, 166)
< .001 .312 -1.32 -1.18 .242
Age: younger than 40 years1 21.12
(4, 165)
< .001 .323 -.68 -.50 .616
Age: older than 55 years1 1.74 1.89 .060
Education level (high/low) 26.02
(3, 166)
< .001 .308 -.43 -.45 .653




< .001 .254 -.19 -.16 .870
Anticancer treatment intent 25.93
(3, 166)
< .001 .307 .18 .15 .882
DSM depressive/anxiety disorder 26.10
(3, 166)
< .001 .308 -.64 -.60 .550
Personality – openness 25.95
(3, 166)
< .001 .307 -.02 -.25 .800
Personality – conscientiousness 27.57
(3, 166)
< .001 .320 -.13 -1.84 .068
Personality – extraversion 30.35
(3, 166)
< .001 .343 -.22 -3.01 .003
Personality – agreeableness 31.06
(3, 166)
< .001 .348 -.32 -3.24 .001
Personality – neuroticism 30.30
(3, 166)
< .001 .342 .22 2.99 .003
Fear of cancer recurrence - severity 25.81
(3, 165)
< .001 .307 .02 .29 .773
Rumination 28.39
(3, 165)
< .001 .328 .13 2.32 .022
Mindfulness 26.37
(3, 166)
< .001 .311 -.04 -.96 .338
1 reference category was age 40-55 years
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Table 4. Relationship between moderator (i.e. predictor x intervention interaction; corrected 
for baseline psychological distress and the main effect of intervention) and psychological 






R2 B t p
Psychological distress (T0) 26.36
(3, 166)
< .001 .310 -.12 -.95 .342
Gender 20.61
(4, 165)
< .001 .317 -3.29 -1.46 .148
Age: younger than 40 years1 14.13
(6, 163)
< .001 .318 -2.53 -.93 .357
Age: older than 55 years1 -.82 -.45 .655
Education level (high/low) 19.6
(4, 165)
< .001 .306 1.40 .73 .467




< .001 .254 -2.36 -.98 .328
Anticancer treatment intent 19.34
(4, 165)
< .001 .303 .31 .12 .902
DSM depressive/ anxiety disorder 19.77
(4, 165)
< .001 .308 -1.76 -.92 .357
Personality – openness 19.35
(4, 165)
< .001 .303 -.01 -.06 .953
Personality – conscientiousness 23.07
(4, 165)
< .001 .343 .37 2.60 .010
Personality – extraversion 23.30
(4, 165)
< .001 .345 .18 1.32 .189
Personality – agreeableness 23.15
(4, 165)
< .001 .344 -.01 -.03 .975
Personality – neuroticism 23.35
(4, 165)
< .001 .346 -.16 -1.41 .161
Fear of cancer recurrence - severity 19.25
(4, 164)
< .001 .303 .03 .18 .858
Rumination 22.28
(4, 164)
< .001 .336 -.17 -1.71 .088
Mindfulness 21.15
(4, 165)
< .001 .323 .16 2.01 .046
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Furthermore, eMBCT appeared to be superior to MBCT in the reduction of 
psychological distress during the follow-up period. So far, research has shown online 
and face-to-face interventions to produce similar effects, as is reported in a large 
meta-analysis about the comparison of online and face-to-face cognitive behavioral 
therapy for patients with somatic and psychiatric disorders (56). As MBCT and eMBCT 
were similar in content, the delivery method might explain why eMBCT resulted in 
a greater reduction of psychological distress during the follow-up. From the start 
of the training, participants in eMBCT had to be more autonomous. This autonomy 
might help to form the habit of more actual mindfulness practice (57), which we 
know is related to better treatment outcomes (55). Furthermore, the flexibility allowed 
by eMBCT could result in practice at a time the participant was ready to absorb 
information, which might also support the efficacy of eMBCT. Finally, it is also possible 
that the individual nature of eMBCT, compared to group MBCT, contributed to the 
greater efficacy. The individual attention of a therapist in eMBCT might serve as a 
catalyst for mindfulness practice or might be more compatible with the individual 
needs of the cancer patients.
Table 5. Effects of change in fear of cancer recurrence/rumination/mindfulness (corrected  
for psychological distress at baseline and intervention) on psychological distress at the  
three month follow-up with hierarchical linear regressions (completer data). 
Working mechanism Step
  variable 
F df p ΔR2 B t p
All1 Step 1 29.63 2, 126 < .001 .320
  Psychological distress T0 .49 6.77 < .001
  Intervention (MBCT/eMBCT) -3.44 -3.37 .001
Fear of cancer Step 2 6.42 1, 125 .013 .033
  Residual change score fear 
  of cancer recurrence T0/T1
1.40 2.53 .013
Rumination Step 2 16.13 1, 125 < .001 .078
  Residual change score 
  rumination T0/T1
1.99 4.02 <.001
Mindfulness Step 2 15.47 1, 125 < .001 .075
  Residual change score 
  mindfulness T0/T1
-2.01 -3.93 < .001
Note: Dependent variable: psychological distress at T3. 




Baseline psychological distress, rumination, neuroticism, extraversion and agreeableness 
predicted treatment outcome at nine month follow-up in both eMBCT and MBCT, 
controlled for baseline psychological distress. More baseline psychological distress 
was related to more psychological distress at the nine month follow-up. More 
rumination and neuroticism at baseline were related to more psychological distress 
at the follow-up (even while controlling for baseline psychological distress). Thus, 
while patients improved after the interventions, it seems that patients with more 
severe complaints at the start of the intervention, had higher levels of distress at 
the nine month follow-up compared to their less distressed counterparts. Other 
studies (e.g. 25) also found that patients with more baseline severity had more severe 
complaints at the follow-up (even though more severe patients benefit relatively more 
from MBIs compared to less severe patients). Booster sessions might be indicated 
for this subgroup of patients.
More extraversion and agreeableness predicted less psychological distress at nine 
month follow-up after both interventions. An earlier study found that when working 
in teams, more extravert and agreeable people were more willing to share what they 
think (58). This willingness to share might also occur in context of MBCT (with the 
therapist and other patients) and eMBCT (with the therapist). By sharing more, one is 
able to receive more input from others, which could result in deepening of knowledge 
about mindfulness that might enable more and faster learning. Furthermore, both 
extraversion and agreeableness are related to more self-compassion (59). As self-
compassion forms a link between mindfulness and positive outcomes (60), more 
extraverted and agreeable people could benefit more from MBCT and eMBCT, 
resulting in less psychological distress. 
With regard to moderation, patients with less mindfulness skills and less 
conscientiousness benefited more from eMBCT than MBCT on the long-term. It is 
possible that the individual attention in eMBCT helped patients who are less mindful 
and conscientious. Furthermore, while patients in MBCT can refrain from discussing 
(the lack of) home practice by letting others in the group share their experiences, 
patients in eMBCT are more acknowledged for their home practice as they receive 
weekly written feedback from their therapist on it. Thus, eMBCT might encourage 
the less conscientious and the less mindful patients to complete their homework. 
The absence of other moderating variables implies that despite the common belief 
that older and less-educated patients might benefit less from online interventions 
like eMBCT, they seemed to do just as well as their younger and higher educated 
counterparts, although the latter group was more represented in our sample. Future 
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Working mechanisms
Finally, we found that a decrease in fear of cancer recurrence and rumination, and an 
increase in mindfulness skills during (e)MBCT were related to lower psychological 
distress nine months after (e)MBCT, which confirmed our hypotheses. These results are 
in accordance with previous research identifying fear of cancer recurrence, rumination 
and mindfulness skills as mediators (26, 27, 30). Furthermore, these results are in 
line with the mindfulness-to-meaning theory, that explains how mindfulness practice 
might decrease stress and rumination in adverse circumstances, through positive 
psychological processes (61), for which evidence was found in cancer patients (62). 
Future research on working mechanisms is necessary and should include measuring 
positive psychological processes in addition to negative psychological processes. 
Strengths and limitations
The current study has a number of strengths. First of all, it is the first in this field to 
directly compare MBCT and eMBCT which were similar in content. Secondly, the 
current study is one of the few to focus on long-term effects of (e)MBCT for cancer 
patients (8). Thirdly, due to promotion of the study website through various online 
and offline media, cancer patients from outside the participating institutes could 
be reached. This inclusion method might benefit the ecological validity of our 
study. However, it could have also have resulted in a self-selection bias, as patients 
interested in mindfulness were probably more likely to participate, which can be 
considered as a drawback. Another limitation of the current study is the absence 
of data about the control condition at the follow-up. Due to ethical constrains, we 
chose to offer patients randomized to the TAU condition participation in one of the 
two interventions after three months. This prevented us from testing whether the 
improvement over time is due to the MBCT interventions or whether this improvement 
is due to natural recovery or regression to the mean, although we did not observe 
this tendency in the TAU group during the three month waiting. Finally, patients 
that missed the nine month follow-up had worse complaints at baseline. As we miss 
the results of this group in the analyses, an underestimation or overestimation of 
effects is possible, although we used restricted maximum likelihood estimation or 
imputation procedures to deal with missingness. Finally, as we had no control group, 
we were not able to do formal mediation analyses, which limits our conclusions 
regarding working mechanisms. 
Conclusion
To the authors’ knowledge, the current study is the first to directly compare an 
online and face-to-face version of MBCT for cancer patients. Results showed that 
patients kept improving over time after both MBCT interventions over the nine month 
follow-up period, based on their level of psychological distress, rumination, positive 
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mental health and mental health-related QoL. Furthermore, we found eMBCT to 
be superior to MBCT in terms of psychological distress reduction at nine month 
follow-up, especially for patients with less mindfulness skills and conscientiousness, 
who seemed to benefit more from eMBCT. No other baseline characteristics were 
differential moderators between the two conditions, so both MBCT and eMBCT 
appeared to be suitable for a large range of cancer patients. Future research is 
necessary to confirm these claims and to include MBIs in the clinical guidelines for 
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CHAPTER 4: Temporal changes in 
mindfulness skills and affect during 
Mindfulness-Based Cognitive Therapy 
for cancer patients
RESUBMITTED  Cillessen, L., van de Ven, M. O. M., Burk, W. J., Bisseling, E. M., Compen, F. R., van der Lee, 
M. L., & Speckens, A. E. M. (resubmitted). Temporal changes in mindfulness skills and affect during 





Objectives: While efficacy research on mindfulness-based interventions in cancer 
patients is growing, research on possible mechanisms of change is lacking. The 
current study investigated general and week-to-week changes and interrelations in 
mindfulness skills and positive and negative affect in Mindfulness-Based Cognitive 
Therapy (MBCT) for cancer patients. 
Methods: 163 cancer patients completed face-to-face or online MBCT. During the 
intervention, mindfulness skills and positive and negative affect were measured 
weekly. Autoregressive latent trajectory models were used to unravel general and 
week-to-week effects. 
Results: Overall, mindfulness skills and positive affect increased, and negative 
affect decreased during MBCT. Higher general levels of mindfulness skills were 
associated with higher general levels of positive affect. Regarding week-to-week 
effects, positive affect in week three, seven and eight, predicted an increase of 
mindfulness skills in the following week. Various general relations were observed 
between mindfulness and negative affect, showing that more mindfulness skills were 
related to less negative affect. To the contrary, week-to-week effects showed higher 
mindfulness consistently predicted more negative affect in the subsequent week. 
Conclusions: In cancer patients, mindfulness skills appeared to be more robustly 
related to negative than to positive affect. Furthermore, mindfulness skills were 
related to increases in negative affect on short-term, possibly due to turning towards 
previously suppressed negative emotions, and decreases in negative affect on 
long-term, possibly due to acceptance of and exposure to negative emotions. Our 
findings reveal the complexity of mechanisms of MBCT and illustrate the necessity 
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Introduction
Thirty to 50% of cancer patients and survivors struggle with significant psychological 
distress and related negative emotions (1, 2). To cope with these complaints, 
mindfulness-based interventions (MBIs) are increasingly offered in psycho-oncological 
care, teaching cancer patients the skill of mindfulness. Mindfulness entails paying 
attention to the present moment, on purpose and with a nonjudgmental attitude 
(3). Mindfulness skills involve self-regulation of mindful attention towards that 
present moment and include observing and describing experiences, acting with 
awareness, nonjudging of and nonreactivity to inner experience (4, 5). Training of 
mindfulness skills is possible. Increases in state mindfulness as a consequence of 
mindfulness practice, can eventually lead to an increase in mindfulness skills, i.e. 
trait mindfulness (6). 
A recent meta-analysis with more than 3000 cancer patients in 29 independent 
randomized controlled trials, reported reductions in psychological distress, 
anxiety and depression at post-treatment and follow-up (7), which is similar to 
other, smaller meta-analyses (8, 9). Despite a substantial number of cancer patients 
benefits from MBIs, there is still room for improvement (7). In an RCT on MBCT and 
eMBCT for cancer patients, 60% of individual pre to post difference scores, did 
not statistically significant change (10). To increase therapeutic gain and reduce 
non-response to MBIs, a focus on working mechanisms is necessary (11). However, 
research on working mechanisms of mindfulness is limited compared to research 
on effectiveness, especially in cancer patients. Furthermore, previous research 
often relied on simple mediation models that assessed the mediator only once, 
limiting the ability to unravel differential relations of mechanisms over time and to 
determine direction of effects (11). 
Despite its limitations, previous research on working mechanisms has provided relevant 
insights. One of the most studied working mechanisms of MBIs is mindfulness skills. 
A meta-analysis of all available mediation studies in a broad clinical and non-clinical 
population has shown that MBIs result in more mindfulness skills, which in turn affect 
intervention outcomes in a positive manner (12). This finding was replicated in another 
meta-analysis that focused on mechanisms of MBIs for recurrent major depressive 
disorder (13). Improvements in emotion (regulation) are another mechanism that is 
increasingly studied. Gu, Strauss (12) even found strong and consistent evidence 
for emotional reactivity as a working mechanism. The mindfulness-to-meaning 
theory explains how increases in mindfulness skills and emotions may result in more 
beneficial outcomes(14). Mindfulness results in decentering and broadened awareness, 
creating space for positive affect (called upward spiral). In turn, negative habitual 
patterns involving negative affect can extinguish. These processes trigger positive 
reappraisal and savoring. Stressors like those encountered by people receiving 
a cancer diagnosis may results in meaningful lessons for personal development. 
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Different types of research have revealed evidence for a relation between mindfulness 
skills and positive affect. Cross-sectional research showed mindfulness skills relate 
to positive affect (15, 16). However, a meta-analysis of MBIs did not reveal consistent 
effects of MBIs on positive affect (17). Randomized controlled trials (RCTs) using 
experience sampling to measure positive affect multiple times showed increases 
of positive affect over time in cancer patients (18) and in adults vulnerable to 
depression (19) due to mindfulness practice. However, a study of mindfulness skills 
and positive affect assessed on a daily basis during an MBI for the general population 
only found partial evidence for this temporal sequence (20). The authors found that 
mindfulness skills predicted changes in positive affect, but positive affect did not 
predict subsequent changes in mindfulness skills (20). A study on a six session loving 
kindness meditation program in employees, reported that more mindfulness practice 
was related to increased positive emotions almost every intervention week, which 
in turn increased personal resources, including mindful attention (21).
MBIs are known to reduce negative affect (22) and symptoms of psychiatric disorders 
as depression, that often go hand-in-hand with negative affect (23). One study tested 
the temporal relations between mindfulness skills and negative affect (20). This 
study measured mindfulness skills and negative affect daily during an MBI for the 
general population. The authors found that mindfulness skills predicted decreases 
in negative affect, but that negative affect did not predict subsequent increases in 
mindfulness skills (20). 
The current study 
The current study tested general and week-to-week associations between mindfulness 
skills and positive/negative affect in a group of cancer patients and survivors during 
their participation in mindfulness-based cognitive therapy (MBCT) (24). To investigate 
both general and week-to-week patterns over the course of MCBT simultaneously, we 
utilized autoregressive latent trajectory (ALT) models (25). These models overcome 
some issues of the simple meditation models, because multiple measurements of 
potential mechanisms can be included, and the relation between different working 
mechanisms can be studied (11). Separate models were created for mindfulness 
skills and positive affect, and mindfulness skills and negative affect.
For both models we expected that general levels and changes over MBCT would 
be related. Based on the mindfulness-to-meaning theory (14), we expected positive 
week-to-week relations between mindfulness skills in a certain week and positive 
affect in the subsequent week, and vice versa. For mindfulness skills and negative 
affect, we expected negative week-to-week relationships from mindfulness skills 
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Methods
Participants
Participants were recruited through various online (e.g. Facebook) and offline (e.g. 
newspapers) media outlets. Interested participants could self-enroll on the study 
website, inclusion criteria were verified via telephone. Inclusion criteria were: 
1) having a diagnosis of any type of cancer; 2) experiencing at least mild psychological 
distress (a score of ≥ 11 on the Hospital Anxiety and Depression Scale (HADS); 
26, 27); 3) computer literacy and internet access; 4) good command of the Dutch 
language; and 5) willingness to participate in either the face-to-face or internet-based 
mindfulness intervention. Exclusion criteria were: 1) severe psychiatric morbidity; 
2) change in psychotropic medication within three months of baseline; and 3) current 
or previous participation in MBCT or MBSR. Patients provided written informed 
consent prior to participation. More details about the recruitment procedure can 
be found elsewhere (28). 
In total, 245 patients were included in the BeMind project. The current study included 
only patients (n=163; 67%) who completed at least four sessions of MBCT (n=84) or 
eMBCT (n=79). Descriptive statistics on these groups can be found in Table 1. There 
were no statistically significant differences in gender, age, education level, type of 
cancer, time since diagnosis, psychiatric diagnosis (depression/anxiety), baseline 
distress or mindfulness skills, positive and negative affect between participants who 
completed at least four sessions vs. participants that dropped out of the intervention, 
and between participants randomized to MBCT vs. eMBCT. Intervention completion 
did not significantly differ between MBCT (70%) and eMBCT (63%). Participants in 
eMBCT completed significantly more sessions (M=8.5; SD=1.4) than those in in the 
MBCT condition (M=7.8; SD=1.3).
Of the included 163 patients, 85% (n=138) were female, and the mean age was 
52 years (SD=10 years). Most participants were highly educated (n=115; 71%). 
The majority had breast cancer (n=103; 63%) and was treated with curative intent 
(n=142; 87%). On average, participants received a cancer diagnosis more than 
three years ago (M=3.4 years, SD=4.7 years). Patients were moderately distressed 
when entering this study (score on Hospital Anxiety and Depression Scale (26, 27); 
M=17.8, SD=6.9). Thirty-one patients (19%) suffered from depression, 16 patients 
(10%) had an anxiety disorder. 
Procedure
The current study reports secondary analyses of data from the BeMind project, a 
multi-center, three-armed randomized controlled trial comparing group face-to-face 
MBCT and individual internet-based eMBCT for distressed cancer patients with a 
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treatment-as-usual (TAU) group (10, 28, 29). This study was approved by the ethical 
review board of the Radboud University Medical Center (CMO Arnhem-Nijmegen, 
2013/542), and pre-registered on Clinicaltrials.gov (NCT02138513). Both MBCT and 
eMBCT outperformed TAU in reduction of psychological distress (10). The focus of 
the current study is on weekly measures obtained during MBCT and eMBCT. These 
measures were not obtained during TAU, because the main aim of the trial was to 
study effectiveness, and to minimalize burden for participants in TAU. Therefore, 
the current study only focused on the trial arms MBCT and eMBCT, and not on TAU. 
MBCT and eMBCT were based on the MBCT program of Segal, Williams (30) and 
were similar in number of sessions, frequency and content. The interventions were 
slightly adapted to fit the needs of cancer patients, i.e., psycho-education about 
stress was replaced by psycho-education about the different phases of grief, 
information about cancer-related physical symptoms such as fatigue was included, 
and the movement exercises were adapted for patients with physical limitations, 
for example edema. The eight week (e)MBCT program included weekly sessions 
(group sessions in MBCT; written information, exercises and therapist feedback in 
individual eMBCT). There was a six-hour silent retreat between session six and seven. 
Patients in eMBCT received instructions to organize their own one-day silent retreat. 
Thus, there were nine sessions in total over a time span of eight to nine weeks. In 
addition to the sessions, patients were requested to meditate at home (45 minutes 
a day, six days a week). 
Table 1. Descriptive statistics of total Bemind sample and intervention completers included in 
the current study, separated by condition (MBCT vs. eMBCT). 
Total Bemind sample 
(N=245)
Intervention completers (≥4 sessions, 
n=163); used in current study
MBCT (n=84) eMBCT (n=79)
Age (M, SD) 51.7 (10.7) 52.6 (10.7) 51.7 (9.9)
Gender (female, n, %) 210 (85.7%) 70 (83.3%) 68 (86.1%)
Higher education (yes vs no, n, %) 166 (67.8%) 59 (70.2%) 56 (70.9%)
Cancer (breast vs other, n, %) 151 (61.6%) 54 (64.3%) 49 (62.0%)
Years since diagnosis (M, SD) 3.5 (4.7) 3.7 (5.3) 3.0 (4.0)
Treatment intent (curative vs palliative, 
N, %)
206 (84.1%) 74 (88.1%) 68 (86.1%)
Depression (n, %) 42 (17.1) 14 (16.7%) 17 (21.5%)
Anxiety disorder (n, %) 27 (11.0) 9 (10.7%) 7 (8.9%)
Psychological distress at baseline 
(M, SD)
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In MBCT, sessions were conducted in face-to-face groups with a maximum of 12 
patients per group. The eMBCT program was individual. In eMBCT, each participant 
was provided with information and exercises around the theme of the session through 
a personal, secure webpage. Participants were encouraged to read the information 
and do the exercises within one week. Participants reflected on their experiences 
by keeping a personal log. The therapist assigned to each participant gave weekly 
feedback based on this log on a set day of the week, thereby guiding the patient 
through the program. 
Both MBCT and eMBCT were taught by nine qualified mental health care professionals 
which were also experienced mindfulness teachers. All of them had previous 
experience with cancer patients and met the criteria of the UK Mindfulness-Based 
Teacher Network (31). To assess adherence to the protocol and teacher competence, 
two randomly chosen videotaped sessions were assessed with the MBI-TAC (32) by 
two independent raters. Of the nine rated teachers , two were rated as beginner 
(22%), three as competent (33%), and four as proficient (44%). No teachers were rated 
as incompetent. The two teachers at beginner-level only taught one MBCT course 
each, and no eMBCT. No teachers in the current study were listed as co-authors. 
Prior to randomization, baseline questionnaires were completed. Participants 
completed the weekly questionnaires before each of the nine sessions of (e)MBCT. 
MBCT participants completed these questionnaires on paper at the beginning 
of each group session, while eMBCT participants completed the questionnaires 
digitally, when starting a new session in the online program. 
Patients in the TAU condition were randomly allocated to MBCT or eMBCT after 
the three-month TAU period. In the current study, we combined data patients who 
were directly randomized to MBCT or eMBCT, and patients who received MBCT 
or eMBCT after TAU. Further details of the study procedures can be found in the 
study protocol (28). 
Materials
The current study focused on data collected in week one through week nine of 
the intervention. All questionnaires were completed each week. Mindfulness skills 
were measured with the Mindful Attention and Awareness Scale (MAAS; 4, 33). The 
MAAS taps into different aspects of awareness and attention, which are seen as core 
characteristics of mindfulness skills (4). It measures the frequency of mindful states. 
The MAAS has 15 items (e.g. ‘I find it difficult to stay focused on what’s happening in 
the present’) that can be answered on a six-point Likert scale, from ‘almost never’ to 
‘almost always’. Higher scores represent higher levels of mindfulness skills. The MAAS 
was validated in an oncology sample (34), and has good psychometric properties, 
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including internal validity (33, 35). The average score was used in this study. Internal 
consistency in the current study was excellent (Cronbach’s α = .88). 
Positive and negative affect were measured with the Positive and Negative Affect 
Scale – Short Form I (PANAS-SF; 36, 37, 38). The PANAS-SF has 20 items that consist 
of ten positive and ten negative affective states (e.g. ‘excited’ and ‘nervous’). For 
each affective state, participants had to indicate on a five-point Likert scale (from 
‘very slight to not at all’ to ‘extremely’) whether they felt this way during the past 
week. Higher scores represent higher levels of positive and negative affect. Various 
psychometric aspects of the PANAS-SF, including internal reliability, temporal stability, 
and convergent and criterion-related validities were rated as acceptable (36). The 
average scale score was used in this study. Internal consistency in the current study 
was good for positive affect (α = .79), and sufficient for negative affect (α = .66). 
Statistical analyses
To study intervention mechanisms, an adequate treatment dose is required (11). 
Therefore, the current study only included participants who completed at least four 
sessions of (e)MBCT, which is considered a sufficient dose in MBI literature (39, 40). 
Data from participants in MBCT were obtained prior to the weekly group sessions, 
resulting in a one week interval between the questionnaires. From seven patients, 
one measurement was excluded from analyses because the questionnaires were 
completed after the group sessions instead of before, which could interfere with 
our results. In eMBCT there was more variability in time between two measurements 
(M = 9.4 days, SD = 7.8 days), compared to MBCT. To ensure consistency in measurement 
timing, we excluded one measurement from 18 patients because the interval between 
assessments was less than one day or more than four weeks. Thus, we removed 
seven MBCT and 18 eMBCT datapoints, representing only 2.2% of all datapoints. 
The total percentage of missing data varied between 18-33% per measurement 
week. Therefore, we utilized analytic procedures that were capable of retaining 
participants with incomplete data (see below). Visual inspection of histograms did 
not reveal any strong violations of skewness or kurtosis, therefore, no transformations 
were used. In all analyses, data of patients that followed MBCT or eMBCT after TAU 
were combined with data of patients that were initially randomized to MBCT or 
eMBCT, as there was no difference between these two groups on variables used in 
our data-analysis (i.e. mindfulness skills, positive and negative affect). 
Descriptive statistics (means, standard deviations) were calculated in SPSS, version 
22 (41). Autoregressive latent trajectory (ALT) models (25) were used to estimate 
latent intercepts and slopes, autoregressive and cross-lagged effects for mindfulness 
skills and positive and negative affect in Mplus version 6 (42). In an ALT model, 
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approach enabled us to study general patterns over the nine weeks (with latent 
intercepts and slopes) and week-to-week patterns (with autoregressive and cross-
lagged paths) simultaneously. The first measurement covaried with the intercept 
and slope (instead of being part of the estimation of intercept and slope), which 
is common practice with ALT models to ensure lagged values can be interpreted 
correctly (43, 44) and to avoid the statistical problem of infinite regression (43). 
Therefore, the intercept should be interpreted as the general initial level accounted 
for week 1, to which we refer as general level. When performing the ALT models, 
full information maximum likelihood was employed so participants with incomplete 
data could be included in the analyzed sample (45). 
Building an ALT model requires the fitting of a series of models with and without 
random slopes and various constraints to find a balance between fit and parsimony. 
The fit of the models was determined with χ2, χ2 divided by the degrees of freedom, 
(CMIN ⁄df), the comparative fit index (CFI), the Tucker-Lewis index (TLI), the Root Mean 
Square Error of Approximation (RMSEA) and the Standardized Root Mean Square 
Residual (SRMR). For CMIN/df, values below 3 were considered to represent good 
fit. For CFI and TLI, values above .90 are considered adequate, while values above 
.95 are indicative of good fit (46). Previously, RMSEA below .05 was a rule of thumb 
to indicate good fit. However, we followed new guidelines (46) that suggest RMSEA 
values below .07 are indicative of good fit. Furthermore, based on our sample size, 
an optimal cut-off would lie between .05 and .06 (47). For SRMR values below .08 
and .05 are considered adequate and good, respectively (46).
The primary analyses included two multivariate ALT models. The first included 
mindfulness skills and positive affect, the second mindfulness skills and negative 
affect. We closely followed the analytical steps of Morin, Maïano (43) for building 
the ALT models. We specified a series of increasingly complex models and used 
χ2 difference tests to determine whether the more complex model improved the 
fit to the observed data. When the simpler model demonstrated a better fit (i.e., 
the improved fit of the more complex model was not statistically significant), the 
former model was retained and compared to subsequent models. Only the most 
parsimonious models that adequately fitted the observed data are reported here. 
In these final models we controlled for intervention type (eMBCT vs. MBCT), by 
including intervention type as a dichotomous predictor of the latent intercept, slope 
parameters and the week one measurement. The results of all tested models and 





Table 2 presents the means and standard deviations of the study variables over the 
nine sessions. 
Table 2. Descriptive statistics of mindfulness, positive affect and negative affect during MBCT 
and eMBCT (combined). 
Mindfulness Positive affect Negative affect
Week Mean SD Mean SD Mean SD
1 3.06 .61 2.83 .72 2.13 .63
2 3.05 .60 2.70 .68 2.10 .73
3 3.21 .58 2.81 .78 2.12 .77
4 3.35 .63 2.88 .72 2.07 .70
5 3.43 .63 2.90 .74 2.09 .72
6 3.53 .62 2.97 .76 2.01 .68
7 3.63 .61 3.01 .77 1.89 .69
8 3.77 .67 3.07 .76 1.87 .71
9 3.85 .63 3.18 .69 1.82 .75
SD = Standard Deviation
Mindfulness skills and positive affect
The conditional ALT model that demonstrated the best fit to the observed data for 
mindfulness skills and positive affect included three sets of equality constraints: 
all concurrent correlations between weekly measures, all autoregressive paths 
for positive affect, and all cross-lagged regression paths from positive affect to 
mindfulness skills. This model provided adequate to good fit to the observed data 
(χ2(139) = 202.5, p < .001; CMIN/DF = 1.46; CFI = .971; TLI =.964; RMSEA = .054; SRMR 
= .073). We focus our description of the results on model parameters pertaining to 
the latent structure (intercepts and slopes; Table 3), and, autoregressive and cross-
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Table 3. Correlations between intercepts and slopes and their descriptives in the final 
conditional ALT model of mindfulness and positive affect. 
1 2 3 4 5 6
1. Intercept mindfulness -- .61** .06 -.23 .81** .59**
2. Intercept postive affect -- -- .103 .02 .44** .75**
3. Slope mindfulness -- -- -- .19 -.01 -.08
4. Slope positive affect -- -- -- -- -.32* -.29
5. Mindfulness W1 -- -- -- -- -- .39**
6. Positive affect W1 -- -- -- -- -- --
Estimate 5.33** 5.05** 2.95** .96* 4.91** 3.80**
Standard error .55 .58 .58 .49 .41 .37
Residual variance .98** 1.00** .99** .99** 1.00** 1.00**
* p <.05, ** p <.001
General changes
With regard to the latent structure, the slope parameters for both measures were 
positive and statistically significant (Table 3); mindfulness skills and positive affect 
increased throughout the MBCT course. In addition, the intercept parameters 
were positively correlated; higher general levels of mindfulness skills were related 
to more positive affect. The intercepts of both measures were not correlated with 
either slope parameter, nor were the slope parameters correlated; general levels 
of mindfulness and positive affect did not relate to general changes in mindfulness 
skills and positive affect. 
Weekly changes
With regard to the model parameters assessing weekly changes, the autoregressive 
paths for positive affect were statistically significant across all eight periods of change 
and the autoregressive paths for mindfulness skills only for the first four periods of 
change. Thus, after adjusting for the general patterns of change captured by the 
latent intercept and slope parameters, positive affect exhibited inter-individual 
stability across the nine weekly assessments, and mindfulness skills only in the 
first half of the intervention. With regard to cross-lagged regression paths, three 
of the eight paths involving positive affect as a predictor of subsequent increases 
in mindfulness skills were statistically significant (see Figure 1), but none of those 








































































































































































Unraveling the effects of Mindfulness-Based Interventions for cancer patients
Mindfulness skills and negative affect
The conditional ALT model that demonstrated the best fit for mindfulness skills and 
negative affect included five sets of equality constraints: the concurrent correlations 
between weekly assessments, the autoregressive paths for mindfulness skills, the 
autoregressive paths for negative affect, and the cross-lagged paths from mindfulness 
skills to negative affect and the cross-lagged paths from negative affect to mindfulness 
skills. This model had adequate to excellent fit (χ2 (153) = 215.0, p < .001; CMIN/
DF = 1.41; CFI = .968; TLI =.964; RMSEA = .051; SRMR = .075). Again, we focus our 
description on model parameters pertaining to the latent structure (Table 4), and, 
autoregressive and cross-lagged regression paths (Figure 2). 
Table 4. Correlations between intercepts and slopes and their descriptives in the final 
conditional ALT model of mindfulness and negative affect. 
1 2 3 4 5 6
1. Intercept mindfulness -- -.53** -.22 .29* .85** -.35**
2. Intercept negative affect -- -- .16 -.47** -.50** .63**
3. Slope mindfulness -- -- -- -.75** -.37** -.003
4. Slope negative affect -- -- -- -- .38** -.10
5. Mindfulness W1 -- -- -- -- -- -.35**
6. Negative affect W1 -- -- -- -- -- --
Estimate 5.49** 2.77** 1.37** -.82* 4.92** 3.82**
Standard error .58 .68 .38 .37 .41 .32
Residual variance .97** .98** 1.00** 1.00** 1.00** .97**
* p <.05, ** p <.001
General changes
With regard to the latent structure, the slope parameters for mindfulness and 
negative affect were both statistically significant (see Table 4); mindfulness skills 
increased and negative affect decreased over the duration of the intervention. 
Furthermore, the latent intercepts were negatively correlated; a higher general 
level of mindfulness skills is related to a lower general level of negative affect. The 
intercepts of both mindfulness skills and negative affect were also associated with the 
slope parameter for negative affect. The positive correlation involving the intercept 
of mindfulness reveals that higher general levels of mindfulness skills were related 
to less pronounced general decreases in negative affect. The negative correlation 










































































































































































Mindfulness skills and negative affect
The conditional ALT model that demonstrated the best fit for mindfulness skills and 
negative affect included five sets of equality constraints: the concurrent correlations 
between weekly assessments, the autoregressive paths for mindfulness skills, the 
autoregressive paths for negative affect, and the cross-lagged paths from mindfulness 
skills to negative affect and the cross-lagged paths from negative affect to mindfulness 
skills. This model had adequate to excellent fit (χ2 (153) = 215.0, p < .001; CMIN/
DF = 1.41; CFI = .968; TLI =.964; RMSEA = .051; SRMR = .075). Again, we focus our 
description on model parameters pertaining to the latent structure (Table 4), and, 
autoregressive and cross-lagged regression paths (Figure 2). 
Table 4. Correlations between intercepts and slopes and their descriptives in the final 
conditional ALT model of mindfulness and negative affect. 
1 2 3 4 5 6
1. Intercept mindfulness -- -.53** -.22 .29* .85** -.35**
2. Intercept negative affect -- -- .16 -.47** -.50** .63**
3. Slope mindfulness -- -- -- -.75** -.37** -.003
4. Slope negative affect -- -- -- -- .38** -.10
5. Mindfulness W1 -- -- -- -- -- -.35**
6. Negative affect W1 -- -- -- -- -- --
Estimate 5.49** 2.77** 1.37** -.82* 4.92** 3.82**
Standard error .58 .68 .38 .37 .41 .32
Residual variance .97** .98** 1.00** 1.00** 1.00** .97**
* p <.05, ** p <.001
General changes
With regard to the latent structure, the slope parameters for mindfulness and 
negative affect were both statistically significant (see Table 4); mindfulness skills 
increased and negative affect decreased over the duration of the intervention. 
Furthermore, the latent intercepts were negatively correlated; a higher general 
level of mindfulness skills is related to a lower general level of negative affect. The 
intercepts of both mindfulness skills and negative affect were also associated with the 
slope parameter for negative affect. The positive correlation involving the intercept 
of mindfulness reveals that higher general levels of mindfulness skills were related 
to less pronounced general decreases in negative affect. The negative correlation 
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general levels of negative affect were associated with more pronounced decreases in 
negative affect. Furthermore, the slope parameters were also significantly correlated 
indicating that stronger increases in mindfulness skills were related to stronger 
decreases in negative affect. 
Weekly changes
With regard to the model parameters assessing weekly changes, all autoregressive 
paths for mindfulness skills and negative affect were positive and statistically significant, 
so mindfulness and negative affect demonstrated inter-individual stability. The 
cross-lagged regression paths involving mindfulness skills as a predictor of changes 
in negative affect were statistically significant across all eight periods of change, 
with more mindfulness skills related to more negative affect in the subsequent 
week. The cross-lagged paths involving negative affect as a predictor of changes 
in subsequent mindfulness skills were not statistically significant. 
Discussion
The current study aimed to unravel general and week-to-week changes in mindfulness 
skills and positive and negative affect, and their interrelations during MBCT and 
eMBCT in cancer patients. To do so, autoregressive latent trajectory models were 
applied to weekly assessments of mindfulness skills and affect during MBCT for 
cancer patients. 
We found that general levels of mindfulness skills and positive affect were related, and 
that mindfulness and positive affect both increased during MBCT. This corresponds 
with previous research (48). Increases in mindfulness skills and positive affect over 
MBCT were however not related to each other. Positive affect in one week predicted 
positive affect in the subsequent week, while this was not always the case for 
mindfulness skills. This may suggest that the general increase in mindfulness might 
be fully accountable for the week-to-week differences. Furthermore, we did not 
found consistent week-to-week relations from mindfulness skills to positive affect 
but we did observe some from positive affect to mindfulness. 
Regarding the relationship between mindfulness skills and negative affect, we 
observed a general tendency for mindfulness to increase, and for negative affect 
to decrease, which is in accordance to previous research (48). We also found that 
these were related to one another. In addition, higher general levels of mindfulness 
skills were related with a lower decrease of negative affect, which could be due to a 
bottom effect (those with high mindfulness skills at the start were also low in negative 
affect). However, the week-to-week timeframe revealed a different picture: more 
mindfulness skills in one week was related to more negative affect in the subsequent 
week. Increases in mindfulness skills may lead to increased allowing of previously 
suppressed negative affect, which is further explained below. 
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Some of our findings contrast with previous research. The absence of a time-bound 
relation between mindfulness skills and positive affect is in contrast with previous 
findings from Snippe, Nyklíček (20). They found that daily measures of mindfulness 
skills predicted increases in positive affect the following day in the general population, 
but not vice versa. They also found that more mindfulness skills on a certain day 
was related to less negative affect, while we found the opposite; mindfulness skills 
in a certain week were related to more negative affect in the subsequent week. 
Furthermore, ter Avest, Greven (49) and colleagues, using a similar design and 
analyses as ours in recurrently depressed patients, showed that general increases in 
mindfulness skills and positive affect over MBCT were related. In addition, they found 
no week-to-week associations between mindfulness skills and negative affect (49).
Differences between previous studies and our results, include different samples 
(cancer patients vs. general population vs. depressed patients), questionnaires 
(MAAS vs. Five Face Mindfulness Questionnaire (50)), analysis (ALT models vs. 
autoregressive multilevel models) or assessment timing (weekly vs. daily). Of these, 
the only aspect in which our study differs from the two studies above, is the sample, 
and there are possible reasons why mechanisms in cancer patients may be different 
to those in healthy or depressed populations. 
Oncology patients might have put their emotions aside to get through the medical 
anti-cancer treatment (i.e. experiential avoidance) (51). After anti-cancer treatment 
is finished, however, continued avoidance hampers the emotional processing of the 
experience. This might cost a lot of energy and may lead to psychological distress, 
and for some even depressive or anxiety disorder. An important aspect of MBCT is 
turning towards the difficult, so mindfulness can help to gently turn towards distress 
and uncertainty related to cancer and its consequences (52-54). 
For cancer patients and survivors, experiential exposure in MBCT may result in a 
short-term increase of negative affect (55), as shown by our week-to-week results. In 
the long run, however, these emotions may extinguish due to experiential exposure, 
supported by acceptance, self-compassion or an improved ability to tolerate negative 
affect (52, 53). This might be shown by the general decrease in negative affect over 
MBCT found in our study. 
Our findings provide partial evidence for the upward spiral model (14, 56). Our results 
indicate that increases in mindfulness skills and positive affect are co-occurring, 
but are partially independent processes in cancer patients. Decreases in negative 
affect may be a more important mechanism of change in cancer patients, while 
for depressed patients outside oncology, increases in positive affect may be more 
important as these can help to mitigate depressive symptoms and increase savoring 
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positive affect may be an important mechanism as well, which may result in direct 
decreases in negative affect (20, 21). 
Obviously, our findings will need to be replicated before they can guide clinical 
practice. However, these new insights may help mindfulness teachers to explain 
cancer patients why a mindfulness training can be challenging at times. This might 
improve expectation management before and during the training. Patients who 
are aware the training could be difficult at times, may feel better equipped when 
encountering negative feelings or increases of symptoms. 
The current study has several strengths. A major strength is the statistical model 
we used. The ALT models enabled us to simultaneously disentangle general and 
week-to-week patterns. In this way, week-to-week patterns were controlled for 
general tendencies in the data, and vice versa. Without these controls, results could 
provide an incomplete or even incorrect picture of mechanisms (57). Specifically, 
we would not have been able to observe time-related differences in the association 
between mindfulness and negative affect when using regular mediation models. A 
second strength of the current study are the repeated measures of our mediators 
during the intervention. 
Some limitations should be mentioned as well. We worked with weekly measures, 
as we could easily administer these at the start of the MBCT sessions. However, it 
is possible that the week-to-week timeframe was too crude, resulting in a lack of 
significant findings on cross-lagged paths. Day-to-day or even moment-to-moment 
assessments might be better able to capture the influence mindfulness skills and affect 
may have on each other (e.g. 20, 58) Therefore, we would recommend researchers 
to focus on different timeframes. Secondly, we lacked weekly measures of a control 
group, as we considered it to be too burdensome for patients in TAU to complete 
weekly measures. Therefore, we cannot be sure whether time patterns observed are 
due to (e)MBCT, or whether these are processes naturally occurring over time. It is 
good to recall though that in our RCT we did find increases in mindfulness skills and 
decreases of psychological distress in eMBCT and MBCT compared to treatment as 
usual (10). Finally, some criticism has been expressed regarding the questionnaires 
we used. Although the MAAS is commonly used, its validity has been criticized due 
to statements being formulated in a negative way (reflecting mindlessness) and its 
restriction to measuring mindful attention and awareness (59). The PANAS, on the 
other hand, has been criticized for including only high arousal emotions (60), while 
mindfulness especially increases lower arousal positive emotions, like calmness (61). 
To conclude, our study showed that a) mindfulness and positive affect increased 
during MBCT and eMBCT for cancer patients, while negative affect decreased, b) 
mindfulness skills were more robustly associated with the decrease of negative 
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affect than the increase of positive affect and c) mindfulness was related to both 
week-to-week increases in negative affect and a decrease of negative affect in 
the long-term. This study is suggests that short-term increases in negative affect 
may be part of the therapeutic process of mindfulness interventions. Replication 
of these findings is desirable. In addition, further research on various mechanisms 
of MBIs, using different timeframes, control conditions and appropriate statistical 
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CHAPTER 5: Predictors and effects of usage 
of an online Mindfulness intervention for 
distressed cancer patients: Usability study
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Background: One in three cancer patients experience high psychological distress. 
Mindfulness-based interventions are effective in reducing psychological distress in 
this patient group. However, these interventions lack availability and flexibility, which 
may compromise participation in the intervention for cancer patients experiencing 
late symptoms like fatigue or pain. Therefore, mindfulness-based interventions are 
increasingly offered via the internet. However, little is known about the usage of 
these online mindfulness-based interventions. 
Objective: The aim of this study was to a) predict uptake of and adherence to online 
mindfulness-based cognitive therapy (eMBCT) using baseline patient characteristics 
(demographic, cancer-related, personality and psychological variables); and b) 
examine the relations between adherence and treatment outcomes in eMBCT for 
cancer patients. 
Methods: A total of 125 cancer patients were assigned to eMBCT in a parent randomized 
controlled trial comparing MBCT and eMBCT with treatment as usual in distressed 
cancer patients. Various usage measures of eMBCT were automatically tracked 
within the online program. Based on activity of use, participants were classified as 
non-users, minimal users, low users and intended users. Questionnaires were used 
to assess baseline characteristics (pre-intervention) and outcomes (pre- and post-
intervention). To answer the research questions data were analyzed with t-tests, 
χ2 tests and linear regression models. 
Results: Based on weekly activity, participants were classified as: non-users (n=17, 14%), 
who completed no exercises in MBCT; minimal users (n=31, 25%), who completed at 
least one exercise of 1-3 sessions; low users (n=12, 10%), who completed at least one 
exercise of 4-7 sessions; and intended users (n=65, 52%), who completed at least 
one exercise of eight to nine sessions. Non-users had more fear of cancer recurrence 
at baseline than users (uptake), and intended users were more conscientious than 
minimal and low users (adherence). Intended users reported a larger reduction in 
psychological distress and more improvement of positive mental health (i.e., emotional, 
psychological, and social well-being) after the intervention than other participants. 
Conclusions: This study showed that adherence was related to improved patient 
outcomes. Patients with strong fear of recurrence or low levels of conscientiousness 
should receive extra attention, as they are less likely to respectively start or complete 
eMBCT. Future research may focus on the development of flexible and adaptive 
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Introduction
About one third of cancer patients and survivors experience high psychological 
distress due to symptoms of anxiety and depression (1, 2). Mindfulness-based 
interventions (MBIs) can help to reduce psychological distress in cancer patients, as 
shown in several large meta-analyses (3, 4). Mindfulness is defined as “paying attention 
in a particular way: on purpose, in the present moment, and non-judgmentally” 
(5). The two most widely used MBIs, mindfulness-based stress reduction (MBSR) 
and mindfulness-based cognitive therapy (MBCT) are usually delivered as group 
interventions with eight weekly group meetings and a silent day (6, 7). All meetings 
include meditation exercises (bodyscan, sitting meditations and gentle movements), 
psycho-education, and group discussions. Participants are instructed to practice 
meditation on a daily basis to cultivate their mindfulness skills. 
Despite its beneficial effects, not all distressed cancer patients and survivors are 
able to participate in a regular face-to-face MBI. As a high proportion of of patients 
have physical problems like severe fatigue (8) or pain (9, 10), traveling on a weekly 
basis to a lengthy meeting at a fixed date and time might be impossible. Therefore, 
researchers started to investigate whether online MBIs, with their higher accessibility 
and flexibility, have similar effects as regular, face-to-face group MBIs. These online 
MBIs reduce travel costs and efforts, have 24/7 availability, and may avoid waitlists 
(11). Furthermore, participants are able to practice at a location and time they prefer, 
and at their own pace (12, 13). 
A recent meta-analysis of online MBIs in various populations showed moderate 
effects on stress and small effects on depression and anxiety (14). Focusing on cancer 
patients, studies on online MBIs revealed promising results. For instance, Zernicke 
et al., (15) found that online mindfulness-based cancer recovery was feasible and 
reduced symptoms of mood disturbance and stress in a randomized pilot study. 
In an actively controlled study, online MBCT (eMBCT) reduced fatigue severity in 
cancer patients (16). Furthermore, our own trial (the BeMind project) showed that 
cancer patients reported a moderate reduction in psychological distress after 
participating in individual eMBCT in comparison with those receiving treatment 
as usual (17). Over the course of a 9 month follow-up, eMBCT resulted in an even 
greater reduction in psychological distress than the classical group-based MBCT 
(18). In terms of cost-effectiveness, both treatments were equally cost-effective 
compared with treatment as usual (19). 
Despite growing evidence on the (cost-)effectiveness of online MBIs, less is known 
about usage of these online interventions. Usage is relevant to address, as it directly 
relates to intervention outcomes (20) and can help to optimize interventions (21). 
Two relevant aspects of usage are uptake (starting with the intervention) and 
adherence (receiving an intended dose of the intervention) (22, 23). Uptake and 
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adherence can be tracked with log data from the intervention website. Commonly 
reported log measures are frequency of use (eg, number of logins), duration of use 
(eg, duration of each login) and activity (eg, number of completed exercises (24). 
These log measures can be tracked with great objectivity (24), although they only 
reflect online and not offline engagement with the intervention. 
A meta-analysis on predictors of adherence in online interventions among adults 
found that women demonstrated greater adherence than men. Mixed findings 
were observed for the relation with age and severity of symptoms (22). Personality 
also seems to affect adherence to online interventions. For instance, a study on a 
web-based occupational health intervention showed that lower levels of negative 
affectivity and impulsivity and higher levels of alexithymia correlated with less 
usage of the online intervention (25). In adults with cancer, uptake was highest in 
females, while older patients demonstrated a greater adherence to online cognitive 
behavioral therapy than younger patients (23). Another study in adults with cancer 
participating in a web-based cognitive behavioral intervention found that different 
user groups did not differ in age, education level, or psychological distress (26). As 
far as we know, predictors of adherence and its relationship to outcome of online 
MBIs for cancer patients have not yet been studied. 
The aim of this study was to examine the usage of individual eMBCT for distressed 
cancer patients in relation to outcome. First, we explored whether various baseline 
patient characteristics (demographic, cancer-related, psychological, and personality 
variables) could predict uptake and adherence. Second, we tested whether adherence 
and the separate usage measures (number of log-ins, total time logged in, mean 
time logged in, number of emails sent to therapist, and number of assignments 
completed) were related to treatment outcome in terms of both psychological 
distress and positive mental health (i.e., emotional, psychological, and social well-
being). We expected that intended users would gain more from the intervention 
than low and minimal users. 
Methods
Study Design
This study concerns secondary analyses of the data from the parent BeMind study, 
a multi-center randomized controlled trial (RCT) studying the effects of group face-
to-face MBCT and eMBCT versus treatment as usual in distressed cancer patients 
(17, 18, 27). This study only includes data of participants immediately randomized 
to eMBCT or those randomized to eMBCT after treatment as usual. All participants 
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Participants
Distressed cancer patients were recruited through various online and offline media, 
and were directed to a study website, where they could self-enroll for the study. 
Inclusion criteria were having any cancer diagnosis; experiencing at least mild 
psychological distress (a score of ≥ 11 on the Hospital Anxiety and Depression Scale 
(HADS); 28, 29); internet access and computer literacy; good command of the Dutch 
language; and willingness to participate in either mindfulness intervention. Exclusion 
criteria were severe psychiatric morbidity; change in psychotropic medication within 
3 months prior to baseline; and current or previous participation in MBCT or MBSR. 
More details about the recruitment procedure can be found elsewhere (27). 
Intervention
The online MBCT intervention followed the protocol of Segal et al., (30), with some 
adaptations to fit the needs of the target group, for instance psycho-education about 
grief and cancer-related fatigue. The intervention was designed to be completed in 9 
weeks, however, the average time to complete the program was 10.4 weeks (SD=4.0 
weeks). Each session was spent on a specific theme, for instance automatic pilot, 
communication or self-care. Participants were provided with information, audio files 
of guided meditations, and assignments around the theme of the session through a 
personal secure webpage. The assignments included for instance the recording of 
pleasant or unpleasant events, or how they experienced the meditation exercises. 
Participants were encouraged to read the information and perform the assigned 
meditation exercises and assignments within 1 week. The therapist provided 
feedback on a predetermined day of the week. All therapists had experience in 
psycho-oncology and were qualified mindfulness trainers according to the criteria of 
the UK Mindfulness-Based Teacher Network (31). More details of eMBCT, including 
screenshots of the intervention, can be found elsewhere (32). 
Measures
Log Data
We measured different aspects of usage with log data, which is recommended 
because different aspects reflect different types of usage (24). Log data of eMBCT 
were retrieved from the study website. These included for each log-in, the time 
logging in and logging out, and the number of assignments saved and submitted. 
It should be noted that after 30 minutes of inactivity participants were automatically 
logged out. Furthermore, all emails from participants to therapists were available. 
From the available data, the following measures were calculated; total time logged 
in, mean time logged in per log-in, number of log-ins (of at least one minute), number 
of completed assignments (which included both those saved by the user and those 
submitted to the therapist), and number of emails sent to therapists. 
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Based on usage, participants were divided into usage groups, which is a common 
practice in this field (e.g. 26). We chose to create categories based on one aspect 
of activity, namely the amount of sessions in which at least one exercise had been 
completed, as frequency and duration may be more biased. Regarding frequency, 
some participants may write their experiences during meditation on paper and add 
them to the online program at a later moment. Regarding duration, we expected 
large variations in duration of use, as the ease and speed of writing may differ. 
Furthermore, activity may be more likely to reflect treatment engagement compared 
with other usage measures (33). As eMBCT is a complete program, in which each 
week provides new knowledge and skills training that builds on the previous week, 
intended usage was defined as completing at least one exercise of eight to nine 
sessions. Low usage was defined as completing at least half of the program (i.e. 
four to seven sessions (e.g. 34, 35). Minimal users completed at least one exercises 
of one to three sessions, while non-users did not complete any of the exercises. 
When focusing on uptake, non-users were compared with users (minimal/low/
intended), and when focusing on adherence, intended users were compared with 
low/minimal users. 
Baseline Characteristics
The following self-reported baseline characteristics were explored as possible 
predictors: gender, age, education level, cancer type (breast vs other), anticancer 
treatment intent (curative vs palliative), personality (openness, conscientiousness, 
extraversion, agreeableness, and neuroticism), baseline psychological distress, 
positive mental health, rumination, fear of cancer recurrence, and mindfulness skills. 
Sociodemographic characteristics and cancer-related variables were assessed in 
the baseline interview and via self-report questionnaires. Psychological predictors 
included baseline psychological distress (described below), baseline positive mental 
health (described below), rumination, fear of cancer recurrence, and mindfulness skills. 
Rumination was measured with the 12-item rumination subscale of the Rumination 
and Reflection Questionnaire (RRQ; 36). Fear of cancer recurrence was measured 
with the nine-item Severity subscale of the Fear of Cancer Recurrence Inventory 
(FCRI; 37, 38). Mindfulness skills were measured with the Five Facet Mindfulness 
Questionnaire Short Form (FFMQ-SF), a 24-item self-report questionnaire (39). 
Personality was assessed with the NEO Five Factor Inventory (NEO-FFI; 40). This 60-
item self-report questionnaire measures five personality characteristics; openness 
to experiences, conscientiousness, extraversion, agreeableness and neuroticism.
Outcome Measures
The outcome measures were self-reported psychological distress and positive 
mental health. Psychological distress was measured with the 14-item HADS 
(theoretical range 0-42), developed to measure depression and anxiety 
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patients (41, 42). Internal consistency in the present study was good (Cronbach α at 
T0 = .87). Positive mental health was measured with the Mental Health Continuum 
Short Form (MHC-SF), a 14-item questionnaire measuring emotional, psychological, 
and social well-being (theoretical range: 0-70) (43). The MHC-SF has adequate 
psychometric properties (44). Internal consistency was excellent (α=.93). Both 
measures were assessed before and after the intervention. 
Data analysis
Data were analyzed with SPSS version 22 (IBM Corp). Statistical significance was 
determined at p < .05 (two-sided). Descriptive statistics for participants and usage 
measures were calculated. With regard to the usage data, 16 participants (12.8%) 
did not log-in at all. For these patients, the number of log-ins was recorded as zero. 
For the other usage measures, missing values were maintained, as recording them 
to zero would lead to bias (e.g. the mean time logged-in over all participants would 
be artificially lowered). 
Visual inspection of histograms revealed all measures of usage were normally 
distributed, except for the number of completed assignments, which had a negative 
skewness, indicating that a large proportion of participants saved all assignments 
(a ceiling effect). For further analyses, the number of completed assignments was 
dichotomized with median split. A score of one (above the median) indicated that 
participants saved or submitted either all 58 assignments or all but one assignment 
(57 assignments), while a score of zero indicates less assignments were completed 
(<57 assignments). We refer to this variable as completed all assignments (yes/no). 
Number of log-ins, total time logged in, mean time logged in, number of emails sent, 
and number of exercises completed were calculated for each group. In the analyses, 
the low and minimal user groups were combined to create more equal group sizes. 
The first research question focused on prediction of uptake (non-users vs users) and 
adherence (intended vs minimal/low users). For each of the user groups, baseline 
patient characteristics (demographic, cancer-related, personality and psychological 
variables) were described. Independent sample t tests and χ2 tests were used to test 
for significant differences between the user groups regarding uptake or adherence. 
To study the relationship between usage and outcome (research question 2), linear 
regressions models were used. These analyses only included participants who 
actually used the intervention (minimal, low, and intended users). Separate models 
were run for usage group (minimal/low vs intended), and per usage measure (total 
time logged in, mean time logged in, number of log-ins, number of assignments 
completed, and number of emails sent to therapists) and outcome measure 
(psychological distress and positive mental health). All models were controlled for 





In total, 125 cancer patients participated in eMBCT. The mean age of the participants 
was 52 years (SD= 10.2). Most participants were female (n = 109, 87%), had breast 
cancer (n = 76, 61%), and were treated with curative intent (N = 102, 82%). The mean 
level of psychological distress on the HADS was 17 (SD= 6.9). 
Regarding the different measures of usage in the total group, participants logged 
in on average 30.5 times (SD= 28.1), with a mean time logged in of 28.1 minutes 
(SD=19.1), and a total time logged in of 1066 minutes (SD= 1217). Participants sent 
on average nine emails (SD=5.8) and completed most assignments (median = 57.5, 
range 1-58). Seventeen participants (14%) were classified as non-users, 31 (25%) as 
minimal users, 12 (10%) as low users and 65 (52%) as intended users. Usage in each 
of the user groups is displayed in Table 1. 
Table 1. Descriptive statistics of usage measures of the user groups (N=125)








Intended users  
(n = 65)
Duration:  
average log-in time, 
mean (SD)1
3.5 (N/A2)3 21.4 (17.9) 24.4 (13.1) 32.3 (19.6)
Duration:  
total log-in time,  
mean (SD)1
7.0 (N/A)3 153.7 (232.5) 588.8 (404.3) 1606.3 (1299.9)
Frequency:  
number of log-ins,  
mean (SD)1
0.12 (.49) 6.6 (6.5) 24.1 (9.4) 51.1 (23.1)
Activity:  
emails sent
0 (N/A) 3.0 (1.6) 7.7 (4.6) 11.6 (5.3)
Activity:  
exercises completed4
0 (N/A) 8.6 (6.5) 36.8 (7.2) 57.7 (.92)
1 Time was measured in minutes. 
2 N/A: not applicable.
3   One participant in the non-user group logged in twice, but did not complete any of the exercises, therefore belonging to the 
non-user group. The duration scores reflect scores of this participant. Standard deviations cannot be calculated for one score. 
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Prediction of uptake and adherence
Prediction of uptake
Table 2 presents the baseline characteristics for users and non-users, and the results 
of the statistical tests comparing differences between these groups. Non-users had 
higher levels of baseline fear of cancer recurrence compared with users (t118=2.27, 
P=.03). This effect is of medium to large size (D=0.69). There were no other relevant 
differences between users and non-users at baseline. 
Table 2. Descriptive statistics of baseline characteristics of uptake (users vs. non-users) and 






or χ2 value) (df)
P value Cohen D
Age (years), mean (SD) 49.4 (11.4) 52.2 (10.1) -1.04 (123) .30 0.26
Gender (female, N, %) 17 (100%) 92 (85%) 2.89 (1) .09 N/A
Higher education (yes vs no, n, %) 8 (47%) 73 (68%) 2.72 (1) .10 N/A
Cancer (breast vs other, n, %) 12 (71%) 64 (59%) 0.79 (1) .37 N/A
Treatment intent (curative vs palliative, 
n, %)
14 (82%) 88 (82%) 0.01 (1) .93 N/A
Neuroticism, mean (SD) 38.3 (8.1) 35.8 (7.8) 1.20 (122) .23 0.31
Extraversion, mean (SD) 37.9 (5.8) 37.9 (6.5) -0.04 (122) .97 0
Openness, mean (SD) 40.0 (6.0) 40.4 (5.2) -0.30 (122) .76 0.07
Altruism, mean (SD) 45.8 (5.6) 46.6 (4.2) -0.73 (122) .47 0.16
Conscientiousness, mean (SD) 42.4 (6.8) 41.8 (5.9) 0.40 (122) .69 0.09
Psychological distress, mean (SD) 16.4 (7.1) 16.8 (6.9) -0.20 (122) .84 0.06
Positive mental health, mean (SD) 39.7 (16.0) 37.4 (13.4) 0.59 (122) .56 0.16
Rumination, mean (SD) 43.2 (9.5) 42.3 (8.3) 0.39 (122) .70 0.10
Fear of Cancer Recurrence, mean (SD) 91.5 (18.7) 78.1 (20.3) 2.27 (122) .03 0.69
Mindfulness, mean (SD) 78.4 (14.4) 77.0 (10.8) 0.44 (119) .66 0.11




Table 3 presents the baseline characteristics for low/minimal and intended users, 
and the results of the statistical tests comparing differences between these groups. 
Intended users were more conscientious when compared with the combined group 
of minimal and low users (t106=-2.04, P=.04). This effect is of small to medium size 
(D=0.39). There were no relevant differences between the two groups. 
Table 3. Descriptive statistics of baseline characteristics of adherence (minimal/low vs 
intended users) and prediction of adherence with independent sample t tests or χ2 tests 
(N=108).





(t-value or  







Age (years) 52.7 (10.1) 51.8 (10.1) 0.41 (106) .68 0.09
Gender (female, n, %) 38 (88%) 54 (83%) 0.58 (1) .45 N/A
Higher education (yes vs no, 
n, %)
25 (58%) 48 (74%) 2.92 (1) .09 N/A
Cancer (breast vs other, n, %) 25 (58%) 39 (60%) 0.04 (1) .85 N/A
Treatment intent (curative vs 
palliative, n, %)
32 (74%) 56 (86%) 2.36 (1) .12 N/A
Neuroticism, mean (SD) 36.8 (7.5) 35.1 (8.1) 1.13 (106) .26 0.22
Extraversion, mean (SD) 36.8 (6.7) 38.7 (6.2) -1.54 (106) .13 0.29
Openness, mean (SD) 39.4 (5.8) 41.1 (4.8) -1.62 (106) .11 0.32
Altruism, mean (SD) 46.1 (3.7) 47.0 (4.5) -1.13 (106) .26 0.22
Conscientiousness, mean (SD) 40.4 (5.8) 42.7 (5.9) -2.04 (106) .04 0.39
Psychological distress,  
mean (SD)
16.6 (6.4) 17.0 (7.4) -0.31 (105) .76 0.06
Positive mental health,  
mean (SD)
37.9 (13.3) 37.1 (13.5) 0.31 (105) .76 0.06
Rumination, mean (SD) 43.1 (6.7) 41.7 (9.2) 0.88 (105) .38 0.17
Fear of Cancer Recurrence, 
mean (SD)
77.4 (19.7) 78.6 (20.8) -0.31 (105) .76 0.06
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Relation between adherence and outcomes
Relations between adherence and outcomes are displayed in Table 4. Participants 
who used the intervention as intended reported less psychological distress 
(t86=-2.47, P=.02) and more positive mental health after the intervention than minimal 
and low users (t86=5.18, P=.02). When focusing on specific usage measures, we found 
that participants who completed all exercises reported less psychological distress 
(t86=-2.80, P=.01) and more positive mental health (t86=5.24, P=.01) after the intervention 
than those who did not. Mean time logged in, total time logged in, number of log-ins, 
and number of emails sent did not appear to be related to psychological distress 
or positive mental health after the intervention.
Discussion
The aim of this study was to predict uptake and adherence of eMBCT and to 
examine the association between adherence and the treatment outcome of eMBCT 
in distressed cancer patients. We divided participants into different user groups 
as follows: non-users (n=17, 14%), minimal users (n=31, 25%), low users (n=12, 
10%) and intended users (n=65, 52%). Regarding uptake, non-users appeared to 
have more fear of cancer recurrence than users. Regarding adherence, intended 
users were more conscientious than minimal and low users. Finally, intended users 
showed a larger reduction of psychological distress and stronger improvement in 
positive mental health than minimal and low users. We did not find any relations of 
number of log-ins, mean and total time logged in, and number of emails sent with 
treatment outcome. Patients who completed all assignments, however, showed 
less psychological distress and more positive mental health after the intervention 
than those who did not. 
About half of the participants used eMBCT as intended. A previous study on online 
cognitive behavioral therapy for cancer patients found a similar percentage of high 
users (44%) (26). 
Regarding prediction of uptake, we found that non-users had more fear of cancer 
recurrence than users. It may be possible that patients with a high fear of recurrence 
are more likely to avoid participation, as it means being confronted with their fear. 
This is in line with a recent study on online self-help for fear of cancer recurrence 
that found that most patients do not log in or express a need for support (45). As 
fear of recurrence is an unmet need among cancer patients (46), this group might 
need more information prior to enrollment in an intervention like eMBCT (47). A 
study on an internet-based intervention for depressive symptoms in primary care 
showed that a brief preparatory informational video increased acceptance of the 
intervention (48). A video about eMBCT for distressed cancer patients could discuss 
evidence for the effectiveness of the intervention, and possible facilitators and 
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barriers (such as confrontation with cancer and fear of recurrence). Preparatory 
face-to-face conversations with a health care provider prior to the eMBCT, in which 
these topics could be discussed, may also be useful. Involving a partner or a close 
friend of the patient during eMBCT may help as well (49).
Table 4. Results of linear regression analyses predicting outcomes from usage group (intended 
vs. minimal/low users) and separate usage measures of intervention users (N=891)
Full model2 Predictor
Adjusted R2 F (df) P B t P 95% CI
Psychological distress




<.001 -2.87 -2.47 .02 -5.19 to -0.56
Number of log-ins 0.32 20.46
(2, 86)
<.001 -0.03 -1.23 .22 -0.07 to 0.02
Mean time logged in 0.31 20.69
(2, 86)
<.001 -0.04 -1.35 .18 -0.09 to 0.02
Total time logged in 0.32 20.40
(2, 86)
<.001 -0.001 -1.20 .23 -0.01 to 0
Emails sent 0.32 19.62
(2, 83)





<.001 -2.80 -2.51 .01 -5.02 to -0.59
Positive mental health




<.001 5.18 2.40 .02 0.88 to 9.48
Number of log-ins 0.45 37.28
(2, 86)
<.001 0.03 0.90 .37 -0.04 to 0.11
Mean time logged in 0.46 36.77
(2, 86)
<.001 0.03 0.50 .62 -0.08 to 0.13
Total time logged in 0.45 36.64
(2, 86)
<.001 0.00 0.33 .74 -0.01 to 0.01
Emails sent 0.46 34.77
(2, 83)
<.001 0.05 0.28 .78 -0.32 to 0.43




<.001 5.24 2.53 .01 1.12 to 9.36
1 Of the 108 users, 19 missed either the pre-measure or the post-measure of the outcomes, resulting in a sample size of 89  
for these analyses. Three participants missed a score on e-mails sent, resulting in a sample size of 86 for these analyses.
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Regarding prediction of adherence, we showed that participants with low 
conscientiousness have trouble completing eMBCT. This is not surprising, as one 
of the aspects of conscientiousness is self-discipline (40). Furthermore, increased 
conscientiousness is associated with increased mindfulness (50), which might catalyst 
participation in an online mindfulness program like this. As we previously found that 
participants with low conscientiousness had better results in eMBCT compared 
with regular group MBCT (18), more individual feedback by a mindfulness teacher 
might support them. Alternatively, patients could be offered a pre-intervention. For 
example, a study on health behavior showed that participants who were poor in 
planning benefitted from a pre-intervention aimed at planning and implementation 
intentions (51). 
Besides fear of cancer recurrence and conscientiousness, we did not find any other 
predictors of usage of eMBCT. This is in accordance with a recent meta-analysis on 
predictors of online intervention adherence which did not find many predictors for 
adherence either (22). A proposed behavioral change model for internet interventions 
suggests that adherence is not only determined by personal characteristics, but 
also by environmental factors, support and website characteristics (52), which we 
also showed in a qualitative study on eMBCT (47). Future researchers might want 
to consider to improve prediction by including all of these factors. In addition, 
qualitative methods can deepen our insight into the possible contributors to the 
usage of eMBCT (e.g. 47). 
Finally, we found that intended users reported less psychological distress and more 
positive mental health after the intervention than minimal and low users. A similar 
pattern was found for participants who completed all assignments as compared 
with those who did not. Thus, it seems that greater activity in eMBCT rather than 
the sheer frequency or duration of use, is related to improved treatment outcome. 
A previous study on an online intervention for depression also found that clinically 
relevant improvement was related to activity rather than frequency and duration 
(53). Our results also match with findings of a meta-analysis on the relation between 
adherence to homework and treatment outcome in MBIs (21). The authors concluded 
that this relation is not linear, suggesting only frequency and duration of practice do 
not provide a complete picture. Thus, different individual usage patterns may be 
beneficial (eg, shorter and frequent sessions or longer and less frequent sessions), 
as long as activity is high. 
Regarding clinical implications, our study showed that half of the participants used 
the program as intended, and that higher activity was related to better outcome. As 
half of the participants did not use the program as intended, participation in these 
kind of interventions should be closely monitored. In our case, monitoring took place 
in the form of weekly written asynchronous contact with a qualified trainer. Possibly, 
112
Chapter 5 
more intensive synchronous digital contact or even blended forms including face-to-
face contact might be necessary for particular subgroups of patients (47). To increase 
uptake of and adherence to this and similar programs, these programs could be 
designed as adaptive interventions in which the type (eg, regular group MBCT or 
eMBCT or hybrid/blended forms), dosage and even content are individualized and 
flexible based on patients’ characteristics, preferences, and clinical presentation, 
as well as their reactions to the intervention (54, 55). However, we should note that 
although only half of the participants did not use eMBCT as intended, previous results 
of the BeMind study showed eMBCT to be superior to treatment as usual (17) , and 
at long term follow-up even to regular face-to-face group MBCT (18).
The strengths of this study include comparison of different usage groups on a large 
number of baseline characteristics, and the examination of the relationship between 
usage and treatment outcome. Another strength is that this study was part of an RCT 
that also included regular group-based MBCT as an intervention arm. Therefore, 
our sample might be less biased towards participants interested in participating in 
an online intervention. Some limitations should be mentioned as well. Firstly, the 
log measures tracked usage of eMBCT. However, participants may be engaged 
with the mindfulness training in ways that were not reflected in the eMBCT log 
measures, as meditation audio files could be downloaded or found on YouTube. 
Although we assume that usage in eMBCT and engagement with training in other 
ways highly overlap, we cannot be sure we measured actual meditation practice in 
this study. As meditation is an important aspect of any mindfulness intervention, this 
is an important point for future research. Second, the amount of emails sent might 
be a less valid measurement of activity. Participants wrote their personal logs, and 
therapists could reply to those personal logs, creating an additional communication 
system next to the emails. Finally, owing to the low number of non-users, the power 
to detect possible differences with t tests comparing non-users and users was low, 
so it is likely that only larger effects were detected.
In conclusion, our study showed that adherence was related to improved patient 
outcomes. Patients with strong fear of recurrence or low levels of conscientiousness 
should receive extra attention, as they are less likely to start or complete eMBCT. 
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The main goal of this thesis was to unravel the effects of mindfulness-based 
interventions (MBIs) for cancer patients. This thesis studied the effect sizes of MBIs 
in this patient group, and investigated potential mediators and moderators of 
MBIs and, in particular, of group face-to-face mindfulness-based cognitive therapy 
(MBCT), and individual internet-based MBCT (eMBCT) with weekly asynchronous 
trainer guidance. 
This chapter starts by summarizing the most important results from the previous 
chapters. Then results are compared with existing literature in the field, resulting in 
several considerations and suggestions for future research. Next, it discusses the 
strengths and limitations of this thesis, followed by the clinical implications of this work. 
Summary
The main aim of Chapter 2 was to study the effects of MBIs on psychological 
distress and other health outcomes in cancer patients and survivors in a large 
and comprehensive systematic review and meta-analysis. Two authors conducted 
independent literature searches in four electronic databases, and screened the 
1804 records retrieved. Randomized controlled trials (RCTs) could be included 
if they studied adult cancer patients (any stage/type/time since diagnosis) who 
received an intervention with mindfulness as a main component and that included 
meditation homework. Assessed outcomes had to include at least one measure of 
distress (including separate and combined measures of perceived stress, anxiety, 
and depression). After removal of duplicates and irrelevant records, 38 papers 
were included, describing 29 independent RCTs. Risk of bias and MBI quality were 
assessed, and eligible data were extracted for meta-analysis. 
The combined results of these 29 RCTs, including 3274 participants, showed small 
but statistically significant effects of MBIs on the combined measure of distress, both 
directly after the intervention (Hedges’s g = 0.32), and at follow-up (g = 0.19). When 
excluding studies with active control groups (including competing interventions 
like cognitive behavioral therapy), effect sizes increased towards medium size 
(g = .40). Regarding the secondary outcomes, small effects were found on anxiety, 
depression, fear of cancer recurrence, fatigue, sleep disturbances, and pain at either 
post-intervention or follow-up. Furthermore, our meta-analysis showed several 
interesting findings regarding moderators of MBIs. We found that MBIs had larger 
effects when 1) interventions adhered to original mindfulness-based stress reduction 
(MBSR) or MBCT protocols, 2) younger patients were included, 3) a passive control 
group was included (compared to active control group/competing intervention), 
and 4) time to follow-up was shorter. Finally, we showed that improvements in 
mindfulness skills were associated with greater reductions in psychological distress 
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Chapters 3, 4, and 5 describe secondary analyses of the BeMind project. The 
BeMind project is a multicenter RCT about the effects of group face-to-face MBCT 
and individual internet-based eMBCT on psychological distress in distressed 
cancer patients. Cancer patients with at least mild distress (indicated by a score of 
11 or higher on the Hospital Anxiety and Depression Scale (1)) were randomized to 
group MBCT (n = 77), internet-based eMBCT (n = 90) or treatment as usual (TAU; 
n = 78). After a three-month TAU period, participants were randomly crossed-over 
to MBCT or eMBCT. 
Chapter 3 focused on the long-term effects of MBCT and eMBCT, and described the 
nine-month follow-up analyses of the BeMind project. After the primary endpoint 
of the RCT at three months after baseline, TAU patients were randomized to group 
MBCT or eMBCT. This means that follow-up data is uncontrolled. In addition to 
consolidation of treatment effects, moderation and potential mediators were also 
addressed in this study. 
Over the course of the nine-month follow-up, we found further reductions in 
psychological distress and rumination, and increases in positive mental health and 
health-related quality of life. These findings suggest that besides improvements 
directly after the intervention (2), participants continued to improve during the 
months after the intervention. Furthermore, we found that patients reported less 
psychological distress over the course of the follow-up after eMBCT in comparison 
to MBCT. Regarding moderators, we found that less rumination and neuroticism 
and more extraversion and agreeableness at baseline predicted less psychological 
distress at the nine-month follow-up after both interventions. Participants who were 
less mindful and conscientious at baseline benefited more from eMBCT compared 
to MBCT at the nine-month follow-up. Regarding mediation, we found that increases 
in mindfulness skills and decreases in rumination and fear of cancer recurrence over 
the course of the intervention period were related to reduction in psychological 
distress over the follow-up period. 
In Chapter 4, we aimed to look more closely at the short-term and long-term 
mechanisms of change of MBIs, and so we took a relatively new statistical approach 
towards studying these mechanisms. We focused on weekly assessments of 
mindfulness and positive and negative affect that were obtained during MBCT and 
eMBCT within the BeMind project. Only those individuals who completed at least 
four sessions of MBCT or eMBCT (n = 163) were included. To unravel both week-to-
week changes, but also more general changes that may take place over the course of 
the whole intervention, autoregressive latent trajectory models were used. Results 
showed that overall, mindfulness and positive affect increased, while negative affect 
decreased during MBCT and eMBCT. During MBCT and eMBCT, higher general 
mindfulness skills were associated with higher general positive affect. In some 
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weeks, positive affect predicted more mindfulness in the subsequent week, but 
not vice versa. Various general relationships were observed between mindfulness 
and negative affect. In particular, stronger increases in mindfulness skills during (e)
MBCT were related to stronger decreases in negative affect during (e)MBCT. The 
week-to-week effects, however, showed a different picture; more mindfulness in a 
certain week consistently predicted more negative affect in the subsequent week. 
Thus, mindfulness may increase negative affect in the short term, possibly because 
participants allow more negative emotions, while in the long term, mindfulness is 
related to  decreases in negative affect. 
Chapter 5 focused specifically on the intervention usage of eMBCT, and therefore 
included participants randomized to eMBCT (n = 125). We mapped different user 
groups and predicted uptake and adherence with a broad range of demographics 
and variables related to cancer, personality, and psychology. We also examined the 
relationship between adherence and intervention outcomes. Intervention usage 
was automatically tracked in the eMBCT program. These measures included the 
number of log-ins (frequency of use), the total log-in time, and mean log-in time per 
log-in (duration of use), and the number of emails sent and the number of exercises 
completed (activity of use). 
Based on weekly activity, participants were classified as: non-users (n = 17, 14%), 
who completed no exercises in MBCT; minimal users (n = 31, 25%), who completed 
at least one exercise in 1-3 sessions; low users (n = 12, 10%), who completed at least 
one exercise in 4-7 sessions; and intended users (n = 65, 52%), who completed at least 
one exercise in 8-9 sessions. We found that non-users had higher baseline levels of 
fear of cancer recurrence compared to other users (minimal, low, and intended users 
combined, reflecting uptake). Furthermore, we observed that intended users were 
more conscientious than minimal and low users (reflecting adherence). Intended 
users had a greater reduction of psychological distress and a greater increase in 
positive mental health compared to low/minimal users.
General discussion
Several topics are discussed below. First, the discussion focuses on the effects of 
MBIs for cancer patients. I look into the effect sizes, long-term effects, and quality 
of the evidence. Second, I focus on the mechanisms of change of MBIs. I look at the 
evidence from this thesis and the literature, integrate them into an existing theoretical 
model (Mindfulness-to-Meaning theory (3)) and describe a case example. Third, 
I focus on what works for whom, addressing both the individual patients, but also 
different MBIs, including those with online delivery. Each of these three sections 
will end with specific suggestions for future research. At the end of this discussion, 
I outline strengths and limitations of the studies in this thesis, followed by the clinical 
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Effects of MBIs for cancer patients
Effect sizes of MBIs
Although every type of empirical research has its limitations, meta-analyses have 
the potential to be our best information source about intervention effects, as they 
can integrate existing evidence (4). In our meta-analysis, we concluded that MBIs are 
effective interventions to help cancer patients reduce psychological distress (primary 
outcome), with effect sizes in medium range when including studies with passive 
control groups and small effect sizes when also including studies with active control 
groups and other evidence-based treatments. Furthermore, statistically significant 
effects were also found on anxiety, depression, fear of cancer recurrence, fatigue, 
sleep disturbances, and pain.
The results of our meta-analysis are comparable to those of a recent meta-analysis 
of 10 RCTS on MBSR and MBCT specifically for breast cancer (5). Previous meta-
analyses including different types of cancer, different kinds of MBIs, and different 
types of studies (also non-RCT) also pointed towards the efficacy of MBIs, with some 
reporting small to medium or even large effect sizes (6-11). All in all, this research 
field provides a fair amount of evidence for a statistically significant decrease in 
psychological distress in cancer patients and survivors. 
However, the effect sizes in these meta-analyses differ. There are several reasons 
for the observed differences. First, it seems that higher effect sizes are found 
when non-RCT designs are examined (9, 11). For instance, Piet and colleagues (9) 
reported effect sizes in the medium range for non-RCT designs, and in the small 
to medium range for RCTs. This illustrates the general finding of higher effect sizes 
in non-randomized or non-controlled designs, compared to RCTs, which are more 
likely to capture the ‘true’ effect of an intervention (12). Second, later meta-analyses, 
including our own, seem to find smaller effects. This might be due to the increased 
quality of trials in the field (e.g. 13). Third, some meta-analyses have a more narrow 
focus, and focus for instance only on MBSR or only on breast cancer patients (e.g. 11). 
Our meta-analysis did show differences in effect sizes between original MBCT 
and MBSR programs and adapted versions, which may explain some differences 
in effect sizes. 
It is also important to address the meaning of the observed effect sizes. Some 
authors have written that effect sizes in the medium range may be indicative of 
clinical importance (14). Furthermore, the effect sizes of MBIs for cancer patients 
are comparable to the effect sizes of cognitive behavioral therapy (CBT) for cancer 
patients (15). However, a narrow focus solely on effect sizes is not sufficient to create a 
complete picture of clinical relevance of MBIs in psycho-oncology (16-18). Therefore, 




When looking at the long-term effects of the MBIs, both our meta-analysis and our 
follow-up study show beneficial results. In our meta-analysis, we found small long-
term effects on psychological distress, with a six month follow-up on average. Most 
previous meta-analyses on MBIs for cancer were not able to examine long-term 
follow-up effects due to the lack of studies with a follow-up. One meta-analysis that 
did examine them found small follow-up effects (9). Another meta-analysis found 
significant follow-up effects on psychological distress at six- and twelve-month 
follow-up, although effects on depression did not reach statistical significance 
at the last follow-up (5). Although both meta-analyses were only able to include a 
small number of RCTs, our meta-analysis included 18 RCTs with follow-up analyses. 
Thus, MBIs seem effective in the long term, although further research on this topic 
is warranted. 
In light of enduring effects, our own follow-up study revealed continued improvement 
during the nine-month follow-up period after MBCT and eMBCT. It seems that 
patients continue to improve in the months following MBCT, particularly in eMBCT. 
Continued meditation practice may provide an explanation for these results, although 
we lack reliable measurements of meditation practice, which is more often reported 
in the field (19). Furthermore, MBIs may lead to other healthy lifestyle changes, like 
exercising or finding a more fulfilling job (20), which may be another explanation 
for continued improvement. 
These results on continued improvement after post-treatment differ from the results 
of our meta-analysis, which showed that long-term effects were somewhat smaller 
compared to post-treatment effects. Our MBCT and eMBCT were more intensive than 
many of the MBIs in the meta-analysis, which may explain this difference. However, 
due to the lack of a control group in our follow-up study, regression to the mean 
and spontaneous improvements may also explain this effect. 
Quality of the evidence
The confidence that we have in the effect sizes of our meta-analysis was rated as 
moderate based on the guidelines of the Grading of Recommendations, Assessment, 
Development, and Evaluation (GRADE) (21). GRADE is a system used to rate the 
quality of evidence in an intervention, and it is increasingly used by organizations 
around the world to establish guidelines for clinical practice. Moderate confidence 
suggests that the true effect is likely to be close to the estimated effect; however, 
there is a possibility that it differs substantially. The evidence was strong in most 
domains (including low risk of bias and high directness of evidence). However, some 
inconsistency/heterogeneity between individual studies was found that could not 
be fully explained by variables included in the meta-analysis. It is possible that some 
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that personality traits may be relevant, but these were usually not measured in the 
included RCTs. In any case, the unexplained heterogeneity resulted in downgrading 
the confidence from high to moderate. 
One part of quality of evidence is the amount of (in)directness; if research practice 
is highly similar to clinical practice, estimates are direct (21). This brings us to 
the discussion of the continuum from efficacy to effectiveness. While efficacy is 
the performance of an intervention under ideal circumstances, effectiveness is 
performance under real-world circumstances (22, 23). The RCTs included in our 
meta-analysis fall in different places along this continuum (most more towards 
efficacy) depending on for instance heterogeneity of the population, eligibility 
criteria, and intervention providers (22, 24). To establish efficacy, defined samples, 
high-quality study designs and data analysis, and positive intervention effects 
(including on follow-up) are necessary (25). Thus, in the current research field, efficacy 
seems reasonably established. To establish effectiveness, we also need accessible 
intervention manuals and therapist training, evaluation in real-world circumstances 
(including level of implementation and engagement), practical importance, and 
evidence about to whom beneficial effects can be generalized. Although some 
aspects of effectiveness are established, like intervention manuals and therapist 
training, more work is needed on especially evaluation in real-world circumstances, 
including level of implementation and engagement. 
So although confidence in the effect size of MBIs for cancer is moderate, suggesting 
that the true effect is likely to be close to the estimated effect, there is a possibility 
that the effect size is substantially different. According to the criteria outlined above, 
efficacy is established, but further testing is needed in real-world circumstances to 
establish effectiveness. 
Future research
As described above, we rated the quality of evidence in our meta-analysis as ‘moderate’ 
and not as ‘high’, due to heterogeneity. This underlines the need for continuation 
of high-quality RCTs. Therefore, these trials should have valid randomization and 
allocation, with thorough reporting, blinding whenever possible, and intention to treat 
analyses (26). Furthermore, these RCTs should include comprehensive descriptions 
of design, sample, and intervention. These descriptions can help to pinpoint 
differences between studies that may account for the observed differences in effect 
sizes in our meta-analysis. Preferably, these descriptions would be standardized, for 
instance by using intervention reporting guidelines like TIDieR (27). We and others 
have concluded that reporting quality is currently not optimal (28) regarding, for 
instance, justification of intervention adaptations, adherence to the intervention 
protocol, and trainer quality. Collaborations and research networks can help to 
increase consistency and develop standardized methods of reporting key variables 
that may moderate results.
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Besides explaining observed heterogeneity, steps have to be taken to establish 
the effectiveness of MBIs in addition to efficacy (23, 25). More evaluation of MBIs in 
real-world circumstances is needed. Therefore, internally valid trials in a community 
setting with community clinicians and trainers are an important future step (23). If 
these trials have a high internal validity, they have an additional function, as they 
can also help explain heterogeneity, as addressed in the previous paragraph. 
Furthermore, these trials may include measures on the level of implementation and 
engagement, which can help to optimize future implementation and dissemination. 
Finally, individual patient data meta-analysis is an important alley for future research 
on the (long-term) effects of MBIs. Valuable information is lost when samples and 
outcomes of RCTs are ‘summarized’ to enable a ‘regular’ meta-analysis, while individual 
patient data meta-analyses do not have this issue (29, 30). To conduct these types of 
meta-analyses, a level uniformity in the research field is required. Again, this requires 
the standardization of the descriptions outlined above. Furthermore, outcome 
measures need to be similar, or scores on different outcome measures should be 
converted so they can be combined. Finally, individual patient data meta-analysis 
requires the sharing of data. Online data repositories are increasingly available, and 
should be used more by the scientific community. 
How do MBIs for cancer patients work? 
Possible mediators of MBIs for cancer patients
In our meta-analysis and follow-up paper we found consistent evidence for mindfulness 
skills as a mediator in MBIs for cancer patients. MBIs increase mindfulness skills, 
and in turn, increases in mindfulness skills are related to better outcomes. This is 
consistent with other studies in cancer patients (e.g. 31, 32, 33), and also with a large 
meta-analysis of 20 RCTs in a broader population (34).
In our follow-up study we also found that rumination and fear of cancer recurrence 
were relevant mechanisms. Decreases in rumination and fear of recurrence caused by 
MBCT and eMBCT were related to more beneficial outcomes after the intervention. 
Evidence for the mediating role of rumination has also been found in a large meta-
analysis (34), while evidence for the mediating role of fear of cancer recurrence is 
also reported in another RCT (35). 
In our weekly measures paper, we showed that affect, and negative affect in 
particular, is a mechanism of change in MBCT and eMBCT. We used analyses 
that looked at general tendencies during MBCT and short-term week-to-week 
effects simultaneously. Interestingly, our study showed that relationships between 
mechanisms are not always as simple as they sometimes seem. We observed that 
increases in mindfulness skills were related to decreases in negative affect over 
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more negative affect in a subsequent week. This contrasts with previous findings. 
For instance, Snippe and colleagues (36), reported that in the general population 
daily mindfulness was related to decreased, instead of increased, negative affect the 
subsequent day. Another study found several relationships between mindfulness 
and positive affect, but did not observe week-to-week effects between mindfulness 
and negative affect in recurrently depressed patients (37). 
Besides differences in methodology, our sample may also explain the difference 
in findings. Oncology patients might have put their emotions aside to get through 
the medical anti-cancer treatment (i.e. experiential avoidance) (38). When gently 
addressing these suppressed emotions in MBCT, mindful experiential exposure may 
result in a short-term increase of negative affect compared to avoidance (39, 40). 
In the long run, this exposure may help to extinguish negative affect, supported by 
increases in acceptance, self-compassion, or improved toleration of negative affect 
(41, 42). For depressed patients outside oncology, increases in positive affect may 
be more important as these can help to mitigate depressive symptoms and increase 
savoring (3, 37, 43). In the general population, increases in positive affect may be 
an important mechanism as well (36, 44). Our findings on mindfulness and negative 
affect should be replicated before firm conclusions can be drawn. Notwithstanding, 
mindfulness skills and affect are very likely to play a role in the working mechanisms 
of MBIs, and the relative importance of different working mechanisms may differ 
for various target groups.
The mediation research discussed above relied on self-report questionnaire data. 
In our user data study on eMBCT, we tracked the number of completed written 
assignments (e.g. the recording of pleasant or unpleasant events, or how participants 
experienced the meditation exercises). Completing all assignments (i.e. adherence) 
was related to better outcomes regarding psychological distress and positive mental 
health. Completing assignments in eMBCT may be indicative of actual mindfulness 
practice (doing meditation exercises). This may explain these findings, as more 
meditation practice is linked to improved outcomes in a meta-analysis (19). 
Integration of findings on mediators with the Mindfulness-to-Meaning model
The Mindfulness-to-Meaning model can help to understand how the mechanisms 
described above work and interact (45, 46). Usually, internal or external stressors 
cause negative mental spirals, including negative cognitive appraisal of the stressor, 
negative affect, and activation of negative schemas and memories. Due to the 
increase in mindfulness skills, cancer patients will be able to consciously attend 
to this negative mental spiral, which can initially result in a temporary increase of 
negative affect. This is also what we observed in our weekly measures paper. 
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Subsequently, increased mindfulness skills help with decentering from this negative 
mental spiral. Decentering is the process of achieving psychological distance (47). This 
process can reduce rumination and fear of cancer recurrence; as negative thoughts 
are no longer repeated over and over (i.e. no more cognitive avoidance), anxiety can 
be extinguished (48). Furthermore, decentering helps broaden awareness. It creates 
space for more positive or meaningful appraisals. In turn, it gives room for positive 
affect to be mindfully noticed, and for more functional behavioral responses, thus 
creating a so-called upward spiral (45). 
This process can be illustrated with a simplified case example from Garland and 
colleagues (3). A 63-year old man ‘Jacob’ was recently diagnosed and treated for a 
form of cancer that could be life threatening. He took a few individual mindfulness 
sessions during his anti-cancer treatment. On a certain morning, he found himself 
overwhelmed with feelings of doom, thinking his life was about to end due to the 
cancer. By mindfully attending to his experiences, he noticed the separate thoughts 
drift by, and the tight feelings in his chest. The tight feelings in his chest triggered 
an increased heartbeat, and more anxious thoughts regarding the possible end of 
this life. This resulted in a short-term increase in negative affect. Again, he mindfully 
acknowledged these feelings, and while negative thoughts and feelings continued 
to pop up, they were less intense and less frequent due to decentering. Jacob could 
see his doomful thoughts as a mental event, instead of an established truth. Worry 
and fears could decrease, because they were no longer fed. Jacob’s awareness 
broadened, and he noticed the beautiful view outside his window. He felt happy to 
be alive, to see this view, and to be able to see his grandchildren grow up.
Future research
Thorough research approaches are needed to unravel complex mechanisms of change 
in MBIs for cancer patients. Research is not often applied using methodology similar 
to our weekly measures article, with analyses that simultaneously focus on general 
tendencies and short-term weekly or daily effects. This is important, however, as 
a focus on daily or weekly effects without corrections for general tendencies may 
lead to spurious findings (49). RCTs that include weekly, daily, or even moment-to-
moment assessments (like with experience sampling methodology (ESM); (50)) are 
necessary to learn more about the dynamic interplay of mediating factors and the 
optimal timing of assessments. 
Increasing mindfulness skills seem to be a central mechanism. To better understand the 
relationship between mindfulness skills, mindfulness practice, and beneficial outcomes, 
valid measurements of mindfulness practice are necessary. This is challenging, as 
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mindfulness practice in internet-based MBIs could help, although participants may 
practice mindfulness outside the online program as well. Measuring informal practice 
is even more challenging, as remembering to be mindful in a stressful moment can 
happen in a split second. Again, although it is quite demanding for patients, ESM 
is an interesting tool for studying this in future research.
New in this research field, but possibly also interesting, is a dynamic complex systems 
approach. This approach takes non-linearity as a starting point, and looks at periods 
of variability and stability (51). It requires multiple measurements over time (like those 
obtained with ESM) and looks at individual trajectories, enabling studies with one 
or only a few participants, in contrast to conventional methods of analysis. Finally, 
qualitative research may provide complementary information as well, as the patients 
themselves can tell what worked from their own subjective experience (e.g. 52).
What works best, and for whom?
What MBIs work best?
Meta-analyses are able to provide the best quality evidence to address the moderation 
of intervention effects. In our meta-analysis, all MBIs for cancer patients appeared to 
be adapted versions of MBSR (53, 54) or MBCT (55). However, the programs differed 
in the degree of adaptation. Some trials use MBIs that are only slightly adapted, and 
for instance include some cancer-specific psycho-education. Some trials use more 
extensively adapted programs, for instance by including new constituents or changing 
the dose. Our meta-analysis showed that programs that are only slight adaptations of 
MBSR and MBCT are more beneficial at long-term follow-up, which is in accordance to 
a previous meta-analysis in somatization disorders (56). The difference we observed 
in effects could not be explained by differences in the intervention dose. Adapted 
programs often add extra content to the MBI, for instance an art module, lengthy 
psycho-education modules, or support group elements. If the programs are not 
extended, traditional elements of MBSR and MBCT like mindfulness meditation and 
group discussion may be shortened or even skipped. This may reduce the effects, 
especially since increases in mindfulness skills are often found to be a mediator (this 
thesis and 34). Previous research showed there is no difference between efficacy of 
MBSR and MBCT in this patient group (5).
Besides the content of the MBI, differences in delivery modes exist as well (e.g. group, 
individual, online, face-to-face). Certain delivery modes may work better compared 
to others. Our follow-up study showed eMBCT resulted in slightly better long-term 
outcomes in terms of psychological distress than MBCT. In eMBCT, patients had 
to be more autonomous from the start, which may have helped to better integrate 
mindfulness practice into their lives (19, 57). In addition, the individual nature of the 
feedback could have strengthened their practice as well. Other research directly 
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comparing online, internet-based and ‘offline’ interventions is scarce, especially in the 
field of mindfulness. However, in our own meta-analysis, sensitivity analysis showed 
that the effect sizes did not change when excluding online MBIs, which may indicate 
that effects between online, internet-based, and ‘offline’ MBIs do not greatly differ. 
Despite their benefits, internet-based interventions, like our eMBCT, are often 
associated with more drop-out, compared to face-to-face interventions (2, 58, 
59). Furthermore, our user data study showed that only half of the patients had 
an intended level of activity in the eMBCT. Therefore, it might be important to 
incorporate persuasive techniques to increase engagement when developing an 
online intervention (60). Potential persuasive techniques could be personalization, 
self-monitoring (tracking own performance), or rewards (61).
Who benefits most from MBIs?
To determine whether MBIs are valuable to an individual patient, it is important 
to consider various patient characteristics (62, 63). In our meta-analysis, we found 
that trials including younger patients had somewhat better results in reducing 
psychological distress. Furthermore, participants were relatively young (mean sample 
age: 55 years) compared with the general population of cancer patients (median 
age 66 years at diagnosis (64)). This may suggest that older patients are less likely 
to participate in an MBI, possibly because they are not interested or because they 
are not referred, and they are somewhat less likely to benefit. We did not find other 
significant person-related intervention moderators. As moderators of treatment 
effects are not often studied in meta-analyses (e.g. 5, 7, 8, 65), we have to rely on 
individual RCTs, including our own, that have included a moderation analysis. 
In the follow-up study, we found that less rumination and neuroticism and more 
extraversion and agreeableness at baseline predicted less psychological distress 
at the nine-month follow-up. More extravert and agreeable people may be more 
likely to share their experiences (66). This can help them receive more input from 
others, including their mindfulness trainer, which could enable more and faster 
learning. Research on treatment for depression also showed that personality traits can 
influence treatment outcome (67). Although personality traits are not often measured 
in psycho-oncology, this may be a relevant recommendation for future research. 
Looking specifically at eMBCT in our user data study, we observed that patients 
with high levels of fear of cancer recurrence had difficulties starting with eMBCT. 
It is possible that patients with a high fear of recurrence are more likely to avoid 
participation, as it means being confronted with their fear. This is in line with a 
recent study on online self-help for fear of cancer recurrence that found that most 
patients do not log in or express a need for support (68). As fear of recurrence is an 
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or additional therapist assistance prior to enrollment in an intervention like eMBCT 
(70). It is possible that group MBCT is more suitable to them. Finally, we found that 
conscientious patients were more likely to use eMBCT as intended. This may be 
due to high self-discipline, which is one of the aspects of conscientiousness (71). 
To date, there is no available evidence that suggests that characteristics of the cancer 
(e.g. tumor type, cancer stage, time since diagnosis) relate to outcomes of MBIs (e.g. 
our follow-up study, our meta-analysis, 2, 72). This may imply that a heterogeneous 
group of cancer patients can benefit from MBIs, although it is important not to 
interpret the lack of a statistical difference as equality between different groups. 
What works best for whom? 
In our follow-up study, we integrated the two questions above, to determine what 
intervention works best for which patient. We found that people who are less mindful 
and less conscientious benefited more from eMBCT than from MBCT. It is possible 
that the individual attention of a trainer in eMBCT helped to support these patients. 
The weekly, individual, and personalized feedback from the trainer might encourage 
these patients to complete their homework, while in group MBCT, patients can 
refrain from discussing (the lack of) home practice by letting others in the group 
share their experiences. Furthermore, it is possible that the therapeutic alliance 
is negatively affected in this subgroup of patients. Previous research showed that 
weaker therapeutic alliance in MBCT was related to higher psychological distress 
compared to a weaker therapeutic alliance in eMBCT (73), which could also explain 
our findings. To date, other studies directly comparing what kinds of MBIs work 
best for which patients are lacking, and is an interesting alley for future research. 
Future research
Although internet-based MBIs seem a fair option, especially for some subgroups of 
patients, the downside of these interventions is the increased amount of drop-out, 
compared to face-to-face interventions. Particularly patients with high levels of fear of 
cancer recurrence have difficulties starting with eMBCT. Blended interventions that 
combine online self-study with group sessions guided by a trainer may be suitable 
for this group in particular. In addition, adherence to internet-based MBIs can be 
optimized, for instance by including persuasive techniques (60). Future research may 
focus on developing and testing these types of interventions. Currently, our own 
group is working with relevant stakeholders to develop and pilot test blended MBCT 
and unguided eMBCT that includes persuasive techniques, like personalization and 
progress tracking. The effectiveness of this intervention will be tested in a large RCT.
To make healthcare more personalized, it is essential to determine what intervention 
works best for whom. RCTs in the field could include moderation analyses regarding 
patient characteristics, as a first step. As we found relationships between personality 
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traits and outcomes, it would be interesting to include personality questionnaires 
in future trials. Furthermore, individual patient data meta-analysis may help answer 
moderation questions due to increased power (29). It would also be informative to 
look at head-to-head comparisons of different treatment options in non-inferiority 
trials. For instance, Garland and colleagues found that MBSR and CBT for cancer 
patients with insomnia had comparable effects in the long term, but the effects of 
CBT took place earlier (74). 
Strengths and limitations
Three of the studies in the current thesis are based on data from the BeMind 
project, which is the first large-scale RCT of MBCT and eMBCT in cancer patients in 
the Netherlands (2). The included population is a heterogeneous group of cancer 
patients. The heterogeneous group can be seen as a strength of the current study, 
as most research in this field is focused on breast cancer patients, which limits 
generalizability (28, 75). In addition, the population is self-selected, which can be 
seen as both a strength and limitation. Self-selection fits within the field of psycho-
oncology, because not all patients with psychological complaints want treatment 
(76). This may reduce the gap between research and practice. However, in contrast 
with consecutive sampling, self-selection does not enable calculation of eligible 
patients or response rates, and may over- or underestimate results (77). 
Although the first part of BeMind study is an RCT, patients in the TAU condition 
crossed-over to MBCT or eMBCT after the primary study endpoint, because we did 
not want patients to wait too long before having the opportunity to participate in 
(e)MBCT. Therefore, the follow-up data are uncontrolled. The weekly measures are 
also uncontrolled, as we considered sending control patients weekly mindfulness 
questionnaires to be too burdensome. Due to the absence of data from a control 
group, it is difficult to rule out alternative explanations, like regression to the mean. 
The main aim of the BeMind project was to look at the effects of MBCT and eMBCT 
in comparison to TAU. As such, the sample size was based on this main question. 
Therefore, it is possible we were unable to detect small effects of secondary research 
questions on mediation and moderation. It is not common for RCTs to be powered to 
detect working mechanisms or moderators. However, despite the obvious difficulties 
in collecting larger samples, future studies might need to do so. Individual patient 
data meta-analyses offer an alternative option to create larger samples.
Regarding the meta-analysis, there are some specific strengths and limitations. The 
broad scope can be viewed as both. It helps to increase generalizability towards a 
heterogeneous population of cancer patients and survivors, and different types of 
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outcome suggests that a heterogeneous group of cancer patients can benefit. 
However, the broad scope may challenge the interpretation of the findings due to 
heterogeneity. We were not able to explain all heterogeneity. Finally, conducting 
many analyses, as we did, brings a lot of new knowledge to generate hypotheses 
for future research, but also brings increased risk for a type-I error. 
Clinical implications
This thesis showed that MBIs for cancer patients have small to medium effect sizes 
in reducing psychological distress, with enduring long-term effects. Furthermore, 
(e)MBCT is cost-effective for cancer patients, although more studies on this topic 
are warranted (78). Although harmful effects of MBIs may occur occasionally and are 
an under-researched area in the field, MBIs are relatively safe interventions (79). In 
addition, in healthcare in general there is an increased focus on self-management, 
adaptation, and resilience when facing health challenges; and MBIs fit with this 
trend (80-82). The tradition of mindfulness assumes suffering is part of life, and 
is therefore normalizing and non-pathologizing (54). MBIs do not have a narrow 
focus on complaints, but are rather a trans-diagnostic approach, teaching generic 
skills that help to deal with all kinds of challenges in life (83). These generic skills 
are beneficial for cancer patients and survivors in particular, as psychological and 
physical comorbidities are common (84-86). Finally, MBIs are short, highly structured, 
and protocolized interventions. Various high-quality mindfulness teacher training 
programs are available. This may contribute to successful implementation of MBIs 
in the field, and may help to increase accessibility (25). Although effectiveness is 
not yet fully established, MBIs are a valuable treatment option for cancer patients 
and survivors, and should be considered and available if patients express a need 
for psycho-oncological care. 
Despite the positive outcomes of MBIs, mindfulness practice can be challenging at 
times. Mindfulness trainers have noticed some extent of struggling in their patients 
during MBIs in clinical practice for years (e.g. 79, 87). We have empirically supported 
this notion, as we observed that a short-lived increase in negative affect during MBCT 
is possible. This suggests turning towards (suppressed) negative affect may be a 
mechanism of change. Although replication is necessary before firm conclusions 
can be drawn, this knowledge can help patients to have realistic expectations, and it 
can help trainers to explain why mindfulness training can be challenging for patients 
at times. It is possible that this could prevent early drop-out from MBIs, because 
the feeling among some participants that the MBI is making things worse could be 
seen as a sign that it may actually be starting to work.
Regarding the types of MBIs, we showed that MBIs that closely adhere to the original 
MBSR and MBCT protocols are preferable above highly adapted programs. Internet-
based MBIs are a good option that have their own particular benefits, like increased 
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flexibility and availability (88). However, the downside of these online interventions 
is the increased amount of drop-out, compared to face-to-face interventions. 
Particularly patients with high levels of fear of cancer recurrences have difficulties 
starting with eMBCT. This group needs additional therapist attention at least, but 
they would possibly benefit more from blended interventions that combine online 
self-study with trainer-led group sessions. 
Finally, some patients benefit more from MBIs than others. Although cancer-related 
characteristics (e.g. type, stage, time since diagnosis) do not seem to relate to 
outcomes, age and some personality factors do. MBIs may be especially considered 
for younger patients. Furthermore, patients who score high on agreeableness, 
extraversion, and conscientiousness seem to obtain more beneficial results. Vice 
versa, older patients and patients who score low on these personality traits on a 
pre-intervention screening could be more closely monitored during MBIs. They 
could receive extra attention from the trainer, for instance with a weekly call between 
sessions. In particular patients who are less mindful and conscientious at start could 
benefit from individual attention from a trainer, as was provided in eMBCT. 
All in all, MBIs are a valuable treatment option for cancer patients and survivors, 
and should be considered and available when patients express a need for psycho-
oncological care. To move clinical practice forward, a focus is needed on effectiveness 
and implementation studies in the research field. Furthermore, individual patient 
data meta-analysis and standardization in descriptions and outcome measures can 
help progress the research field, and enable us to learn more about what MBIs work 
for which patients, and in turn inform personalized healthcare. Finally, advanced 
designs, like ESM and complex systems approaches, combined with sophisticated 
data-analysis techniques can help us learn more about the working mechanisms 
of mindfulness. 
Despite being a valuable treatment option, the accessibility of MBIs is not optimal. 
First, based on experiences in the field, not all institutions offer a protocolized MBI 
program, underlining the need for research on implementation. Second, accessibility 
is not optimal due to restrictions in the reimbursement of MBIs for cancer patients. 
MBIs are only reimbursed by health care insurers if cancer patients meet the criteria 
for psychiatric disorders, like a depression or anxiety disorder. However, patients 
without a formal psychiatric diagnosis can also have psychological complaints 
and might also benefit from MBIs. A pilot has therefore been launched to explore 
the broadening of reimbursement (https://www.iknl.nl/survivorship/behandelen/
pilot-aanpassingsstoornis), and will hopefully lead to increased accessibility of 
psycho-oncological care in general and MBIs in particular. We hope that in a not 
too distant future, psycho-social interventions like MBIs will be available to support 
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Inleiding
Het aantal mensen dat te maken krijgt met een kankerdiagnose stijgt al jaren, onder 
andere door vergrijzing en de groeiende wereldpopulatie (1). Door betere screening 
en behandelmethoden, overleven steeds meer mensen kanker (2, 3). Het leven na 
kanker kan uitdagend zijn; één derde tot zelfs de helft van deze mensen krijgt te 
maken met psychische distress (4-6). Psychische distress is een complexe negatieve 
emotionele ervaring op psychologisch, sociaal of spiritueel gebied, bijvoorbeeld 
sombere of depressieve gedachtes, of angstige gevoelen. Dit kan een met effectieve 
coping (omgang) met kanker in de weg kan staan (7). Psychische distress vermindert 
kwaliteit van leven (8), en kan vragen om psychologische behandeling (4). Deze 
behandeling kan bestaan uit een mindfulness interventie (ofwel Mindfulness-based 
interventions, afgekort als ‘MBIs’). 
Mindfulness is een bepaalde vorm van aandacht, namelijk bewust, zonder oordeel 
en gericht op het huidige moment (9). Mindfulness helpt mensen niet samen te 
vallen met negatieve gebeurtenissen, maar deze van een afstandje te bekijken. Zo 
kunnen zij niet-behulpzame automatische reacties herkennen of zelfs voorkomen, 
en bewust een meer behulpzame respons kiezen (10). Mindfulness beoefening komt 
oorspronkelijk uit het Boeddhisme. Op basis hiervan ontwikkelde Jon-Kabat-Zinn, 
moleculair bioloog, de eerste mindfulness interventie, genaamd Mindfulness-Based 
Stress Reduction (MBSR), voor mensen met chronische pijn die onvoldoende baat 
hadden bij reguliere zorg (9, 11). Later werd Mindfulness-Based Cognitieve Therapie 
(MBCT) ontwikkeld, voor mensen die kampen met terugkerende depressies (12). 
MBCT en MBSR lijken veel op elkaar, maar MBCT omvat meer elementen uit de 
cognitieve therapie (13). 
MBIs zoals MBSR en MBCT zijn gewoonlijk gestructureerde groepsinterventies, met 
acht weken lang wekelijkse sessies van 2 tot 2.5 uur. In die sessies is ruimte voor 
mindfulness meditaties, bespreking van ervaringen van deelnemers en psycho-
educatie. Ook is er een stiltedag waarop mindfulness oefeningen centraal staan. 
Dagelijks huiswerk (zo’n 30-60 minuten) is een belangrijk onderdeel van de interventie, 
en bestaat uit mindfulness meditaties, informele mindfulness oefeningen zoals eten 
met aandacht, en reflectie en registratieopdrachten. MBIs worden bij voorkeur 
begeleid door een gekwalificeerde mindfulness trainer, die gezondheidsprofessional 
is en ervaring heeft met de doelgroep in kwestie (14). 
142
Appendix
Evidentie voor mindfulness interventies
Uit een meta-analyse van 142 studies, met meer dan 12.000 deelnemers met een 
psychiatrische stoornis, blijkt dat MBIs beter zijn in het verminderen van psychische 
klachten dan geen behandeling (Cohen’s D = 0.55) en aspecifieke actieve controles 
(D = 0.35), en ongeveer even goed als andere bewezen effectieve interventies 
(15). De eerste meta-analyse bij kankerpatiënten bekeek 9 gerandomiseerde 
trials (16). MBIs zorgden voor vermindering van angst- en depressieve klachten 
(respectievelijk Hedges’s g = 0.37 en 0.44). Dit wordt bevestigd in meer recentere 
meta-analyses (17-20). Echter, de meest uitgebreide meta-analyse is niet meer up-
to-date (16), en recentere meta-analyses zijn veelal beperkt qua deelnemers (bv. 
alleen borstkankerpatiënten) of MBIs (bv. alleen MBSR). Daarnaast kijken deze meta-
analyses niet naar werkingsmechanismen of moderatoren (die de vraag ‘welke MBI 
werkt voor welke patiënt?’ beantwoorden) van MBIs. 
Mechanismen van mindfulness
Over werkingsmechanismen van MBIs is minder bekend dan effectiviteit, terwijl deze 
kennis helpt om MBIs te verbeteren (21, 22). Belangrijke werkingsmechanismen zijn 
vermindering van reactiviteit, de mate waarin een situatie een negatieve gedachte 
of emotie oproept (23), vermindering van piekeren of rumineren en verbetering van 
mindfulness vaardigheden (23, 24). Bij kankerpatiënten is hier nog relatief weinig 
onderzoek naar gedaan. Onderzoek wat wel is gedaan, laat zien dat verbetering 
van mindfulness vaardigheden (25-28) en vermindering van piekeren, rumineren 
en angst voor terugkeer (28, 29) mogelijke mechanismen van MBIs zijn. Volgens de 
Mindfulness-to-Meaning theory (30, 31) zorgen mindfulness vaardigheden ervoor 
dat je jezelf niet langer identificeert met (negatieve) gedachten of gevoelens (de 
Engelse term hiervoor is ‘decentering’). Hierdoor kan de aandacht, die eerst enkel 
gericht was op de negatieve gedachtes of gevoelens, verbreden naar alle ervaringen 
(positief en negatief) van dat moment. Daardoor ontstaat ruimte voor positief affect 
(gevoel), en wordt negatief affect verminderd. Dat draagt weer bij aan verdere 
verbreding van de aandacht, wat weer bijdraagt aan meer mindfulness.
Eerder onderzoek naar mediatoren is vaak beperkt doordat deze onderzoeken 
slechts enkele metingen en simpele modellen gebruiken, die dynamische interacties 
van werkingsmechanismen moeilijk kunnen vangen (21). Daarom maken sommige 
onderzoekers gebruik van meerdere metingen en geavanceerde statistische 
technieken. Hun onderzoek in een gezonde populatie laat zien dat mindfulness op een 
bepaalde dag, zorgt voor meer positief affect en minder negatief affect de volgende 
dag, maar niet andersom (32). Bij depressieve deelnemers bleek mindfulness op 
dit moment samen te hangen met meer positief affect en minder negatief affect op 
een later moment. Andersom bleek meer positief affect en minder negatief affect 
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Wat werkt voor wie?
Naast werkingsmechanismen, is er steeds meer aandacht voor de vraag ‘wat werkt 
voor wie?’, met als doel uit te vinden welke mensen het meeste baat hebben bij welke 
MBIs. Hier is slechts weinig onderzoek naar gedaan, maar er zijn aanwijzingen dat 
kankerpatiënten die hoog scoren op neuroticisme en vermijding meer baat hebben 
bij MBIs (34, 35). Daarnaast zijn er verschillende soorten MBIs, waarvan sommige 
mogelijk effectiever zijn dan anderen (36). Ook wordt er steeds meer gewerkt met 
internet-based mindfulness interventies, bijvoorbeeld via een online platform met 
oefeningen. Deze interventies zijn uiterst flexibel en kunnen beter beschikbaar zijn 
dan reguliere face-to-face MBIs (37, 38). De eerste studies naar internet-based MBIs 
laten positieve effecten zien (35, 39). Kijken welke mensen meer of juist minder baat 
hebben bij internet-based MBIs in vergelijking met face-to-face MBIs, draagt bij aan 
het verwijzen van patiënten naar een voor hen passende MBI. 
In dit proefschrift
Dit proefschrift richt zich op het in kaart brengen van de effecten van MBIs 
bij kankerpatiënten. Daartoe horen drie aspecten, namelijk de effectiviteit, 
werkingsmechanismen en moderatoren (‘wat werkt voor wie?’) van MBIs. In het 
bijzonder is er aandacht voor face-to-face groep MBCT en individuele internet-
based eMBCT. 
In hoofdstuk 2 wordt een uitgebreide meta-analyse beschreven over de effecten 
van MBIs op psychische distress en andere uitkomsten. Twee auteurs zochten 
onafhankelijk in de literatuur, en screenden de 1.804 zoekresultaten. Er werden 
negenentwintig gerandomiseerde trials met volwassen kankerpatiënten (elk type 
en stadium van de kanker en elke tijd sinds diagnose) die gebruikmaakten van een 
interventie met mindfulness als belangrijkste component meegenomen in de meta-
analyse. Samen beschrijven deze gerandomiseerde trials resultaten van meer dan 
3.000 deelnemers. De resultaten lieten kleine positieve effecten zien van MBIs op 
vermindering van psychische distress, zowel meteen na de interventie (Hedges’s 
g = 0.32), als gemiddeld zes maanden na afloop (g = 0.19). Wanneer de studies met 
bewezen effectieve niet werden meegenomen, waren de effecten groter (g = .40). 
Verder werden positieve effecten van MBIs gevonden op angst- en depressieve 
klachten, angst voor terugkeer, vermoeidheid, slaapstoornissen en pijn. Effecten 
van MBIs waren groter wanneer de MBIs leken op MBSR of MBCT (in tegenstelling 
tot MBIs die sterk afweken) en wanneer de deelnemers jonger waren, wanneer er 
een passieve controlegroep was, en de tijd tot follow-up korter. Tot slot zagen we 
dat verbeteringen in mindfulness vaardigheden samenhingen met verminderingen 
in psychische distress. 
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Hoofdstuk 3, 4 en 5 beschrijven secundaire analyses van het BeMind project. BeMind 
is een gerandomiseerde trial over de effecten van face-to-face groepsMBCT en 
individuele internet-based eMBCT in vergelijking met gebruikelijke zorg, waaraan 
verschillende centra in Nederland deelnamen. Kankerpatiënten met minstens 
milde klachten van psychische distress werden via loting toegewezen aan MBCT 
(n = 77), eMBCT (n = 90) of gebruikelijke zorg (n = 78). Na het belangrijkste eindpunt 
drie maanden na de start van het onderzoek, kregen deelnemers die gebruikelijke 
zorg ontvingen, MBCT of eMBCT aangeboden. Uit de primaire resultaten van dit 
onderzoek blijkt dat zowel MBCT als eMBCT psychische distress verminderen in 
vergelijking met gebruikelijke zorg (Cohen’s d, = 0.45 en 0.71, respectievelijk) (35). 
Hoofdstuk 3 focust op de langetermijneffecten van MBCT en eMBCT gedurende 
een follow-up van 9 maanden. Omdat de deelnemers die gebruikelijke zorg kregen 
na drie maanden alsnog MBCT of eMBCT ontvingen, is er geen controlegroep. We 
zagen dat gedurende de follow-up van negen maanden, psychische distress na 
MBCT en eMBCT bleef afnemen. Dit bleek met name het geval bij eMBCT. Bij zowel 
MBCT als eMBCT nam ook rumineren verder af, en positieve mentale gezondheid 
en gezondheids-gerelateerde kwaliteit van leven namen toe. Het lijkt er dus op dat 
patiënten blijven verbeteren in de maanden na MBCT en eMBCT. Verder vonden we 
dat meer van de persoonlijkheidstrekken extraversie en vriendelijkheid samenhingen 
met minder psychische distress op de negen maanden follow-up. Deelnemers die 
minder mindful en consciëntieus waren, hadden op diezelfde follow-up betere 
resultaten als ze aan eMBCT meededen in vergelijking met MBCT. Verbeteringen in 
mindfulness vaardigheden en verminderingen in ruminatie en angst voor terugkeer 
tijdens MBCT en eMBCT hingen samen met vermindering van psychische distress 
tijdens de follow-up periode. 
Hoofdstuk 4 richt zich op de mechanismen achter MBCT en eMBCT met behulp van 
een relatief nieuwe, geavanceerde statistische methode. Hiervoor werden wekelijkse 
metingen van mindfulness vaardigheden, positief affect en negatief affect gebruikt, 
die afgenomen waren tijdens MBCT en eMBCT. In de analyses (‘autoregressive latent 
trajectory models’) bekeken we effecten van week-tot-week en effecten over de 
gehele interventieperiode van MBCT en eMBCT gelijktijdig. We zagen dat tijdens 
de interventies mindfulness vaardigheden en positieve affecten toenamen, terwijl 
negatief affect afnam. Een hoger algemeen niveau van mindfulness vaardigheden 
hing samen met een hoger algemeen niveau van positief affect. In sommige weken 
voorspelde meer positief affect meer mindfulness in de erop volgende week, maar 
andersom, van mindfulness vaardigheden naar positief affect, werden geen relaties 
gevonden. Over de gehele interventieperiode werden relaties tussen het algemene 
niveau van mindfulness vaardigheden en negatief affect gezien, waarbij met name 
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met sterkere afnames in negatief affect. De week-tot-week effecten lieten een ander 
plaatje zien; meer mindfulness vaardigheden deze week, hingen samen met meer 
negatief affect in de volgende week. Het lijkt erop dat mindfulness op korte termijn 
negatief affect kan doen stijgen, mogelijk doordat mensen onderdrukte negatieve 
emoties gaan toelaten. We noemen dat ook wel emotionele ‘exposure’. Op de lange 
termijn hangt mindfulness dan juist samen met minder negatief affect, mogelijk 
doordat er ruimte is voor verwerking van negatieve emoties. 
Hoofdstuk 5 gaat specifiek in op het gebruik van eMBCT, en bekijkt daarom de 
125 deelnemers die eMBCT volgden. Er werden groepen gemaakt op basis van 
intensiteit van gebruik van eMBCT. Met een brede range van demografische en 
kanker-gerelateerde variabelen werden ‘uptake’ (starten met eMBCT) en ‘adherence’ 
(de interventie afmaken) voorspeld. Interventiegebruik werd automatisch bijgehouden 
binnen het eMBCT platform, en bestond uit het aantal log-ins, de totale log-in tijd, 
en de gemiddelde log-in tijd, het aantal verstuurde e-mails en het aantal afgeronde 
opdrachten (reflectie en registratie). 
Gebaseerd op wekelijkse activiteit, werden deelnemers onderverdeeld in ‘niet-
gebruikers’, die geen opdrachten afmaakten in eMBCT (n = 17, 14%); ‘minimale 
gebruikers’, die minstens één opdracht in 1-3 sessies afmaakten (n = 31, 25%), 
‘matige gebruikers’, die minstens één opdracht in 4-7 sessies afmaakten (n = 12, 
10%), en ‘optimale gebruikers’, die minstens één opdracht in 8-9 sessies afmaakten. 
We vonden dat niet-gebruikers een hoger niveau van angst voor terugkeer van 
kanker hadden bij baseline, in vergelijking met gebruikers. Verder vonden we dat 
optimale gebruikers meer consciëntieus waren dan andere gebruikers. Optimale 
gebruikers verminderen ook meer in psychische distress en verbeterden meer in 
positieve mentale gezondheid. 
Discussie
De discussie bespreekt de effectiviteit, werkingsmechanismen en moderatoren 
(‘wat werkt voor wie?’) van MBIs voor mensen met kanker.
Effecten van MBIs bij kankerpatiënten
Onze meta-analyse liet zien dat MBIs effectief zijn in het verminderen van klachten 
van psychische distress, met medium effectgroottes in vergelijking met passieve 
controlegroepen, en kleine effectgroottes wanneer ook andere effectieve interventies 
worden geïncludeerd. Dit is vergelijkbaar met eerdere meta-analyses van specifieke 




Medium effectgroottes zoals wij die vinden, zijn volgens sommige onderzoekers 
indicatief voor klinische relevantie van een interventie (41). Verder zijn de effectgroottes 
ongeveer gelijk aan die van cognitieve gedragstherapie bij kanker (42). Echter, ook 
andere zaken zijn relevant voor klinische relevantie. Zo lieten zowel onze meta-analyse 
als het follow-up artikel positieve effecten op de lange termijn zien. Dit zou kunnen 
komen door doorzetting van mindfulness beoefening na de interventie, of gezonde 
veranderingen in leefstijl die werden getriggerd door deelname aan een MBI. 
Daarnaast is het belangrijk kwaliteit van het bewijs te bekijken. Volgens onze meta-
analyse is de kwaliteit in dit onderzoeksveld ‘medium’ (43). Om de kwaliteit op te 
schroeven naar ‘hoog’, is het noodzakelijk om beter te verklaren waarom effect 
groottes tussen verschillende studies zo verschillen, iets wat niet volledig mogelijk 
was bij onze meta-analyse. Daarnaast blijkt dat veel trials meer kijken naar ‘efficacy’, 
wat de werking onder optimale onderzoeksomstandigheden is, en minder trials zich 
richten op ‘effectiveness’, wat staat voor de werking binnen de normale klinische 
praktijk. Dit laatste is ook belangrijk voor succesvolle implementatie van MBIs in 
de psycho-oncologie. 
Toekomstige onderzoek zou dus kunnen bestaan uit trials die zich richten op 
‘effectiveness’. Wanneer deze van hoge kwaliteit zijn (met degelijke randomisatie, 
beschrijvingen en analyses), kunnen die ook gebruikt worden om verschillen tussen 
trials verder te verklaren. Meer uniformiteit in uitkomstmaten en beschrijvingen 
van de MBIs kan daar ook aan bijdragen. Samenwerking tussen verschillende 
onderzoeksinstituten die zich toeleggen op MBIs voor kankerpatiënten is hiervoor 
van belang. 
Werkingsmechanismen van MBIs bij kanker
We vonden in onze meta-analyse en follow-up studie dat verbetering van mindfulness 
vaardigheden een belangrijk mechanisme van MBIs is. Uit de follow-up studie 
kwam daarnaast ook dat vermindering van ruminatie en angst voor terugkeer 
werkingsmechanismen zijn. Dit komt overeen met eerder onderzoek bij kankerpatiënten 
en in een bredere populatie (bv. 23, 27, 44). Uit ons wekelijkse metingen paper bleek 
verder dat affect, en met name negatief affect, ook een relevant werkingsmechanisme is.
De relatie tussen mindfulness en negatief affect bleek tweeledig. Op de korte termijn 
zorgden mindfulness vaardigheden voor een stijging in negatief affect, mogelijk 
doordat patiënten negatieve emoties, die zij eerder onderdrukten, nu toelieten 
(45). Op de lange termijn zou deze vorm van ‘exposure’, ofwel het onder ogen zien 
van deze emoties, behulpzaam kunnen zijn (46). Hierdoor sudderen deze negatieve 
emoties niet langer onder de oppervlakte, wat veel energie kost, maar ontstaat 
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van negatief affect wanneer mindfulness vaardigheden verbeterden. Deze resultaten 
komen niet geheel overeen met eerdere onderzoeken in andere doelgroepen (32, 
47). Mogelijk komt dat doordat juist kankerpatiënten veel onderdrukte negatieve 
emoties hebben, omdat zij op een soort ‘overlevingsstand’ door de fase van anti-
kankerbehandeling gaan, waarin soms weinig ruimte is voor emoties en verwerking. 
Met de Mindfulness-to-Meaning theorie kunnen deze resultaten verklaard worden 
(30, 31). Interne of externe stressoren zorgen gewoonlijk voor een negatieve spiraal 
met negatieve emoties en gedachtes. Mindfulness vaardigheden helpen hier bewust 
van te worden, wat kan leiden tot een tijdelijke stijging van negatief affect. Aandacht 
wordt dan verbreed (‘decentering’ van de negatieve spiraal) zodat er ook ruimte 
is voor positief affect en andere ervaringen, en de cirkel van piekeren, rumineren 
rumineren en angst voor terugkeer doorbroken wordt. 
Vervolgonderzoek naar mechanismen kan gebruik maken van meerdere metingen 
(eventueel zelfs van moment tot moment met event sampling methodology (48)). 
Geavanceerde statistische analyses zijn daarbij noodzakelijk. 
Wat werkt voor wie?
We vonden dat interventies die sterk lijken op de oorspronkelijke MBSR en MBCT 
betere resultaten boekten dan interventies die daar sterk vanaf weken, mogelijk 
doordat daar minder mindfulness beoefening in zit. Ook zagen we dat op de lange 
termijn eMBCT iets beter werkt dan MBCT, en dan met name voor mensen die minder 
mindful en consciëntieus zijn. Mogelijk past de individuele opzet in combinatie met 
de persoonlijke feedback deze deelnemers beter. Wel zagen we dat mensen met 
grotere angst voor terugkeer van kanker bij aanvang meer moeite hadden met 
eMBCT te starten. Zij hebben mogelijk meer begeleiding nodig, of juist eerder een 
reguliere groepsMBCT. Ook bleek dat ongeveer de helft van de mensen eMBCT zo 
gebruikte als bedoeld was, wat suggereert dat toekomstige interventies gebruik 
zouden kunnen maken van technologieën die gebruik optimaliseren (bv. reminders 
of personalisatie). 
Jongere patiënten hebben mogelijk wat meer baat bij MBIs. In onze meta-analyse 
vonden we geen aanwijzingen dat kankertype, stadium of tijd sinds diagnose 
samenhingen met de resultaten, wat suggereert dat MBIs voor een brede groep 
mensen met kanker behulpzaam zouden kunnen zijn. In de follow-up studie bleek 
dat deelnemers die extraverter en vriendelijker waren, betere resultaten behaalden. 
Deelnemers die meer consciëntieus zijn, hadden meer kans eMBCT af te ronden, 
wat ook weer samenhing met betere resultaten. 
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Vervolgonderzoek zou zich dus kunnen richten op persoonlijkheidsfacetten als 
potentiële moderatoren, iets wat nu weinig gedaan wordt. Vergelijkende studies 
van verschillende MBIs, of MBIs met andere interventies kunnen helpen psycho-
oncologie meer ‘personalized’ te maken. 
Sterke kanten en beperkingen
Het BeMind project heeft een zelf-geselecteerde steekproef, wat zowel pluspunten 
heeft (dicht bij klinische praktijk) als minpunten (over- of onderschatting resultaten, 
bijvoorbeeld doordat alleen mensen meedoen die zelf actief op zoek naar een MBI 
en dus positieve verwachtingen hebben). Daarnaast mist een controlegroep, en was 
er minder power om kleine effecten te detecteren in deze secondaire studies. Onze 
meta-analyse was zeer uitgebreid qua inclusiecriteria, wat generaliseerbaarheid ten 
goede komt. Echter maakte dit ook dat we veel verschillen vonden tussen studies, 
die zich moeilijk lieten verklaren. 
Klinische implicaties
MBIs zijn effectieve interventies voor een brede range van kankerpatiënten, zowel 
op korte als lange termijn. Verder bleek uit ander onderzoek met de BeMind data 
dat MBCT en eMBCT kosteneffectief zijn (49). MBIs passen in de focus van huidige 
gezondheidszorg, die zich richt op veerkrachtig omgaan met de lichamelijke en 
mentale uitdagingen van het leven (50). De korte en gestructureerde aard en 
beschikbaarheid van gedegen opleidingen tot mindfulness trainer maakt dat ze 
geschikt zijn voor succesvolle implementatie. Ondanks dat de werking in de gewone 
klinische praktijk nog verder onderzocht mag worden, zijn MBIs een waardevolle 
behandeloptie voor mensen die kanker hebben of hadden, en last hebben van 
psychische distress. MBIs zouden voor deze groep beschikbaar moeten zijn. 
Verder is relevant voor de klinische praktijk dat MBIs kortdurend negatief affect 
kunnen verhogen (1), dat programma’s die sterk lijken op MBSR en MBCT de 
voorkeur genieten (2), dat internet-based MBIs ook heel effectief kunnen zijn, juist 
voor mensen die minder mindful en conscientieus zijn, maar juist niet voor mensen 
met veel angst voor terugkeer omdat zij een grote drempel ervaren om te starten 
(3). Tot slot zien we dat variabelen gerelateerd aan de kanker niet samen lijken te 
hangen met de effectiviteit, maar sommige persoonlijkheidsaspecten (vriendelijkheid, 
consciëntieus zijn en extraversie) en leeftijd juist wel (4). 
De beschikbaarheid van MBIs in de klinische praktijk is niet optimaal, onder andere 
door beperkte vergoeding vanuit de zorgverzekering. Wij hopen dat psycho-
sociale interventies zoals MBIs in de toekomst beschikbaar zijn voor iedereen die 
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Dankwoord
Het promotieonderzoek waaruit dit proefschrift is voortgekomen, ging vloeiend en 
soepel van start. Het follow-up artikel, nu hoofdstuk 3, stond binnen enkele maanden 
en werd met minimale aanpassing bijna gelijk bij het tweede tijdschrift geaccepteerd. 
En ook de andere artikelen volgden elkaar in een prima tempo op. Tot het einde in 
zicht kwam. Die beruchte laatste loodjes. Zoveel leuke andere werkzaamheden die 
tijd en aandacht vroegen, waardoor er weinig tijd overbleef voor dit proefschrift. 
Daarnaast verwelkomden mijn man en ik ons ons zoontje Max, en ik hoef niemand 
te vertellen wat de voorkeur geniet als je kan kiezen tussen met je baby lummelen 
of voor de honderdste keer je discussie herschrijven. Maar er ligt een boekje in jouw 
handen, dus het is goed gekomen! 
Mijn promotieteam staat natuurlijk aan de basis hiervan. Allereerst Anne. Ik weet 
nog goed hoe verbaasd je keek toen ik na een maand of twee aangaf dat ik me 
regelmatig verveelde onder werktijd, en dat ik me dan alleen voelde ik dat kleine 
kantoortje rechtsachter. Ik kreeg leuke extra werkzaamheden, mocht anderen 
helpen met hun analyses en artikelen, mocht mee gaan draaien in onderwijs, en 
zo veel meer. Bedankt voor jouw vertrouwen daarin. Ik bracht natuurlijk al veel 
wetenschappelijke vaardigheden mee, maar heb op andere terreinen veel bij kunnen 
leren, en ben de afgelopen jaren gegroeid naar mijn huidige functie als postdoc (én 
psycholoog én mindfulness trainer én docent). Ik waardeer jouw open en eerlijke 
communicatie enorm (oké, meestal dan). Jij houdt niet alleen mijzelf, maar ook de 
rest van het promotieteam scherp, en dat is de kwaliteit van dit proefschrift zeker 
ten goede gekomen. Wat ik erg bijzonder vind, is hoe je meedenkt en meehelpt 
om mijn ambities waar te maken. Ook daarvoor; enorm bedankt. 
Dan Monique. Vrij snel na de start van mijn promotietraject moesten we op zoek 
naar een nieuwe dagelijks begeleider. Ik bevond mezelf in de luxe positie dat ik 
daarover mocht meebeslissen. Anne had allerlei (ongetwijfeld goede) suggesties, 
maar ik had natuurlijk allang bedacht dat ik jou wilde vragen. Jij begeleidde 
me al bij mijn masterscriptie in de research master, en ik heb genoten van onze 
samenwerking destijds. Wat was ik blij toen je toezegde dat je me ook graag tijdens 
mijn promotietraject wilde begeleiden. En ook later ben ik daar nog heel vaak blij 
mee geweest. Ik vind je een enorm goede onderzoeker. Je noemt altijd precies die 
dingen, waar niemand nog aan had gedacht, en die we overduidelijk wel moesten 
meenemen. Nog fijner vond ik het, dat we samen konden praten over hoe het écht 
ging, en wat ik écht nodig had. Je hielp me enorm niet te verzanden in al die leuke 




Marije sluit als derde lid van mijn promotieteam. Vanuit het Helen Dowling Instituut 
in Bilthoven was je wat meer op de achtergrond betrokken, maar daardoor zeker 
niet minder waardevol. Wat voelde ik me altijd welkom als ik vanuit Nijmegen naar 
Bilthoven was afgereisd, naar jullie prachtige locatie in het bos. Je zorgde ervoor dat 
ik over mijn onderzoek kon vertellen aan de behandelaren, en gaf me een kijkje in 
de keuken van de psycho-oncologische zorg. Daardoor kreeg ik veel meer gevoel 
en achtergrond bij de al dan niet significante p-waardes die uit de analyses kwamen. 
Met name wanneer we sparden over de interpretatie van diezelfde p-waardes, was 
je op dreef. Mooi hoe jij die psycho-oncologische zorg als het ware belichaamt, 
om maar in de mindfulness terminologie te blijven. Ik heb daar veel van geleerd, 
en het motiveert me om in mijn nieuwe projecten steeds de koppeling te zoeken 
met de praktijk. 
Dan gaat mijn dank uit naar al die andere collega’s die direct betrokken waren bij 
dit onderzoeksproject. Melanie, bedankt dat je me wegwijs hebt gemaakt op het 
Centrum, en me heb geholpen bij die vliegende start. Bill, thank you for the help 
with the stats of these complicated (in our article we call it sophisticated; it’s all about 
framing) autoregressive latent trajectory models. Rogier Donders, ook jij bedankt 
voor de statistiekhulp. Bobby and Maja from Aarhus University in Denmark, thank 
you for teaching me all about meta-analyses, and for the pleasant stay in Aarhus. I 
enjoyed our visit at the food market together! 
Speciale dank gaat uit naar Félix en Else. Jullie hebben het BeMind onderzoek, waarvan 
ik de data heb gebruikt voor een groot deel van mijn proefschrift, uitgevoerd, en al 
het vele werk gedaan wat komt kijken bij het managen van zo’n grote multicenter 
RCT. Ik zie deze BeMind data een beetje als jullie kindje, en heb mijn uiterste best 
gedaan om er net zo goed voor te zorgen als jullie hebben gedaan. Bedankt dat ik 
jullie vele vragen mocht (en mag) stellen. Het BeMind onderzoek was er niet geweest 
zonder de subsidie van Pink Ribbon/KWF. Ik was nog volop met mijn studie bezig 
toen het BeMind onderzoek startte, maar ken de verhalen over de moeizame start, 
doordat vergoeding voor mindfulness uit de basisverzekering verdween. Daarom 
dank aan alle trainers die de MBCT verzorgden, ondanks slechts een kleine financiële 
vergoeding. En ook veel dank aan alle deelnemers, die al die vragenlijsten trouw 
hebben ingevuld. Uiteindelijk gaat het om jullie, dat jullie passende ondersteuning 
krijgen wanneer dat nodig is. 
Dan zijn de collega’s aan de beurt die niet direct bij het promotie onderzoek betrokken 
waren, maar zeker net zo noodzakelijk voor het slagen daarvan. En natuurlijk noem 
ik daarbij Imke als eerste. Im, wat was ik blij dat jij bij het Centrum kwam werken. 
Ik zat dus eenzaam in dat kamertje rechtsachter, maar toen jij er was, verhuisde ik 
al snel naar jou, op de onderzoekerskamer. We verschillen bijna als water en vuur, 
maar we klikten gelijk. We hebben zo ongeveer alle emoties die er bestaan met 
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vermanend toe als we nu écht moesten stoppen met praten en gaan werken (sorry 
Anne). Jij bent een belangrijke reden waarom ik heb altijd zo naar mijn zin heb op 
werk. Ik mis jouw nuchtere aanwezigheid in dit thuiswerktijdperk. Bedankt dat jij 
mijn paranimf bent!
In elk proefschrift van het Centrum voor Mindfulness staat een lovend stukje over 
de dames van het secretariaat, Kelly, Ramona en Irma. En dat is niet voor niks. Jullie 
leveren fantastische ondersteuning, én zorgen ervoor dat het Centrum een warm 
bad is. Hoe druk het ook is bij jullie, er is altijd even ruimte te vragen hoe het gaat, 
en even van je af te praten als dat nodig is. Bedankt voor al jullie meelevende steun! 
Tjipco, Rhoda en Else, ik heb ervan genoten om jullie te helpen met jullie artikelen. 
Jullie delen met elkaar dat statistiek een struikelblok is, én dat jullie desondanks 
niet bang zijn om erin te duiken. En dat kan ik dan weer enorm waarderen. Fijn om 
samen in SPSS rond te neuzen en de data te laten spreken. 
Speciale dank ook aan Nicole en Coen, mijn opleiders tot mindfulness trainer. Ik ging 
erin om mindfulness trainer te worden, en ik kwam eruit als een ‘rijper en steviger’ 
mens. Renée, ook bedankt voor jouw bijdrage hierin, het was fijn onder jouw nuchtere 
en stevige vleugel samen mijn eerste MBCT groep te geven.
Daarnaast ook veel dank aan al die andere fijne collega’s. Marleen, we starten tegelijk, 
en zijn (bijna) tegelijk klaar. Zoals ik pas al eens tegen je zei, ik vind het inspirerend 
hoe authentiek jij bent, in al jouw keuzes. Karen, wat een heerlijke symbiose om 
samen te werken; ik leer van de klinische praktijk, en jij van onderzoek. Mette, wat 
leuk om jou te mogen begeleiden bij het Buddy project, de opvolger van BeMind. 
Marloes, Dirk, Ellen, Rinie, Annelieke, Jelle, en oud-collega’s Félix, Carolien, Wendy, 
Kiki, Hanne, Mira, Lotte, bedankt voor alle collegiale steun. 
Het werkgerelateerde gedeelte van het leven kan alleen goed gaan, als het privé 
ook goed zit. Hoewel ik me besef dat ik niet zo veel praat over mijn werk (en zeker 
niet als het goed gaat, meestal alleen als ik wat te klagen heb), zijn jullie onmisbaar 
geweest in het slagen van dit project. Allereerst al mijn lieve vriendinnen. Sanne, 
wat hebben wij een geschiedenis samen. Allebei paardenmeisjes, maar wel van 
het nuchtere soort (en jij meer dan ik). Van stappen tot de vroege ochtend, katers 
uitslapen in jouw of mijn bed, die beruchte pan, naar het meer serieuze leven, met 
man en vriend, een baan, cavia’s (in mijn geval), een hond (in jouw geval) én allebei 
een zoontje die elkaar nog geen half jaartje schelen. Op naar de volgende levensfase, 
samen met de boys de herrie in de binnenspeeltuin verdragen. En nog steeds rijden 
we samen paard, en ik hoop dat we dat altijd mogen blijven doen. Bedankt dat je 
er altijd voor me bent, en niks je te gek is! 
Lieve meiden van de research master, Annick, Ilse en Steffi, jullie weten uit eigen 
ervaring hoe het is een promotie traject te doen. Wat fijn om daarover te kunnen 
praten. Annick en Ilse, onze wilde haren zijn langzaam wat uitgevallen, maar we 
moeten als kersverse (bijna) moeders onze Steffi maar volgen, die zorgt dat we 
jong blijven en niet teveel vervallen in burgelijke meuk. Fijn dat we samen over 
echt alles kunnen praten. Annick, wij deelden samen een kantoor en begeleider 
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(dat was Monique) tijdens de research master, en de cirkel is rond nu jij ook mijn 
paranimf wil zijn!
En dan die andere paardenmeiskes; Dimphy, Lisa en Michelle. Jeetje, wat kennen 
wij elkaar ook al lang! Soms mis ik nog steeds die onbezorgde tijden samen op 
manege de Horst, en op zaterdagmiddag altijd frietjes halen bij de cafetaria om de 
hoek. Toen er nog tijd was om vier, vijf, of zelfs zes keer in de week met de paarden 
bezig te zijn. Helaas hebben we dit jaar carnaval samen moeten missen, maar ook 
buiten dat, hou ik van onze avondjes samen, met altijd enorme verwennerij aan 
eten. En Dimf, nu heb ik de kans; heel erg bedankt dat jij samen met Niels de rol van 
ceremoniemeester wilde vervullen bij onze bruiloft. Het was fantastisch!
Anne, Naomi, Tara en Aukje, mijn psychologievriendinnen. Samen vlogen we de 
studie door, al werd dat af en toe gehinderd door, jawel, meer stapavonden. We zien 
elkaar nu een stuk minder, maar als we samenzijn, is het als vanouds. Anne (en ja, 
ook Frank) in het speciaal bedankt voor onze fijne gesprekken, en al jullie te gekke 
demo’s van de nieuwste gadgets.
Kim, ook jij weet uit eerste hand hoe het is een promotietraject te doen, en begrijpt 
me als geen ander. Op naar veel fijne wandelingen! 
Dan ook Jaspers vrienden en ‘aanhang’; wat is het leuk en fijn dicht bij elkaar in de 
buurt te wonen en in dezelfde levensfase te zitten. Dat onze kinderen maar veel 
samen mogen spelen, terwijl wij koffie of een drankje leuten. 
Tot slot ook dank aan alle lieve stalgenootjes, voor alle kletspraatjes over onze 
paardenkinderen en andere dingen. Tijdens een ritje op Blukkie is mindfulness 
bijna vanzelfsprekend, en verdwijnt de dagelijkse sores naar de achtergrond. Ik 
kom altijd vol energie weer thuis.   
En dan mijn lieve familie. Alle leden van de grote (en groeiende) familie Cillessen, 
in deze tijden zien we elkaar te weinig. Hopelijk lukt het volgende zomer weer een 
familiedag te plannen. Wie neemt de organisatie op zich? Daarbij missen we opa 
en oma Cillessen, allebei al jaren overleden. Opa, die me altijd stiekem stukken brie 
voerde toen ik klein was, en oma, die me het vertrouwen gaf dat gebroken harten 
helen, toen ik ouder was. 
Zo’n familiedag is wellicht ook een leuke nieuwe traditie voor de Theunissenkant. 
Ome Henk en tante Rosé, heerlijk om familie in de straat te hebben wonen tijdens 
mijn jeugd. Naast het spelen met Peter en Tomas, genoot ik er altijd van om de 
hond Pepper uit te laten. Wat waren mijn basisschoolvriendinnetjes jaloers. En 
wat een geluk dat opa en oma naast ons woonden! Opa, altijd als ik geen zin had 
in school, riep je dat ik naar het ‘schoolpaleis’ mocht. Je bouwde een elektrische 
scooter voor me (weer waren die basisschoolvriendinnetjes jaloers) én plantte 
me regelmatig tussen de bloemen voor een fotoshoot. Je hebt ons veel te vroeg 
onverwacht verlaten. Oma, bij jou kon ik altijd terecht voor een praatje mét snoep, 
en dan met name chocola. De achterdeur stond altijd open. Ongelofelijk wat een 
kracht jij altijd toonde, ondanks de moeilijke tijden in het leven. Sinds kort moeten 
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Dan de schoonfamilie. Waar mijn gezin van oorsprong klein is, is Jaspers gezin juist 
gezellig groot! Wat is het leuk om zoveel zwagers en schoonzussen te hebben. Daan 
en Eva, Marc en Franca, heerlijk om jullie uni verhalen te horen; ik mis die tijden 
weleens (viel dat al op uit dat stuk hierboven?). Thijs, jij bent de stoerste oom voor 
Max met het kleinste hartje. Geweldig hoe jij ons altijd helpt als we (weer) geen 
idee hebben op klusgebied. Leuk om Inge nu naast jouw zij te zien, welkom in de 
familie! Sophie en Rutger, dank voor het oppassen op Max, alle sterke verhalen én 
de onbetaalbare blik op Jaspers gezicht bij zijn laatste kerstcadeau. Schoonouders 
Hans en Judith, fijn om altijd bij jullie aan te mogen schuiven voor het eten en 
gezelligheid, ook al hebben we daar het afgelopen jaar veel te weinig gebruik van 
kunnen maken. Bedankt voor alle oprechte interesse in de stand van zaken met 
betrekking tot dit proefschrift. Schoonmoeder Ingeborg, je weet precies wat je in 
huis moet halen als we op bezoek komen. Als iets niet lekker loopt, ben je er met 
oprechte steun, ik waardeer jouw eerlijkheid. Fantastisch om te zien hoe jullie drie 
de nieuwe rol als grootouder vervullen. 
En dan zijn jullie aan de beurt, lieve mam en pap. Jullie leerden mij als geen ander 
met beide benen op de grond te blijven staan. Dat het de kleine dingen zijn die 
tellen. Ik kijk terug op een fantastische, warme en veilige jeugd, en waar ik dit altijd 
als vanzelfsprekend heb beschouwd, besef ik me in mijn werk als psycholoog nu 
steeds meer hoe dat mij de wind in de zeilen heeft gegeven. Jullie staan altijd voor 
mij, voor ons, klaar. Of we onszelf nu (weer) buiten hebben gesloten, van huis weg 
zijn gegaan zonder te weten of het lijmpistool wel uit het stopcontact is (nee beste 
lezer, dat bleek niet het geval) of voor een opbeurend belletje op de late avond. 
Zonder jullie had dit proefschrift er niet gelegen. De 60 inmiddels gepasseerd, 
en ik gun jullie nog zoveel genieten. Bedankt voor jullie liefdevolle zorg voor Max. 
En dan mijn eigen gezin. Lieve Jasper, lieve Max.  De liefde die ik voor jullie voel is 
met geen pen te beschrijven. Jas, we delen onze liefde en passie voor de natuur, voor 
onze medemens én houden van dezelfde Netflix series. We vullen elkaar aan; jij hebt 
de gunfactor, ik de octocore. Het ouderschap heeft ons een spiegel voorgehouden, 
en ons, en onze relatie, nog meer doen groeien. Je houdt me scherp, en zegt waar 
het op staat. Jij bent in voor de meeste van mijn gekke ideeën (behalve die duurzame 
tandpasta tabletten), en ik voor de meest van de jouwe (nee, we nemen geen grotere 
TV). Je bent mijn grote liefde, mijn allerbeste maatje, en we doen het leven samen. 
Dat leven dwarrelt om jou heen, jouw vrolijkheid en lichtheid doen niet alleen mijn 
hart smelten. Ik voel me een gezegend mens, dat ik mijn leven met jou mag leven. 
Bedankt dat ik kan zijn wie ik ben, en dat jij bent wie je bent. 
En dan onze Max. Tijdens de zwangerschap leerde je me al wat mildheid is; dat 
proefschrift zakte genadeloos op de prioriteitenlijst, en dat was oké. En lieve Max, 
wat is het toch intens om dan ineens ouder te zijn van zo’n hulpeloos klein wezentje! 
Je bent geboren met de vrolijke lichtheid van je vader, en de felheid van je moeder. 
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Heerlijk om te zien hoe jij groeit en de wereld ontdekt. Eindeloos rondkijken, 
onderzoeken en eten zijn jouw passies, slapen is dat helaas niet. Wat voor nog wat 
vertraging bij dit proefschrift zorgde, en ook dat was oké. Ik hoop, lieve Max, dat jij 
in jouw leven kan genieten van de grote en kleine dingen, dat je een tevreden mens 
zal zijn, dat je geluk mag hebben en mild zal zijn voor de wereld om jou heen, en 
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Activities + conferences Hours 
Supervisor Master Thesis student Gezondheidspsychologie 25
Coordinator and Tutor Mindfulness for (bio)medical professionals 45
Coordinator and Teacher Research Skills 25
Member and presenter Gammaraad psychosociale oncolgie 30
Attendee and presenter Grand Round Radboudumc Psychiatrie 100
Member and presenter research meeting and journal club Centre for Mindfulness 75
Attendee and presenter journal club psychosociale oncologie 20
Attendee and presenter Donders stress meeting 15
Attendee Donders Discussions 16
Research visit Aarhus University, Denmark 80
Reviewer for journals BMJ open, Journal of Medical Internet Research,  
Pain Medicine, Motivation and Emotions. 
21
Cursus Loopbaanmanagement voor promovendi 56
Cursus Netwerken en solliciteren 56
International Conference on Mindfulness 2018 Amsterdam (11-13 july 2018) 28
NVvP voorjaarscongres Maastricht 2019 (4-3-2019) 8
Conferentie HIPEC, Rotterdam (18-6-2019) 4
Landelijk Mindfulness Symposium (4-10-2019) 35
International conference on Emotions, well-being, and health (18-10-2019) 8
NISPA dag (7-11-2019) 4
Verenging cognitieve gedragstherapie najaarscongres (28-11-2019) 10
Landelijk Mindfulness Symposium (2-10-2020) 10
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Courses ECTS
Donders Graduate School Introduction Day October 2017
Achieving your goals January 2018 1.5
Basiscursus Regelgeving en Organisatie voor Klinisch on-
derzoekers (BROK)
February 2018 1.8
Projectmanagement voor promovendi February 2018 2
Presentation Skills April 2018 1.5
Qualitative research methods May 2018 3
Effective writing methods October 2018 3
Analytic Storytelling December 2018 1
Perfecting your academic writing skills February 2019 1.5
Education in a nutshell January 2019 1
Science Journalism March 2019 3
Scientific Integrity (Radboudumc) May 2019 0.7
Grant writing and presenting for funding committees November 2019 1
Graduate School day 2x June 2018 & July 
2020
0.7




This thesis is based on the results of human studies, which were conducted in 
accordance with the principles of the Declaration of Helsinki. 
The medical and ethical review board Committee on Research Involving Human 
Subjects Region Arnhem Nijmegen, Nijmegen, The Netherlands has given approval 
to conduct the BeMind project (CMO Arnhem – Nijmegen 2013/542). The BeMind 
project is stored on the Radboudumc, department server: (H:)PSYdata$ in the folder: 
H:\Research\BeMind. The patient data for the analyses of the studies as presented 
in chapter 3, 4 and 5 are stored on this departments’ H-drive in a secured folder 
specifically for this project to which access is only granted to authorized personnel, 
as to be determined by the management of the department of Psychiatry. 
All paper informed consent forms are stored in a locked cabinet at the Centre for 
Mindfulness. Data management and monitoring were performed using a Microsoft 
Excel file which is also stored in the secured folder on the department server. An 
audit trail was incorporated to provide evidence of the activities that has altered 
the original data. The privacy of the participants in this study is warranted by use 
of encrypted and unique individual subject codes. This code correspondents with 
the code used in the patient report forms. The code was stored separately from 
the study data in a separate folder on the department server. Patient report forms 
were converged from Surveymonkey to SPSS (SPSS Inc., Chicago, Illinois, USA). The 
original Surveymonkey files are also available. 
The data will be saved for 15 years after termination of the study (December 21, 2015). 
Using these patient data in future research is only possible after a renewed permission 
by the patient as recorded in the informed consent. The datasets analyzed during 
these studies are available from the corresponding author on reasonable request.
The meta-analysis described in chapter 2 is stored on the Radboudumc, department 
server (H:)PSYdata$. There were no data from individual patients involved in 
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Donders Graduate School for Cognitive 
Neuroscience
For a successful research Institute, it is vital to train the next generation of young 
scientists. To achieve this goal, the Donders Institute for Brain, Cognition and 
Behaviour established the Donders Graduate School for Cognitive Neuroscience 
(DGCN), which was officially recognised as a national graduate school in 2009. The 
Graduate School covers training at both Master’s and PhD level and provides an 
excellent educational context fully aligned with the research programme of the 
Donders Institute. 
The school successfully attracts highly talented national and international students 
in biology, physics, psycholinguistics, psychology, behavioral science, medicine 
and related disciplines. Selective admission and assessment centers guarantee the 
enrolment of the best and most motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni 
show a continuation in academia with postdoc positions at top institutes worldwide, 
e.g. Stanford University, University of Oxford, University of Cambridge, UCL London, 
MPI Leipzig, Hanyang University in South Korea, NTNU Norway, University of Illinois, 
North Western University, Northeastern University in Boston, ETH Zürich, University 
of Vienna etc.. Positions outside academia spread among the following sectors: 
specialists in a medical environment, mainly in genetics, geriatrics, psychiatry 
and neurology. Specialists in a psychological environment, e.g. as specialist in 
neuropsychology, psychological diagnostics or therapy. Positions in higher education 
as coordinators or lecturers. A smaller percentage enters business as research 
consultants, analysts or head of research and development. Fewer graduates stay 
in a research environment as lab coordinators, technical support or policy advisors. 
Upcoming possibilities are positions in the IT sector and management position in 
pharmaceutical industry. In general, the PhDs graduates almost invariably continue 
with high-quality positions that play an important role in our knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please 
visit: https://www.ru.nl/donders/graduate-school/phd/
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